<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Drug‐eluting balloon angioplasty versus uncoated balloon angioplasty for peripheral arterial disease of the lower limbs - Kayssi, A - 2016 | Cochrane Library</title> <meta content="Drug‐eluting balloon angioplasty versus uncoated balloon angioplasty for peripheral arterial disease of the lower limbs - Kayssi, A - 2016 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011319.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Drug‐eluting balloon angioplasty versus uncoated balloon angioplasty for peripheral arterial disease of the lower limbs - Kayssi, A - 2016 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011319.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD011319.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Drug‐eluting balloon angioplasty versus uncoated balloon angioplasty for peripheral arterial disease of the lower limbs" name="citation_title"/> <meta content="Ahmed Kayssi" name="citation_author"/> <meta content="University of Toronto" name="citation_author_institution"/> <meta content="ahmed.kayssi@mail.utoronto.ca" name="citation_author_email"/> <meta content="Talal Al‐Atassi" name="citation_author"/> <meta content="University of Ottawa Heart Institute" name="citation_author_institution"/> <meta content="George Oreopoulos" name="citation_author"/> <meta content="University of Toronto" name="citation_author_institution"/> <meta content="Graham Roche‐Nagle" name="citation_author"/> <meta content="University of Toronto" name="citation_author_institution"/> <meta content="Kong Teng Tan" name="citation_author"/> <meta content="University of Toronto" name="citation_author_institution"/> <meta content="Dheeraj K Rajan" name="citation_author"/> <meta content="University of Toronto" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="8" name="citation_issue"/> <meta content="10.1002/14651858.CD011319.pub2" name="citation_doi"/> <meta content="2016" name="citation_date"/> <meta content="2016/08/04" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011319.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011319.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011319.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Amputation, Surgical [statistics &amp; numerical data]; Angioplasty, Balloon [*methods, mortality]; Drug‐Eluting Stents; Femoral Artery; Lower Extremity [*blood supply]; Paclitaxel [*therapeutic use]; Peripheral Arterial Disease [mortality, *therapy]; Popliteal Artery; Randomized Controlled Trials as Topic; Tibial Arteries; Time Factors; Vascular Patency" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011319.pub2&amp;doi=10.1002/14651858.CD011319.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011319.pub2&amp;doi=10.1002/14651858.CD011319.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011319.pub2&amp;doi=10.1002/14651858.CD011319.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011319.pub2&amp;doi=10.1002/14651858.CD011319.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011319.pub2&amp;doi=10.1002/14651858.CD011319.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011319.pub2&amp;doi=10.1002/14651858.CD011319.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011319.pub2&amp;doi=10.1002/14651858.CD011319.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011319.pub2&amp;doi=10.1002/14651858.CD011319.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011319.pub2&amp;doi=10.1002/14651858.CD011319.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011319.pub2&amp;doi=10.1002/14651858.CD011319.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011319.pub2&amp;doi=10.1002/14651858.CD011319.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011319.pub2&amp;doi=10.1002/14651858.CD011319.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011319.pub2&amp;doi=10.1002/14651858.CD011319.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011319.pub2&amp;doi=10.1002/14651858.CD011319.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011319.pub2&amp;doi=10.1002/14651858.CD011319.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011319.pub2&amp;doi=10.1002/14651858.CD011319.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011319.pub2&amp;doi=10.1002/14651858.CD011319.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011319.pub2&amp;doi=10.1002/14651858.CD011319.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011319.pub2&amp;doi=10.1002/14651858.CD011319.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011319.pub2&amp;doi=10.1002/14651858.CD011319.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011319.pub2&amp;doi=10.1002/14651858.CD011319.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011319.pub2&amp;doi=10.1002/14651858.CD011319.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011319.pub2&amp;doi=10.1002/14651858.CD011319.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="p32VIvbS";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD011319\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD011319\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011319\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011319\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","ru","fa","zh_HANS"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD011319.pub2",title:"Drug\\u2010eluting balloon angioplasty versus uncoated balloon angioplasty for peripheral arterial disease of the lower limbs",firstPublishedDate:"Aug 4, 2016 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Vascular Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=p32VIvbS&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011319.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD011319.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD011319.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD011319.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011319.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD011319.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Conclusiones de los autores&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Antecedentes&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Objetivos&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Métodos&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Discusión&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD011319.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD011319.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD011319.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD011319.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>4051 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD011319.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011319.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011319.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011319.pub2/full#CD011319-abs-0003"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011319.pub2/full#CD011319-sec-0097"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011319.pub2/full#CD011319-sec-0022"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011319.pub2/full#CD011319-sec-0023"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011319.pub2/full#CD011319-sec-0028"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011319.pub2/full#CD011319-sec-0029"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011319.pub2/full#CD011319-sec-0053"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011319.pub2/full#CD011319-sec-0091"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011319.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011319.pub2/appendices#CD011319-sec-0102"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011319.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011319.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/table_n/CD011319StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/table_n/CD011319StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011319.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011319.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011319.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD011319.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD011319.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD011319.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2016 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Drug‐eluting balloon angioplasty versus uncoated balloon angioplasty for peripheral arterial disease of the lower limbs </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011319.pub2/information#CD011319-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Ahmed Kayssi</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011319.pub2/information#CD011319-cr-0003">Talal Al‐Atassi</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011319.pub2/information#CD011319-cr-0004">George Oreopoulos</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011319.pub2/information#CD011319-cr-0005">Graham Roche‐Nagle</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011319.pub2/information#CD011319-cr-0006">Kong Teng Tan</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011319.pub2/information#CD011319-cr-0007">Dheeraj K Rajan</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/information/en#CD011319-sec-0106">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 04 August 2016 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD011319.pub2">https://doi.org/10.1002/14651858.CD011319.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD011319-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011319-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD011319-abs-0002">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD011319-abs-0006">فارسی</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD011319-abs-0008">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD011319-abs-0001" lang="en"> <section id="CD011319-sec-0001"> <h3 class="title" id="CD011319-sec-0001">Background</h3> <p>Atherosclerotic peripheral arterial disease (PAD) can lead to disabling ischemia and limb loss. Treatment modalities have included risk factor optimization through life‐style modifications and medications, or operative approaches using both open and minimally invasive techniques, such as balloon angioplasty. Drug‐eluting balloon (DEB) angioplasty has emerged as a promising alternative to uncoated balloon angioplasty for the treatment of this difficult disease process. By ballooning and coating the inside of atherosclerotic vessels with cytotoxic agents, such as paclitaxel, cellular mechanisms responsible for atherosclerosis and neointimal hyperplasia are inhibited and its devastating complications are prevented or postponed. DEBs are considerably more expensive than uncoated balloons, and their efficacy in improving patient outcomes is unclear. </p> </section> <section id="CD011319-sec-0002"> <h3 class="title" id="CD011319-sec-0002">Objectives</h3> <p>To assess the efficacy of drug‐eluting balloons (DEBs) compared with uncoated, nonstenting balloon angioplasty in people with symptomatic lower‐limb peripheral arterial disease (PAD). </p> </section> <section id="CD011319-sec-0003"> <h3 class="title" id="CD011319-sec-0003">Search methods</h3> <p>The Cochrane Vascular Trials Search Co‐ordinator (TSC) searched the Specialised Register (last searched December 2015) and Cochrane Register of Studies (CRS) (2015, Issue 11). The TSC searched trial databases for details of ongoing and unpublished studies. </p> </section> <section id="CD011319-sec-0004"> <h3 class="title" id="CD011319-sec-0004">Selection criteria</h3> <p>We included all randomized controlled trials that compared DEBs with uncoated, nonstenting balloon angioplasty for intermittent claudication (IC) or critical limb ischemia (CLI). </p> </section> <section id="CD011319-sec-0005"> <h3 class="title" id="CD011319-sec-0005">Data collection and analysis</h3> <p>Two review authors (AK, TA) independently selected the appropriate trials and performed data extraction, assessment of trial quality, and data analysis. The senior review author (DKR) adjudicated any disagreements. </p> </section> <section id="CD011319-sec-0006"> <h3 class="title" id="CD011319-sec-0006">Main results</h3> <p>Eleven trials that randomized 1838 participants met the study inclusion criteria. Seven of the trials included femoropopliteal arterial lesions, three included tibial arterial lesions, and one included both. The trials were carried out in Europe and in the USA and all used the taxane drug paclitaxel in the DEB arm. Nine of the 11 trials were industry‐sponsored. Four companies manufactured the DEB devices (Bard, Bavaria Medizin, Biotronik, and Medtronic). The trials examined both anatomic and clinical endpoints. There was heterogeneity in the frequency of stent deployment and the type and duration of antiplatelet therapy between trials. Using GRADE assessment criteria, the quality of the evidence presented was moderate for the outcomes of target lesion revascularization and change in Rutherford category, and high for amputation, primary vessel patency, binary restenosis, death, and change in ankle‐brachial index (ABI). Most participants were followed up for 12 months, but one trial reported outcomes at five years. </p> <p>There were better outcomes for DEBs for up to two years in primary vessel patency (odds ratio (OR) 1.47, 95% confidence interval (CI) 0.22 to 9.57 at six months; OR 1.92, 95% CI 1.45 to 2.56 at 12 months; OR 3.51, 95% CI 2.26 to 5.46 at two years) and at six months and two years for late lumen loss (mean difference (MD) ‐0.64 mm, 95% CI ‐1.00 to ‐0.28 at six months; MD ‐0.80 mm, 95% CI ‐1.44 to ‐0.16 at two years). DEB were also superior to uncoated balloon angioplasty for up to five years in target lesion revascularization (OR 0.28, 95% CI 0.17 to 0.47 at six months; OR 0.40, 95% CI 0.31 to 0.51 at 12 months; OR 0.28, 95% CI 0.18 to 0.44 at two years; OR 0.21, 95% CI 0.09 to 0.51 at five years) and binary restenosis rate (OR 0.44, 95% CI 0.29 to 0.67 at six months; OR 0.38, 95% CI 0.15 to 0.98 at 12 months; OR 0.26, 95% CI 0.10 to 0.66 at two years; OR 0.12, 95% CI 0.05 to 0.30 at five years). There was no significant difference between DEB and uncoated angioplasty in amputation, death, change in ABI, change in Rutherford category and quality of life (QoL) scores, or functional walking ability, although none of the trials were powered to detect a significant difference in these clinical endpoints. We carried out two subgroup analyses to examine outcomes in femoropopliteal and tibial interventions as well as in people with CLI (4 or greater Rutherford class), and showed no advantage for DEBs in tibial vessels at six and 12 months compared with uncoated balloon angioplasty. There was also no advantage for DEBs in CLI compared with uncoated balloon angioplasty at 12 months. </p> </section> <section id="CD011319-sec-0007"> <h3 class="title" id="CD011319-sec-0007">Authors' conclusions</h3> <p>Based on a meta‐analysis of 11 trials with 1838 participants, there is evidence of an advantage for DEBs compared with uncoated balloon angioplasty in several anatomic endpoints such as primary vessel patency (high‐quality evidence), binary restenosis rate (moderate‐quality evidence), and target lesion revascularization (low‐quality evidence) for up to 12 months. Conversely, there is no evidence of an advantage for DEBs in clinical endpoints such as amputation, death, or change in ABI, or change in Rutherford category during 12 months' follow‐up. Well‐designed randomized trials with long‐term follow‐up are needed to compare DEBs with uncoated balloon angioplasties adequately for both anatomic and clinical study endpoints before the widespread use of this expensive technology can be justified. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD011319-abs-0003" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011319-abs-0003">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD011319-abs-0005">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD011319-abs-0007">فارسی</a> </li> <li class="section-language"> <a class="" href="full/ru#CD011319-abs-0004">Русский</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD011319-abs-0009">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD011319-abs-0003" lang="en"> <h3>Uncoated balloon angioplasty versus drug‐eluting balloon angioplasty for peripheral arterial disease of the lower limbs </h3> <p><b>Background</b> </p> <p>Peripheral arterial disease (PAD) of the lower limbs is a widespread condition that affects many people. In its advanced form, PAD can lead to pain, infections, and amputation. People with PAD are usually first treated with medicines and lifestyle modifications including strategies to stop smoking and a walking program to optimize their general health. People who require an operation might have a traditional open surgery or a less invasive procedure known as angioplasty, which uses a balloon to open the blockages in the arteries. A new type of angioplasty, known as drug‐eluting balloon (DEB) angioplasty, has emerged as a promising alternative to traditional balloon angioplasty for the treatment of patients with PAD. By using DEBs to balloon and coat the inside of the blood vessels (tubes that carry blood around the body) with medicines to treat cancer (chemotherapy) such as paclitaxel, the hope is to halt the progression of PAD and prevent or postpone its devastating complications. The goal of this review was to determine how DEB angioplasty compares with traditional balloon angioplasty for the treatment of PAD of the lower limbs. </p> <p><b>Study characteristics and key results</b> </p> <p>Our review included 11 clinical trials that randomized 1838 participants (current until December 2015). The trials included thigh and leg arteries above and below the knee. The trials were carried out in Europe and the USA, and all used DEBs that contained paclitaxel. Four companies manufactured the DEB devices: Bard, Bavaria Medizin, Biotronik, and Medtronic. Most participants were followed for 12 or more months (called follow‐up). At six and 12 months of follow‐up, DEBs were associated with improved primary vessel patency, which is an indicator of whether a vessel is still patent without any further interventions (blood flowing well), late lumen loss, which is the difference in millimeters between the angioplastied segment and how narrow it is on follow‐up, target lesion revascularization, which is an indicator of whether a person received more than one treatment to the same artery during the period covered by the study, and binary restenosis, which occurs when a treated artery becomes narrowed again after being previously treated. </p> <p>Unfortunately, early anatomic (structural) advantages of DEBs were not accompanied by improvements in quality of life, functional walking ability, or in the occurrence of amputation or death. When we specifically examined arteries below the knee and people who had very advanced PAD, we found no clinical or angiographic advantage for DEBs at 12 months of follow‐up compared with uncoated balloon angioplasty. In summary, DEBs have several anatomic advantages over uncoated balloons for the treatment of lower limb PAD for up to 12 months after undergoing the procedure. However, more data are needed to assess the long‐term results of this treatment option adequately. </p> <p><b>Quality of the evidence</b> </p> <p>All the trials had differences in the way in which they inserted the balloons, and in the type and duration of additional antiplatelet (anticlotting) therapy, leading to downgrading of the quality of the evidence. The quality of the evidence presented was moderate for target lesion revascularization and change in Rutherford category (a way of classifying PAD), and high for amputation, primary vessel patency, binary restenosis, death, and change in ankle‐brachial index (which is used to predict the severity of PAD). </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD011319-sec-0097" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011319-sec-0097">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD011319-sec-0135">Español</a> </li> </nav> </div> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD011319-sec-0097"></div> <h3 class="title" id="CD011319-sec-0098">Implications for practice</h3> <section id="CD011319-sec-0098"> <p>Our analysis has demonstrated an advantage for drug‐eluting balloon (DEB) angioplasty compared with uncoated balloon angioplasty in treating lower extremity peripheral arterial disease (PAD) for up to five years in several domains. The quality of the evidence was low to high depending on the outcome. The advantage of DEB is limited to anatomic endpoints such as primary vessel patency, late lumen loss, target lesion revascularization, and binary restenosis. However, there is insufficient evidence to compare DEB and uncoated balloon angioplasty adequately in clinical outcomes such as change in quality of life (QoL) and walking impairment score. </p> <p>Given the high re‐intervention rates in people with PAD, the superiority of DEB compared with uncoated balloon angioplasty in the anatomic endpoints reported in our analysis is encouraging. However, rigorous long‐term clinical outcome data are needed before one can conclude that DEB are superior to uncoated balloon angioplasty, especially given the considerably increased costs currently associated with DEB. </p> </section> <h3 class="title" id="CD011319-sec-0099">Implications for research</h3> <section id="CD011319-sec-0099"> <p>Future well‐designed, publicly funded trials that are adequately powered to detect meaningful clinical endpoints, such as amputation and change in QoL, are needed to assess the utility of DEBs in the management of people with lower‐extremity PAD better, and to allow for the stratification of outcomes by arterial segment and indication for the intervention. However, given the small effect size differences in clinical endpoints between DEB and uncoated balloon angioplasty, and the rapidly evolving endovascular treatment modalities for PAD, it is unlikely that there will be any future randomized controlled trials powered to detect clinical endpoints because of the substantial cost and logistic challenges involved. We identified 13 studies that are either ongoing or are pending publication, in addition to the 11 studies included in our analysis. The eventual publication of short‐ and long‐term data from those studies will hopefully allow for a more rigorous analysis in future versions of this review. Furthermore, as data from more studies becomes available, we plan to perform more subgroup analyses by paclitaxel dose and type of carrier used in the DEB. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD011319-sec-0022" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD011319-sec-0022"></div> <div class="table" id="CD011319-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Drug‐eluting balloon versus uncoated balloon angioplasty at 12 months</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>Drug‐eluting balloon compared to uncoated balloon angioplasty at 12 months</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> people with peripheral arterial disease of the lower limbs<br/> <b>Setting:</b> hospital<br/> <b>Intervention:</b> drug‐eluting balloon angioplasty<br/> <b>Comparison:</b> uncoated balloon angioplasty </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with uncoated balloon angioplasty at 12 months</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with drug‐eluting balloon angioplasty at 12 months</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Amputation</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 1.56<br/> (0.73 to 3.33) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1649<br/> (9 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊕<br/> High <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>14 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>22 per 1000<br/> (10 to 46) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Primary vessel patency</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>OR 1.92<br/> (1.45 to 2.56) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>882<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕⊕<br/> High <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>479 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>638 per 1000<br/> (571 to 702) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>487 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>645 per 1000<br/> (579 to 708) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Target lesion revascularization</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>OR 0.40<br/> (0.31 to 0.51) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>1900<br/> (11 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> Low <sup>1, 2, 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>264 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>126 per 1000<br/> (100 to 155) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>368 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>189 per 1000<br/> (153 to 229) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Binary restenosis</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>OR 0.38<br/> (0.15 to 0.98) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>1094<br/> (4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕⊝<br/> Moderate <sup>1, 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>350 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>170 per 1000<br/> (75 to 346) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>477 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>257 per 1000<br/> (120 to 472) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Death</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>OR 1.09<br/> (0.64 to 1.85) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>1649<br/> (9 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕⊕<br/> High <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>43 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>46 per 1000<br/> (28 to 76) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>45 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>49 per 1000<br/> (29 to 80) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Change in Rutherford category</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in Rutherford category in the intervention group was 0.1 lower (0.29 lower to 0.1 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>623<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> Moderate <sup>1 4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>A positive change in Rutherford category reflects a worsening clinical status, although in this case the difference was not statistically significant </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Change in ankle‐brachial index</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in ankle‐brachial index in the intervention group was 0.03 lower (0.07 lower to 0.01 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>656<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> High <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>A negative change in the ankle‐brachial index reflects a worsening clinical status, although in this case the difference was not statistically significant </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>OR:</b> odds ratio; <b>RCT:</b> randomized controlled trial. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> All of the included trials were at a high risk of performance bias due to lack of blinding of operators. However, because this is an intrinsic limitation to intervention trials, we did not downgrade the GRADE class because of performance bias.<br/> <sup>2</sup> Funnel plot analysis indicated a likely publication bias, which resulted in downgrading of the GRADE class.<br/> <sup>3</sup> There was moderate heterogeneity between the included studies (P &lt; 0.001), which resulted in downgrading of the GRADE class.<br/> <sup>4</sup> There was moderate heterogeneity between the included studies (P = 0.04), which resulted in downgrading of the GRADE class. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD011319-sec-0023" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011319-sec-0023">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD011319-sec-0115">Español</a> </li> </nav> </div> </div> <section class="background" lang="en"> <div class="section-header" id="CD011319-sec-0023"></div> <section id="CD011319-sec-0024"> <h3 class="title" id="CD011319-sec-0024">Description of the condition</h3> <p>Peripheral arterial disease (PAD) is a major healthcare challenge resulting in significant age‐related patient morbidity. It is estimated to affect 4% of adults aged 40 years or older and 14.5% of adults aged 70 years or older in the USA (<a href="./references#CD011319-bbs2-0059" title="SelvinE , ErlingerTP . Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999‐2000. Circulation2004;110(6):738‐43. ">Selvin 2004</a>). The presence of PAD does not always lead to symptoms, and asymptomatic PAD has been reported in 8% of Scottish adults (<a href="./references#CD011319-bbs2-0047" title="FowkesFGR , HousleyE , CawoodEHH , MacintyreCCA , RuckleyCV , PrescottRJ . Edinburgh artery study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. International Journal of Epidemiology1991;20(2):384‐92. ">Fowkes 1991</a>). </p> <p>People with symptomatic lower‐limb PAD commonly present with intermittent claudication (IC). The prevalence of IC in people with PAD is estimated to be 3% in people aged 40 years and 6% in people aged 60 years (<a href="./references#CD011319-bbs2-0054" title="NorgrenL , HiattWR , DormandyJA , NehlerMR , HarrisKA , FowkesFG , TASC II Working Group. Inter‐society consensus for the management of peripheral arterial disease (TASC II). Journal of Vascular Surgery2007;45(Suppl S):S5‐67. ">Norgren 2007</a>). About 25% of people with IC will develop more severe claudication and a deterioration in functional status of their affected limb. Some of those people will also eventually develop critical limb ischemia (CLI) (<a href="./references#CD011319-bbs2-0054" title="NorgrenL , HiattWR , DormandyJA , NehlerMR , HarrisKA , FowkesFG , TASC II Working Group. Inter‐society consensus for the management of peripheral arterial disease (TASC II). Journal of Vascular Surgery2007;45(Suppl S):S5‐67. ">Norgren 2007</a>). Major amputation is required in less than 10% of people with IC (<a href="./references#CD011319-bbs2-0039" title="AquinoR , JohnnidesC , MakarounM , WhittleJC , MulukVS , KelleyME , et al. Natural history of claudication: long‐term serial follow‐up study of 1244 claudicants. Journal of Vascular Surgery2001;34(6):962‐70. ">Aquino 2001</a>). </p> </section> <section id="CD011319-sec-0025"> <h3 class="title" id="CD011319-sec-0025">Description of the intervention</h3> <p>The medical management of lower‐limb PAD is based on an appropriate diet and exercise regimen and vascular disease risk‐factor modification through smoking‐cessation, blood pressure control, tight control of blood sugar levels in people with diabetes, and the prescription of lipid‐lowering and antiplatelet medications (<a href="./references#CD011319-bbs2-0049" title="HirschAT , HaskalZJ , HertzerNR , BakalCW , CreagerMA , HalperinJL , et al. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter‐Society Consensus; and Vascular Disease Foundation. Circulation2006;113(11):e463‐654. ">Hirsch 200</a>). Surgical management is indicated when people develop CLI or debilitating IC that is refractory to nonoperative management. </p> <p>While bypass with an autologous vein or prosthetic conduit is the mainstay of open surgical management of PAD, percutaneous endovascular interventions provide another treatment alternative. Percutaneous interventions use ultrasound and fluoroscopic guidance to access and cannulate the diseased artery. A balloon catheter is then employed to provide pneumatic dilation of the stenotic or occluded vessel segment. The first balloon catheters used for this purpose were not coated with any medications and showed excellent efficacy in treating these diseased arteries (<a href="./references#CD011319-bbs2-0054" title="NorgrenL , HiattWR , DormandyJA , NehlerMR , HarrisKA , FowkesFG , TASC II Working Group. Inter‐society consensus for the management of peripheral arterial disease (TASC II). Journal of Vascular Surgery2007;45(Suppl S):S5‐67. ">Norgren 2007</a>). More recently, drug‐eluting balloons (DEBs), in addition to stents, have been placed to provide additional support when balloon angioplasty results are not satisfactory. </p> <p>Balloon angioplasty, with or without stent placement, has the advantage of a shorter hospital stay and fewer short‐term postinterventional complications compared with bypass surgery. It has also been shown to be similar to open surgery in overall and amputation‐free survival at two years (<a href="./references#CD011319-bbs2-0042" title="AdamDJ , BeardJD , ClevelandT , BellJ , BradburyAW , ForbesJF , et al. BASIL trial participants. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet2005;366(9501):1925‐34. ">BASIL 2005</a>). However, on long‐term follow‐up, bypass surgery with autologous venous conduit was associated with a seven‐month increase in overall survival while amputation‐free survival remained the same (<a href="./references#CD011319-bbs2-0043" title="BradburyAW , BASIL trial investigators and participants. Bypass versus angioplasty in severe ischaemia of the leg (BASIL) trial in perspective. Journal of Vascular Surgery2010;51(5 Suppl):1S‐4S. ">Bradbury 2010</a>). In cases where autologous venous conduit is not available for bypass, the differences between balloon angioplasty and bypass using a prosthetic graft are probably minimal in terms of outcome (<a href="./references#CD011319-bbs2-0043" title="BradburyAW , BASIL trial investigators and participants. Bypass versus angioplasty in severe ischaemia of the leg (BASIL) trial in perspective. Journal of Vascular Surgery2010;51(5 Suppl):1S‐4S. ">Bradbury 2010</a>). </p> </section> <section id="CD011319-sec-0026"> <h3 class="title" id="CD011319-sec-0026">How the intervention might work</h3> <p>Elastic recoil and vessel restenosis secondary to neointimal hyperplasia remain a challenge for all of the available lower‐limb PAD treatment interventions. Numerous strategies have sought to delay vessel restenosis, including the use of drug‐eluting stents and DEBs. To date, there is only one commercially available drug‐eluting stent for use in the superficial femoral artery (<a href="./references#CD011319-bbs2-0046" title="DakeMD , AnselGM , JaffMR , OhkiT , SaxonRR , SmouseHB , et al. Zilver PTX Investigators. Sustained safety and effectiveness of paclitaxel‐eluting stents for femoropopliteal lesions: 2‐year follow‐up from the Zilver PTX randomized and single‐arm clinical studies. Journal of the American College of Cardiology2013;61(24):2417‐27. ">Dake 2013</a>). </p> <p>DEBs were developed to provide a complete and homogenous coating of an antiproliferative agent to the arterial wall (<a href="./references#CD011319-bbs2-0058" title="SeedialSM , GhoshS , SaundersRS , SuwanabolPA , ShiX , LiuB , et al. Local drug delivery to prevent restenosis. Journal of Vascular Surgery2013;57(5):1403‐14. ">Seedial 2013</a>). The most commonly used agent is paclitaxel, a highly lipophilic drug that has been shown to prevent neointimal hyperplasia after balloon angioplasty (<a href="./references#CD011319-bbs2-0040" title="AxelDI , KunertW , GoggelmannC , OberhoffM , HerdegC , KuttnerA , et al. Paclitaxel inhibits arterial smooth muscle cell proliferation and migration in vitro and in vivo using local drug delivery. Circulation1997;96(2):636‐45. ">Axel 1997</a>). The immunosuppressant agent sirolimus has also been used to prevent neointimal hyperplasia (<a href="./references#CD011319-bbs2-0058" title="SeedialSM , GhoshS , SaundersRS , SuwanabolPA , ShiX , LiuB , et al. Local drug delivery to prevent restenosis. Journal of Vascular Surgery2013;57(5):1403‐14. ">Seedial 2013</a>). The advantages of DEBs compared with other percutaneous treatment modalities include the absence of stent thrombosis or scaffolding to disrupt patterns of flow, immediate drug release, and no residual foreign body (<a href="./references#CD011319-bbs2-0058" title="SeedialSM , GhoshS , SaundersRS , SuwanabolPA , ShiX , LiuB , et al. Local drug delivery to prevent restenosis. Journal of Vascular Surgery2013;57(5):1403‐14. ">Seedial 2013</a>). However, DEBs are more costly and carry the potential for long‐term negative vessel remodeling and elastic recoil. </p> </section> <section id="CD011319-sec-0027"> <h3 class="title" id="CD011319-sec-0027">Why it is important to do this review</h3> <p>Randomized controlled trials have demonstrated the safety and efficacy of angioplasty using DEBs compared with conventional uncoated balloon angioplasty. Our goal is to review the evidence for the use of DEBs in the management of lower‐limb PAD systematically. This will help guide decision‐making when considering whether to use this costly treatment modality and determine whether it is associated with improved clinical outcomes compared with conventional balloon angioplasty. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD011319-sec-0028" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011319-sec-0028">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD011319-sec-0120">Español</a> </li> </nav> </div> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD011319-sec-0028"></div> <p>To assess the efficacy of drug‐eluting balloons (DEBs) compared with uncoated, nonstenting balloon angioplasty in people with symptomatic lower‐limb peripheral arterial disease (PAD). </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD011319-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011319-sec-0029">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD011319-sec-0121">Español</a> </li> </nav> </div> </div> <section class="methods" lang="en"> <div class="section-header" id="CD011319-sec-0029"></div> <section id="CD011319-sec-0030"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD011319-sec-0031"> <h4 class="title">Types of studies</h4> <p>Randomized controlled trials (RCTs) that compare DEBs with uncoated balloon angioplasty for IC or CLI. </p> </section> <section id="CD011319-sec-0032"> <h4 class="title">Types of participants</h4> <p>People with IC or CLI undergoing drug‐eluting or uncoated balloon angioplasty for symptomatic lower‐limb PAD. </p> </section> <section id="CD011319-sec-0033"> <h4 class="title">Types of interventions</h4> <p>We compared DEBs for PAD of the lower limbs with uncoated, nonstenting balloon angioplasty. Endovascular access in the included studies was established percutaneously or through a limited incision. We did not include studies of DEBs for the treatment of instent restenosis of the lower‐limb, as well as studies where DEBs were used simultaneously in combination with other angioplasty techniques (such as hybrid procedures involving surgery and DEBs). Our review focused on primary arterial interventions only. We excluded reinterventions and studies using cutting balloon angioplasty. </p> </section> <section id="CD011319-sec-0034"> <h4 class="title">Types of outcome measures</h4> <section id="CD011319-sec-0035"> <h5 class="title">Primary outcomes</h5> <p> <ul id="CD011319-list-0001"> <li> <p>Incidence of amputation.</p> </li> <li> <p>Amputation‐free survival, defined as the probability of being alive without an amputation.</p> </li> <li> <p>Amputation‐free rate, defined as the patency of the target vessels and freedom from amputation. </p> </li> <li> <p>Vessel patency (primary and secondary), as determined by delayed arterial lumen loss, target lesion revascularization, and binary restenosis rate measured with duplex ultrasound or angiography. </p> </li> <li> <p>Death.</p> </li> </ul> </p> </section> <section id="CD011319-sec-0036"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD011319-list-0002"> <li> <p>Change in Fontaine stage or Rutherford category of PAD (<a href="./references#CD011319-bbs2-0054" title="NorgrenL , HiattWR , DormandyJA , NehlerMR , HarrisKA , FowkesFG , TASC II Working Group. Inter‐society consensus for the management of peripheral arterial disease (TASC II). Journal of Vascular Surgery2007;45(Suppl S):S5‐67. ">Norgren 2007</a>). </p> </li> <li> <p>Change in ankle‐brachial index (ABI).</p> </li> <li> <p>Change in quality of life (QoL) scores.</p> </li> <li> <p>Change in functional walking ability, as measured by the Walking Impairment Questionnaire (WIQ). </p> </li> </ul> </p> </section> </section> </section> <section id="CD011319-sec-0037"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD011319-sec-0038"> <h4 class="title">Electronic searches</h4> <p>The Cochrane Vascular Trials Search Co‐ordinator (TSC) searched the Specialised Register (December 2015). In addition, the TSC searched the Cochrane Register of Studies (CRS) (<a href="http://www.metaxis.com/CRSWeb/Index.asp" target="_blank">www.metaxis.com/CRSWeb/Index.asp</a>; (CENTRAL) 2015, Issue 11). See <a href="./appendices#CD011319-sec-0103">Appendix 1</a> for details of the search strategy used to search the CRS. The Specialised Register is maintained by the TSC and is constructed from weekly electronic searches of MEDLINE, Embase, CINAHL, AMED, and through handsearching relevant journals. The full list of the databases, journals, and conference proceedings which have been searched, as well as the search strategies used are described in the <a href="http://www.mrw.interscience.wiley.com/cochrane/clabout/articles/PVD/frame.html" target="_blank">Specialised Register</a> section of the Cochrane Vascular module in the<i>Cochrane Library</i> (<a href="http://www.cochranelibrary.com/" target="_blank">www.cochranelibrary.com</a>). </p> <p>In addition, the TSC searched the following trial databases for details of ongoing and unpublished studies. See <a href="./appendices#CD011319-sec-0104">Appendix 2</a> for details of the search. </p> <p> <ul id="CD011319-list-0003"> <li> <p>World Health Organization International Clinical Trials Registry (<a href="http://apps.who.int/trialsearch/" target="_blank">apps.who.int/trialsearch/</a>). </p> </li> <li> <p>ClinicalTrials.gov (<a href="http://clinicaltrials.gov/" target="_blank">clinicaltrials.gov/</a>). </p> </li> <li> <p>ISRCTN registry (<a href="http://www.controlled-trials.com/" target="_blank">www.controlled‐trials.com/</a>). </p> </li> </ul> </p> </section> <section id="CD011319-sec-0039"> <h4 class="title">Searching other resources</h4> <p>We examined the bibliographies of relevant papers found from the electronic searches to identify other studies. We also attempted to contact study authors for additional information when necessary. </p> </section> </section> <section id="CD011319-sec-0040"> <h3 class="title" id="CD011319-sec-0040">Data collection and analysis</h3> <section id="CD011319-sec-0041"> <h4 class="title">Selection of studies</h4> <p>Two review authors (AK and TA) independently selected trials for inclusion in this review. These trials were sent to a third review author (DR), who assessed and confirmed their suitability for inclusion and acted as an adjudicator in the event of disagreement. The <a href="#CD011319-sec-0030">Criteria for considering studies for this review</a> section details the inclusion criteria used in this selection process. </p> </section> <section id="CD011319-sec-0042"> <h4 class="title">Data extraction and management</h4> <p>Two review authors (AK and TA) extracted the data from each trial, including participant demographics (age, gender, comorbidities, Fontaine stage or Rutherford category of PAD, and ABI), interventions (DEBs and other balloon types, vessels treated, history of previous stent placement), and outcomes (as specified in the <a href="#CD011319-sec-0030">Criteria for considering studies for this review</a> section). A third review author (DR), then cross‐checked the data and acted as an adjudicator in the event of disagreement. Statistical analysis complied with the standard methods of Cochrane Vascular. We used the computer software package Review Manager 5 to perform all statistical analyses and generate figures (<a href="./references#CD011319-bbs2-0055" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>). </p> </section> <section id="CD011319-sec-0043"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors (AK and TA) assessed potential risks of bias for all included studies using the Cochrane's tool for assessing risk of bias (<a href="./references#CD011319-bbs2-0048" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). The tool assesses bias in six different domains: sequence generation; allocation concealment; blinding of participants, personnel, and outcome assessors; incomplete outcome data; selective outcome reporting; and other sources of bias. Each domain receives a score of high, low, or unclear depending on each review author's judgment. A third review author (DR) acted as an adjudicator in the event of disagreement. Where doubt existed as to a potential risk of bias, we contacted the study authors for clarification. </p> </section> <section id="CD011319-sec-0044"> <h4 class="title">Measures of treatment effect</h4> <p>We calculated and reported continuous outcome measures such as lumen loss using the mean difference (MD) and associated 95% confidence interval (CI) between the two treatment groups. We calculated and reported dichotomous outcome measures including the occurrence of a postprocedural complication such as death using the odds ratio (OR) and associated 95% CI, depending on the reported data. We based calculations on an intention‐to‐treat approach and all randomized participants were included in the analysis regardless of loss to follow‐up. In one study (<a href="./references#CD011319-bbs2-0005" title="WerkM , LangnerS , ReinkensmeierB , BoettcherHF , TepeG , DietzU , et al. Inhibition of restenosis in femoropopliteal arteries: paclitaxel‐coated versus uncoated balloon: femoral paclitaxel randomized pilot trial. Circulation2008;118(13):1358‐65. ">FemPac 2008</a>), where the late lumen loss and change in ABI were reported as medians, rather than means, we converted the median values to means as per the method described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD011319-bbs2-0048" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). </p> </section> <section id="CD011319-sec-0045"> <h4 class="title">Unit of analysis issues</h4> <p>The unit of analysis was the treated limb for outcomes in which repeat or additional procedures on the contralateral side were possible and reported. The unit of analysis was the individual participant when considering participant death, QoL scores, and change in functional walking ability. </p> </section> <section id="CD011319-sec-0046"> <h4 class="title">Dealing with missing data</h4> <p>We contacted authors of the included studies to inquire about missing or incomplete data, such as information on participants who dropped out of the study, and missing statistics. We excluded no studies from the meta‐analysis due to concerns about missing data. </p> </section> <section id="CD011319-sec-0047"> <h4 class="title">Assessment of heterogeneity</h4> <p>We assessed inter‐study heterogeneity visually using a forest plot. We also calculated the I<sup>2</sup> statistic to measure the amount of inter‐study heterogeneity. We considered I<sup>2</sup> values less than 50% as indicative of low heterogeneity, I<sup>2</sup> values between 50% and 75% as indicative of moderate heterogeneity, and I<sup>2</sup> values greater than 75% as indicative of significant heterogeneity (<a href="./references#CD011319-bbs2-0048" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). </p> </section> <section id="CD011319-sec-0048"> <h4 class="title">Assessment of reporting biases</h4> <p>We constructed a funnel plot to test for reporting bias in meta‐analyses that included 10 or more studies (<a href="./references#CD011319-bbs2-0048" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). </p> </section> <section id="CD011319-sec-0049"> <h4 class="title">Data synthesis</h4> <p>We used a fixed‐effect model to calculate the pooled treatment effect data and 95% CIs for continuous and dichotomous outcome variables, as detailed under <a href="#CD011319-sec-0044">Measures of treatment effect</a>. We used a random‐effects model when we found significant heterogeneity (defined as I<sup>2</sup> greater than 75%). We created a forest plot for each treatment effect, as per Cochrane Vascular guidelines. </p> </section> <section id="CD011319-sec-0050"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We performed subgroup analyses by the arterial segments treated (femoropopliteal versus tibial), and the severity of PAD (studies that only included participants with a Rutherford's class greater than 4). We were unable to perform subgroup analyses by type of DEB pharmacologic agent, as all the studies used paclitaxel. </p> </section> <section id="CD011319-sec-0051"> <h4 class="title">Sensitivity analysis</h4> <p>We sequentially excluded studies with a high risk of bias in several domains (as described in the <a href="#CD011319-sec-0043">Assessment of risk of bias in included studies</a> section) and performed a pooled sensitivity analysis in order to assess whether the included studies, deemed to be biased, impacted the final analysis. </p> <section id="CD011319-sec-0052"> <h5 class="title">'Summary of findings' table</h5> <p>We prepared 'Summary of findings' tables to present the evidence for DEB versus uncoated balloon angioplasty at 12 months of follow‐up in participants who underwent endovascular lower‐limb interventions for symptomatic PAD. We chose this time point because the greatest amount of data from the included trials was available at 12 months of follow‐up. We used no external information in generating the 'Assumed risk' column. We used the GRADE approach to evaluate the evidence and assign one of four levels of quality: high, moderate, low, or very low (<a href="./references#CD011319-bbs2-0048" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). No departures from the standard methods for generating these tables were required. We included the following primary and secondary endpoints described under the <a href="#CD011319-sec-0034">Types of outcome measures</a> section: amputation, primary vessel patency, target lesion revascularization, binary restenosis, death, change in Rutherford category, and change in ABI. These endpoints were chosen because we deemed them to be the most clinically relevant. </p> </section> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD011319-sec-0053" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD011319-sec-0053"></div> <section id="CD011319-sec-0054"> <h3 class="title">Description of studies</h3> <section id="CD011319-sec-0055"> <h4 class="title">Results of the search</h4> <p>See <a href="#CD011319-fig-0001">Figure 1</a>. </p> <div class="figure" id="CD011319-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD011319-fig-0001" src="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> </section> <section id="CD011319-sec-0056"> <h4 class="title">Included studies</h4> <p>The review included 11 randomized controlled trials that compared DEB with uncoated balloon angioplasty for lower extremity IC or CLI (<a href="./references#CD011319-bbs2-0001" title="A prospective, multi‐centre, randomized controlled, first in man study to assess the safety and performance of the Passeo‐18 Lux paclitaxel releasing PTA balloon catheter vs. the uncoated Passeo 18 balloon catheter in patients with stenosis and occlusion of the femoropopliteal arteries (BIOLUX P‐I). clinicaltrials.gov/ct2/show/NCT01221610 (accessed 15 August 2015). ScheinertD , SchulteKL , ZellerT , LammerJ , TepeG . Paclitaxel‐releasing balloon in femoropopliteal lesions using a BTHC excipient: twelve‐month results from the BIOLUX P‐I randomized trial. Journal of Endovascular Therapy2015;22:14‐21. TepeG , SchulteK‐L , ZellerT , LammerJ , PfaffingerP , SchmidtA , et al. Six‐month results of the BIOLUX P‐I first in man study comparing a paclitaxel‐releasing balloon catheter versus an uncoated balloon catheter in femoropopliteal lesions. Cardiovascular and Interventional Radiology2012; Vol. 35:S264‐5. ZellerT , LammerJ , RastanA , SchulteK , TepeG , ScheinertD . Twelve‐month results of the BIOLUX P‐I first‐in‐man study comparing a paclitaxel‐releasing balloon catheter versus an uncoated catheter in femoropopliteal lesions. Vasa ‐ Journal of Vascular Diseases2013;42(Suppl 84):FV 9.7. ">BIOLUX P‐I</a>; <a href="./references#CD011319-bbs2-0002" title="BIOTONIK's ‐ first in men study of the Passeo‐18 LUX drug releasing PTA balloon catheter vs. the uncoated Passeo 18 balloon catheter in subjects requiring revascularization of infrapopliteal arteries (BIOLUX P‐II). clinicaltrials.gov/ct2/show/NCT01867736 (accessed 15 August 2015). DelooseK , ZellerT , ScheinertD , BeschornerU . BIOLUX P‐II: a randomized clinical trial of Passeo‐18 Lux DRB vs POBA for the treatment of infrapopliteal artery lesions. Journal of the American College of Cardiology2014; Vol. 64, issue Suppl B. ScheinertD , BrodmannM , ZellerT , BosiersM , PeetersP , Karl‐LudwigS , et al. BIOLUX P‐II: a randomized clinical trial of Passeo‐18 lux drug releasing balloon versus plain old balloon angioplasty for the treatment of infrapopliteal artery lesions. Journal of the American College of Cardiology2014;64(11 Suppl 1):B79. ">BIOLUX P‐II</a>; <a href="./references#CD011319-bbs2-0003" title="LiistroF , PortoI , AngioliP , GrottiS , RicciL , DucciK , et al. Drug‐eluting balloon in peripheral intervention for below the knee angioplasty evaluation (DEBATE‐BTK): a randomized trial in diabetic patients with critical limb ischemia. Circulation2013;128(6):615‐21. ">DEBATE‐BTK 2013</a>; <a href="./references#CD011319-bbs2-0004" title='FanelliF , CannavaleA , BoattaE , CoronaM , LucatelliP , WlderkA , et al. Lower limb multilevel treatment with drug‐eluting balloons: 6‐month results from the DEBELLUM randomized trial. Journal of Endovascular Therapy2012;19(5):571‐80. FanelliF , CannavaleA , CoronaM , LucatelliP , WlderkA , SalvatoriFM . The "DEBELLUM" ‐ lower limb multilevel treatment with drug eluting balloon ‐ randomized trial: 1‐year results. Journal of Cardiovascular Surgery2014;55(2):207‐16. '>DEBELLUM 2012</a>; <a href="./references#CD011319-bbs2-0005" title="WerkM , LangnerS , ReinkensmeierB , BoettcherHF , TepeG , DietzU , et al. Inhibition of restenosis in femoropopliteal arteries: paclitaxel‐coated versus uncoated balloon: femoral paclitaxel randomized pilot trial. Circulation2008;118(13):1358‐65. ">FemPac 2008</a>; <a href="./references#CD011319-bbs2-0006" title="ZellerT , BaumgartnerI , ScheinertD , BrodmannM , BosiersM , MicariA , et al. Drug‐eluting balloon versus standard balloon angioplasty for infrapopliteal arterial revascularization in critical limb ischemia: 12‐month results from the IN.PACT DEEP randomized trial. Journal of the American College of Cardiology2014;64(15):1568‐76. ZellerT , BaumgartnerI , ScheinertD , BrodmannM , BosiersM , MicariA , et al. IN.PACT Amphirion paclitaxel eluting balloon versus standard percutaneous transluminal angioplasty for infrapopliteal revascularization of critical limb ischemia: rationale and protocol for an ongoing randomized controlled trial. Trials2014;15:63. ">IN.PACT DEEP 2014</a>; <a href="./references#CD011319-bbs2-0007" title="LairdJR , SchneiderP , TepeG , BrodmannM , ZellerT , MetzgerC , et al. Durability of treatment effect using a drug‐coated balloon for femoropopliteal lesions 24‐month results of IN.PACT SFA. Journal of the American College of Cardiology2015;66(21):2329‐38. TepeG , LairdJ , SchneiderP , BrodmannM , KrishnanP , MicariA , et al. Drug‐coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12‐month results from the IN.PACT SFA randomized trial. Circulation2015;131(5):495‐502. ">IN.PACT SFA 2015</a>; <a href="./references#CD011319-bbs2-0008" title="ScheinertD , DudaS , ZellerT , KrankenbergH , RickeJ , BosiersM , et al. The LEVANT I (Lutonix paclitaxel‐coated balloon for the prevention of femoropopliteal restenosis) trial for femoropopliteal revascularization: first‐in‐human randomized trial of low‐dose drug‐coated balloon versus uncoated balloon angioplasty. JACC. Cardiovascular Interventions2014;7(1):10‐9. ">LEVANT I 2014</a>; <a href="./references#CD011319-bbs2-0009" title="RosenfieldK , JaffMR , WhiteCJ , Rocha‐SinghK , Mena‐HurtadoC , MetzgerDC , et al. Trial of a paclitaxel‐coated balloon for femoropopliteal artery disease. New England Journal of Medicine2015;373(2):145‐53. ">LEVANT II 2015</a>; <a href="./references#CD011319-bbs2-0010" title="WerkM , AlbrechtT , MeyerDR , AhmedMN , BehneA , DietzU , et al. Paclitaxel‐coated balloons reduce restenosis after femoro‐popliteal angioplasty: evidence from the randomized PACIFIER trial. Circulation. Cardiovascular Interventions2012;5(6):831‐40. ">PACIFIER 2012</a>; <a href="./references#CD011319-bbs2-0011" title="TepeG , SchnorrB , AlbrechtT , BrechtelK , ClaussenCD , SchellerB , et al. Angioplasty of femoral‐popliteal arteries with drug‐coated balloons: 5‐year follow‐up of the THUNDER trial. JACC. Cardiovascular Interventions2015;8(1):102‐8. TepeG , ZellerT , AlbrechtT , HellerS , SchwarzwälderU , BeregiJP , et al. Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg. New England Journal of Medicine2008;358(7):689‐99. ">THUNDER 2008</a>). The <a href="./references#CD011319-sec-0112" title="">Characteristics of included studies</a> table lists these in more detail. </p> <p>All of the included studies were partially or entirely conducted in Europe. Three studies also enrolled people in the USA (<a href="./references#CD011319-bbs2-0007" title="LairdJR , SchneiderP , TepeG , BrodmannM , ZellerT , MetzgerC , et al. Durability of treatment effect using a drug‐coated balloon for femoropopliteal lesions 24‐month results of IN.PACT SFA. Journal of the American College of Cardiology2015;66(21):2329‐38. TepeG , LairdJ , SchneiderP , BrodmannM , KrishnanP , MicariA , et al. Drug‐coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12‐month results from the IN.PACT SFA randomized trial. Circulation2015;131(5):495‐502. ">IN.PACT SFA 2015</a>; <a href="./references#CD011319-bbs2-0008" title="ScheinertD , DudaS , ZellerT , KrankenbergH , RickeJ , BosiersM , et al. The LEVANT I (Lutonix paclitaxel‐coated balloon for the prevention of femoropopliteal restenosis) trial for femoropopliteal revascularization: first‐in‐human randomized trial of low‐dose drug‐coated balloon versus uncoated balloon angioplasty. JACC. Cardiovascular Interventions2014;7(1):10‐9. ">LEVANT I 2014</a>; <a href="./references#CD011319-bbs2-0009" title="RosenfieldK , JaffMR , WhiteCJ , Rocha‐SinghK , Mena‐HurtadoC , MetzgerDC , et al. Trial of a paclitaxel‐coated balloon for femoropopliteal artery disease. New England Journal of Medicine2015;373(2):145‐53. ">LEVANT II 2015</a>). Most studies examined treatments for femoropopliteal arteries (<a href="./references#CD011319-bbs2-0001" title="A prospective, multi‐centre, randomized controlled, first in man study to assess the safety and performance of the Passeo‐18 Lux paclitaxel releasing PTA balloon catheter vs. the uncoated Passeo 18 balloon catheter in patients with stenosis and occlusion of the femoropopliteal arteries (BIOLUX P‐I). clinicaltrials.gov/ct2/show/NCT01221610 (accessed 15 August 2015). ScheinertD , SchulteKL , ZellerT , LammerJ , TepeG . Paclitaxel‐releasing balloon in femoropopliteal lesions using a BTHC excipient: twelve‐month results from the BIOLUX P‐I randomized trial. Journal of Endovascular Therapy2015;22:14‐21. TepeG , SchulteK‐L , ZellerT , LammerJ , PfaffingerP , SchmidtA , et al. Six‐month results of the BIOLUX P‐I first in man study comparing a paclitaxel‐releasing balloon catheter versus an uncoated balloon catheter in femoropopliteal lesions. Cardiovascular and Interventional Radiology2012; Vol. 35:S264‐5. ZellerT , LammerJ , RastanA , SchulteK , TepeG , ScheinertD . Twelve‐month results of the BIOLUX P‐I first‐in‐man study comparing a paclitaxel‐releasing balloon catheter versus an uncoated catheter in femoropopliteal lesions. Vasa ‐ Journal of Vascular Diseases2013;42(Suppl 84):FV 9.7. ">BIOLUX P‐I</a>; <a href="./references#CD011319-bbs2-0005" title="WerkM , LangnerS , ReinkensmeierB , BoettcherHF , TepeG , DietzU , et al. Inhibition of restenosis in femoropopliteal arteries: paclitaxel‐coated versus uncoated balloon: femoral paclitaxel randomized pilot trial. Circulation2008;118(13):1358‐65. ">FemPac 2008</a>; <a href="./references#CD011319-bbs2-0007" title="LairdJR , SchneiderP , TepeG , BrodmannM , ZellerT , MetzgerC , et al. Durability of treatment effect using a drug‐coated balloon for femoropopliteal lesions 24‐month results of IN.PACT SFA. Journal of the American College of Cardiology2015;66(21):2329‐38. TepeG , LairdJ , SchneiderP , BrodmannM , KrishnanP , MicariA , et al. Drug‐coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12‐month results from the IN.PACT SFA randomized trial. Circulation2015;131(5):495‐502. ">IN.PACT SFA 2015</a>; <a href="./references#CD011319-bbs2-0008" title="ScheinertD , DudaS , ZellerT , KrankenbergH , RickeJ , BosiersM , et al. The LEVANT I (Lutonix paclitaxel‐coated balloon for the prevention of femoropopliteal restenosis) trial for femoropopliteal revascularization: first‐in‐human randomized trial of low‐dose drug‐coated balloon versus uncoated balloon angioplasty. JACC. Cardiovascular Interventions2014;7(1):10‐9. ">LEVANT I 2014</a>; <a href="./references#CD011319-bbs2-0009" title="RosenfieldK , JaffMR , WhiteCJ , Rocha‐SinghK , Mena‐HurtadoC , MetzgerDC , et al. Trial of a paclitaxel‐coated balloon for femoropopliteal artery disease. New England Journal of Medicine2015;373(2):145‐53. ">LEVANT II 2015</a>; <a href="./references#CD011319-bbs2-0010" title="WerkM , AlbrechtT , MeyerDR , AhmedMN , BehneA , DietzU , et al. Paclitaxel‐coated balloons reduce restenosis after femoro‐popliteal angioplasty: evidence from the randomized PACIFIER trial. Circulation. Cardiovascular Interventions2012;5(6):831‐40. ">PACIFIER 2012</a>; <a href="./references#CD011319-bbs2-0011" title="TepeG , SchnorrB , AlbrechtT , BrechtelK , ClaussenCD , SchellerB , et al. Angioplasty of femoral‐popliteal arteries with drug‐coated balloons: 5‐year follow‐up of the THUNDER trial. JACC. Cardiovascular Interventions2015;8(1):102‐8. TepeG , ZellerT , AlbrechtT , HellerS , SchwarzwälderU , BeregiJP , et al. Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg. New England Journal of Medicine2008;358(7):689‐99. ">THUNDER 2008</a>), and three studies only examined tibial arteries (<a href="./references#CD011319-bbs2-0002" title="BIOTONIK's ‐ first in men study of the Passeo‐18 LUX drug releasing PTA balloon catheter vs. the uncoated Passeo 18 balloon catheter in subjects requiring revascularization of infrapopliteal arteries (BIOLUX P‐II). clinicaltrials.gov/ct2/show/NCT01867736 (accessed 15 August 2015). DelooseK , ZellerT , ScheinertD , BeschornerU . BIOLUX P‐II: a randomized clinical trial of Passeo‐18 Lux DRB vs POBA for the treatment of infrapopliteal artery lesions. Journal of the American College of Cardiology2014; Vol. 64, issue Suppl B. ScheinertD , BrodmannM , ZellerT , BosiersM , PeetersP , Karl‐LudwigS , et al. BIOLUX P‐II: a randomized clinical trial of Passeo‐18 lux drug releasing balloon versus plain old balloon angioplasty for the treatment of infrapopliteal artery lesions. Journal of the American College of Cardiology2014;64(11 Suppl 1):B79. ">BIOLUX P‐II</a>; <a href="./references#CD011319-bbs2-0003" title="LiistroF , PortoI , AngioliP , GrottiS , RicciL , DucciK , et al. Drug‐eluting balloon in peripheral intervention for below the knee angioplasty evaluation (DEBATE‐BTK): a randomized trial in diabetic patients with critical limb ischemia. Circulation2013;128(6):615‐21. ">DEBATE‐BTK 2013</a>; <a href="./references#CD011319-bbs2-0006" title="ZellerT , BaumgartnerI , ScheinertD , BrodmannM , BosiersM , MicariA , et al. Drug‐eluting balloon versus standard balloon angioplasty for infrapopliteal arterial revascularization in critical limb ischemia: 12‐month results from the IN.PACT DEEP randomized trial. Journal of the American College of Cardiology2014;64(15):1568‐76. ZellerT , BaumgartnerI , ScheinertD , BrodmannM , BosiersM , MicariA , et al. IN.PACT Amphirion paclitaxel eluting balloon versus standard percutaneous transluminal angioplasty for infrapopliteal revascularization of critical limb ischemia: rationale and protocol for an ongoing randomized controlled trial. Trials2014;15:63. ">IN.PACT DEEP 2014</a>). The <a href="./references#CD011319-bbs2-0004" title='FanelliF , CannavaleA , BoattaE , CoronaM , LucatelliP , WlderkA , et al. Lower limb multilevel treatment with drug‐eluting balloons: 6‐month results from the DEBELLUM randomized trial. Journal of Endovascular Therapy2012;19(5):571‐80. FanelliF , CannavaleA , CoronaM , LucatelliP , WlderkA , SalvatoriFM . The "DEBELLUM" ‐ lower limb multilevel treatment with drug eluting balloon ‐ randomized trial: 1‐year results. Journal of Cardiovascular Surgery2014;55(2):207‐16. '>DEBELLUM 2012</a> trial examined both femoropopliteal and tibial arteries. Every included trial used paclitaxel as the balloon‐coating drug. </p> <p>Medtronic manufactured the most‐frequently studied DEBs and sponsored three trials (<a href="./references#CD011319-bbs2-0006" title="ZellerT , BaumgartnerI , ScheinertD , BrodmannM , BosiersM , MicariA , et al. Drug‐eluting balloon versus standard balloon angioplasty for infrapopliteal arterial revascularization in critical limb ischemia: 12‐month results from the IN.PACT DEEP randomized trial. Journal of the American College of Cardiology2014;64(15):1568‐76. ZellerT , BaumgartnerI , ScheinertD , BrodmannM , BosiersM , MicariA , et al. IN.PACT Amphirion paclitaxel eluting balloon versus standard percutaneous transluminal angioplasty for infrapopliteal revascularization of critical limb ischemia: rationale and protocol for an ongoing randomized controlled trial. Trials2014;15:63. ">IN.PACT DEEP 2014</a>; <a href="./references#CD011319-bbs2-0007" title="LairdJR , SchneiderP , TepeG , BrodmannM , ZellerT , MetzgerC , et al. Durability of treatment effect using a drug‐coated balloon for femoropopliteal lesions 24‐month results of IN.PACT SFA. Journal of the American College of Cardiology2015;66(21):2329‐38. TepeG , LairdJ , SchneiderP , BrodmannM , KrishnanP , MicariA , et al. Drug‐coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12‐month results from the IN.PACT SFA randomized trial. Circulation2015;131(5):495‐502. ">IN.PACT SFA 2015</a>; <a href="./references#CD011319-bbs2-0010" title="WerkM , AlbrechtT , MeyerDR , AhmedMN , BehneA , DietzU , et al. Paclitaxel‐coated balloons reduce restenosis after femoro‐popliteal angioplasty: evidence from the randomized PACIFIER trial. Circulation. Cardiovascular Interventions2012;5(6):831‐40. ">PACIFIER 2012</a>). Two trials also used Medtronic devices but did not report receiving any industry sponsorship (<a href="./references#CD011319-bbs2-0003" title="LiistroF , PortoI , AngioliP , GrottiS , RicciL , DucciK , et al. Drug‐eluting balloon in peripheral intervention for below the knee angioplasty evaluation (DEBATE‐BTK): a randomized trial in diabetic patients with critical limb ischemia. Circulation2013;128(6):615‐21. ">DEBATE‐BTK 2013</a>; <a href="./references#CD011319-bbs2-0004" title='FanelliF , CannavaleA , BoattaE , CoronaM , LucatelliP , WlderkA , et al. Lower limb multilevel treatment with drug‐eluting balloons: 6‐month results from the DEBELLUM randomized trial. Journal of Endovascular Therapy2012;19(5):571‐80. FanelliF , CannavaleA , CoronaM , LucatelliP , WlderkA , SalvatoriFM . The "DEBELLUM" ‐ lower limb multilevel treatment with drug eluting balloon ‐ randomized trial: 1‐year results. Journal of Cardiovascular Surgery2014;55(2):207‐16. '>DEBELLUM 2012</a>). Bavaria Medizin (<a href="./references#CD011319-bbs2-0005" title="WerkM , LangnerS , ReinkensmeierB , BoettcherHF , TepeG , DietzU , et al. Inhibition of restenosis in femoropopliteal arteries: paclitaxel‐coated versus uncoated balloon: femoral paclitaxel randomized pilot trial. Circulation2008;118(13):1358‐65. ">FemPac 2008</a>; <a href="./references#CD011319-bbs2-0011" title="TepeG , SchnorrB , AlbrechtT , BrechtelK , ClaussenCD , SchellerB , et al. Angioplasty of femoral‐popliteal arteries with drug‐coated balloons: 5‐year follow‐up of the THUNDER trial. JACC. Cardiovascular Interventions2015;8(1):102‐8. TepeG , ZellerT , AlbrechtT , HellerS , SchwarzwälderU , BeregiJP , et al. Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg. New England Journal of Medicine2008;358(7):689‐99. ">THUNDER 2008</a>), Bard (<a href="./references#CD011319-bbs2-0008" title="ScheinertD , DudaS , ZellerT , KrankenbergH , RickeJ , BosiersM , et al. The LEVANT I (Lutonix paclitaxel‐coated balloon for the prevention of femoropopliteal restenosis) trial for femoropopliteal revascularization: first‐in‐human randomized trial of low‐dose drug‐coated balloon versus uncoated balloon angioplasty. JACC. Cardiovascular Interventions2014;7(1):10‐9. ">LEVANT I 2014</a>; <a href="./references#CD011319-bbs2-0009" title="RosenfieldK , JaffMR , WhiteCJ , Rocha‐SinghK , Mena‐HurtadoC , MetzgerDC , et al. Trial of a paclitaxel‐coated balloon for femoropopliteal artery disease. New England Journal of Medicine2015;373(2):145‐53. ">LEVANT II 2015</a>), and Biotronik (<a href="./references#CD011319-bbs2-0001" title="A prospective, multi‐centre, randomized controlled, first in man study to assess the safety and performance of the Passeo‐18 Lux paclitaxel releasing PTA balloon catheter vs. the uncoated Passeo 18 balloon catheter in patients with stenosis and occlusion of the femoropopliteal arteries (BIOLUX P‐I). clinicaltrials.gov/ct2/show/NCT01221610 (accessed 15 August 2015). ScheinertD , SchulteKL , ZellerT , LammerJ , TepeG . Paclitaxel‐releasing balloon in femoropopliteal lesions using a BTHC excipient: twelve‐month results from the BIOLUX P‐I randomized trial. Journal of Endovascular Therapy2015;22:14‐21. TepeG , SchulteK‐L , ZellerT , LammerJ , PfaffingerP , SchmidtA , et al. Six‐month results of the BIOLUX P‐I first in man study comparing a paclitaxel‐releasing balloon catheter versus an uncoated balloon catheter in femoropopliteal lesions. Cardiovascular and Interventional Radiology2012; Vol. 35:S264‐5. ZellerT , LammerJ , RastanA , SchulteK , TepeG , ScheinertD . Twelve‐month results of the BIOLUX P‐I first‐in‐man study comparing a paclitaxel‐releasing balloon catheter versus an uncoated catheter in femoropopliteal lesions. Vasa ‐ Journal of Vascular Diseases2013;42(Suppl 84):FV 9.7. ">BIOLUX P‐I</a>; <a href="./references#CD011319-bbs2-0002" title="BIOTONIK's ‐ first in men study of the Passeo‐18 LUX drug releasing PTA balloon catheter vs. the uncoated Passeo 18 balloon catheter in subjects requiring revascularization of infrapopliteal arteries (BIOLUX P‐II). clinicaltrials.gov/ct2/show/NCT01867736 (accessed 15 August 2015). DelooseK , ZellerT , ScheinertD , BeschornerU . BIOLUX P‐II: a randomized clinical trial of Passeo‐18 Lux DRB vs POBA for the treatment of infrapopliteal artery lesions. Journal of the American College of Cardiology2014; Vol. 64, issue Suppl B. ScheinertD , BrodmannM , ZellerT , BosiersM , PeetersP , Karl‐LudwigS , et al. BIOLUX P‐II: a randomized clinical trial of Passeo‐18 lux drug releasing balloon versus plain old balloon angioplasty for the treatment of infrapopliteal artery lesions. Journal of the American College of Cardiology2014;64(11 Suppl 1):B79. ">BIOLUX P‐II</a>) sponsored two trials each. </p> <p>We also identified 13 trials that were either ongoing or awaiting publication (see <a href="./references#CD011319-sec-0114" title="">Characteristics of ongoing studies</a> table). We contacted authors of all ongoing studies to request study data. </p> </section> <section id="CD011319-sec-0057"> <h4 class="title">Excluded studies</h4> <p>We excluded 14 trials from our review (<a href="./references#CD011319-bbs2-0012" title="Cotavance™ Paclitaxel‐coated balloon versus uncoated balloon angioplasty for treatment of in‐stent restenosis in SFA and popliteal arteries COPA CABANA Study. clinicaltrials.gov/ct2/show/NCT01594684 (accessed 15 August 2015). ">COPA CABANA</a>; <a href="./references#CD011319-bbs2-0013" title="LiistroF , AngioliP , PortoI , RicciL , DucciK , GrottiS , et al. Paclitaxel‐eluting balloon vs. standard angioplasty to reduce recurrent restenosis in diabetic patients with in‐stent restenosis of the superficial femoral and proximal popliteal arteries: the DEBATE‐ISR study. Journal of Endovascular Therapy2014;21(1):1‐8. ">DEBATE‐ISR</a>; <a href="./references#CD011319-bbs2-0014" title="LiistroF , GrottiS , PortoI , AngioliP , RicciL , DucciK , et al. Drug‐eluting balloon in peripheral intervention for the superficial femoral artery: the DEBATE‐SFA randomized trial (drug eluting balloon in peripheral intervention for the superficial femoral artery). JACC. Cardiovascular Interventions2013;6(12):1295‐302. ">DEBATE SFA</a>; <a href="./references#CD011319-bbs2-0015" title="Directional atherectomy followed by a paclitaxel‐coated balloon to inhibit restenosIs and maintain vessel patency: a pilot study of anti‐restenosis treatment. clinicaltrials.gov/ct2/show/NCT01366482 (accessed 15 August 2015). ">DEFINITIVE AR</a>; <a href="./references#CD011319-bbs2-0016" title="European study of POBA versus Cotavance paclitaxel coated balloon for the treatment of infrapopliteal lesions in critical limb ischemia. clinicaltrials.gov/ct2/show/NCT01260870 (accessed 15 August 2015). ">EURO CANAL</a>; <a href="./references#CD011319-bbs2-0017" title="Femoral artery in‐stent restenosis (FAIR) trial. clinicaltrials.gov/ct2/show/record/NCT01305070 (accessed 15 August 2015). ">FAIR</a>; <a href="./references#CD011319-bbs2-0018" title="TackeJ , KieselbachD , SchulteKL . [The Freeway stent study]. Presented at the Transcatheter Cardiovascular Therapeutics Conference in Washington, D.C.September 2014. ">Freeway Stent Study</a>; <a href="./references#CD011319-bbs2-0019" title="SiablisD , KitrouPM , SpiliopoulosS , KatsanosK , KarnabatidisD . Paclitaxel‐coated balloon angioplasty versus drug‐eluting stenting for the treatment of infrapopliteal long‐segment arterial occlusive disease: the IDEAS randomized controlled trial. JACC. Cardiovascular Interventions2014;7(9):1048‐56. ">IDEAS</a>; <a href="./references#CD011319-bbs2-0020" title="Randomized trial of paclitaxel eluting balloon or conventional balloon for treatment of in‐stent restenosis of the superficial femoral artery in patients with symptomatic peripheral artery disease (ISAR‐PEBIS). clinicaltrials.gov/ct2/show/NCT01083394 (accessed 15 August 2015). ">ISAR‐PEBIS</a>; <a href="./references#CD011319-bbs2-0021" title="Randomized trial of stenting after dilation with or without paclitaxel eluting balloon or atherectomy in patients with symptomatic peripheral artery disease. clinicaltrials.gov/ct2/show/NCT00986752 (accessed 15 August 2015). ">ISAR‐STATH</a>; <a href="./references#CD011319-bbs2-0022" title="A monocenter randomized clinical trial of PAClitaxel drUg‐eluting BAlloon versus standard percutaneous transluminal angioplasty to reduce restenosis in patients with in‐stent stenoses in the superficial femoral and proximal popliteal artery. clinicaltrials.gov/ct2/show/NCT01247402 (accessed 15 August 2015). ">PACUBA 1</a>; <a href="./references#CD011319-bbs2-0023" title="Photoablative atherectomy followed by a paclitaxel‐coated balloon to inhibit restenosis in instent femoro‐popliteal obstructions. clinicaltrials.gov/ct2/show/NCT01298947 (accessed 15 August 2015). ">PHOTOPAC</a>; <a href="./references#CD011319-bbs2-0024" title="KarimiA , deBoerSW , van denHeuvelD , FiooleB , VroegindeweijD , HeyligersJMM , et al. Randomized trial of Legflow® paclitaxel eluting balloon and stenting versus standard percutaneous transluminal angioplasty and stenting for the treatment of intermediate and long lesions of the superficial femoral artery (RAPID trial): study protocol for a randomized controlled trial. Trials2013;14:87. ">RAPID</a>; <a href="./references#CD011319-bbs2-0025" title="Swedish drug‐elution trial in peripheral arterial disease ‐ a multicenter, prospective randomized controlled clinical trial based on the Swedish Vascular Registry (SWEDVASC) Platform. clinicaltrials.gov/ct2/show/NCT02051088 (accessed 15 August 2015). ">SWEDEPAD</a>). The reasons for exclusion are outlined in the <a href="./references#CD011319-sec-0113" title="">Characteristics of excluded studies</a> table. Studies were most commonly excluded for comparing DEB and bare‐metal or drug‐eluting stenting (<a href="./references#CD011319-bbs2-0014" title="LiistroF , GrottiS , PortoI , AngioliP , RicciL , DucciK , et al. Drug‐eluting balloon in peripheral intervention for the superficial femoral artery: the DEBATE‐SFA randomized trial (drug eluting balloon in peripheral intervention for the superficial femoral artery). JACC. Cardiovascular Interventions2013;6(12):1295‐302. ">DEBATE SFA</a>; <a href="./references#CD011319-bbs2-0019" title="SiablisD , KitrouPM , SpiliopoulosS , KatsanosK , KarnabatidisD . Paclitaxel‐coated balloon angioplasty versus drug‐eluting stenting for the treatment of infrapopliteal long‐segment arterial occlusive disease: the IDEAS randomized controlled trial. JACC. Cardiovascular Interventions2014;7(9):1048‐56. ">IDEAS</a>; <a href="./references#CD011319-bbs2-0024" title="KarimiA , deBoerSW , van denHeuvelD , FiooleB , VroegindeweijD , HeyligersJMM , et al. Randomized trial of Legflow® paclitaxel eluting balloon and stenting versus standard percutaneous transluminal angioplasty and stenting for the treatment of intermediate and long lesions of the superficial femoral artery (RAPID trial): study protocol for a randomized controlled trial. Trials2013;14:87. ">RAPID</a>), DEB and uncoated balloon angioplasty for the management of instent restenosis (<a href="./references#CD011319-bbs2-0012" title="Cotavance™ Paclitaxel‐coated balloon versus uncoated balloon angioplasty for treatment of in‐stent restenosis in SFA and popliteal arteries COPA CABANA Study. clinicaltrials.gov/ct2/show/NCT01594684 (accessed 15 August 2015). ">COPA CABANA</a>; <a href="./references#CD011319-bbs2-0013" title="LiistroF , AngioliP , PortoI , RicciL , DucciK , GrottiS , et al. Paclitaxel‐eluting balloon vs. standard angioplasty to reduce recurrent restenosis in diabetic patients with in‐stent restenosis of the superficial femoral and proximal popliteal arteries: the DEBATE‐ISR study. Journal of Endovascular Therapy2014;21(1):1‐8. ">DEBATE‐ISR</a>; <a href="./references#CD011319-bbs2-0017" title="Femoral artery in‐stent restenosis (FAIR) trial. clinicaltrials.gov/ct2/show/record/NCT01305070 (accessed 15 August 2015). ">FAIR</a>; <a href="./references#CD011319-bbs2-0018" title="TackeJ , KieselbachD , SchulteKL . [The Freeway stent study]. Presented at the Transcatheter Cardiovascular Therapeutics Conference in Washington, D.C.September 2014. ">Freeway Stent Study</a>; <a href="./references#CD011319-bbs2-0020" title="Randomized trial of paclitaxel eluting balloon or conventional balloon for treatment of in‐stent restenosis of the superficial femoral artery in patients with symptomatic peripheral artery disease (ISAR‐PEBIS). clinicaltrials.gov/ct2/show/NCT01083394 (accessed 15 August 2015). ">ISAR‐PEBIS</a>; <a href="./references#CD011319-bbs2-0022" title="A monocenter randomized clinical trial of PAClitaxel drUg‐eluting BAlloon versus standard percutaneous transluminal angioplasty to reduce restenosis in patients with in‐stent stenoses in the superficial femoral and proximal popliteal artery. clinicaltrials.gov/ct2/show/NCT01247402 (accessed 15 August 2015). ">PACUBA 1</a>), or DEB with or without atherectomy (<a href="./references#CD011319-bbs2-0015" title="Directional atherectomy followed by a paclitaxel‐coated balloon to inhibit restenosIs and maintain vessel patency: a pilot study of anti‐restenosis treatment. clinicaltrials.gov/ct2/show/NCT01366482 (accessed 15 August 2015). ">DEFINITIVE AR</a>; <a href="./references#CD011319-bbs2-0021" title="Randomized trial of stenting after dilation with or without paclitaxel eluting balloon or atherectomy in patients with symptomatic peripheral artery disease. clinicaltrials.gov/ct2/show/NCT00986752 (accessed 15 August 2015). ">ISAR‐STATH</a>). One trial compared DEB with or without photoablation therapy for the prevention of instent restenosis (<a href="./references#CD011319-bbs2-0023" title="Photoablative atherectomy followed by a paclitaxel‐coated balloon to inhibit restenosis in instent femoro‐popliteal obstructions. clinicaltrials.gov/ct2/show/NCT01298947 (accessed 15 August 2015). ">PHOTOPAC</a>). The <a href="./references#CD011319-bbs2-0025" title="Swedish drug‐elution trial in peripheral arterial disease ‐ a multicenter, prospective randomized controlled clinical trial based on the Swedish Vascular Registry (SWEDVASC) Platform. clinicaltrials.gov/ct2/show/NCT02051088 (accessed 15 August 2015). ">SWEDEPAD</a> trial compared drug‐eluting technologies (balloon or stents) with nondrug‐eluting technologies (balloons or stents). The <a href="./references#CD011319-bbs2-0016" title="European study of POBA versus Cotavance paclitaxel coated balloon for the treatment of infrapopliteal lesions in critical limb ischemia. clinicaltrials.gov/ct2/show/NCT01260870 (accessed 15 August 2015). ">EURO CANAL</a> was terminated early before any data were collected because the manufacturer withdrew the product from the market. </p> </section> </section> <section id="CD011319-sec-0058"> <h3 class="title">Risk of bias in included studies</h3> <p>See 'Risk of bias' tables in the <a href="./references#CD011319-sec-0112" title="">Characteristics of included studies</a> table and summary results in <a href="#CD011319-fig-0002">Figure 2</a> and <a href="#CD011319-fig-0003">Figure 3</a>. </p> <div class="figure" id="CD011319-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgments about each risk of bias item presented as percentages across all included studies." data-id="CD011319-fig-0002" src="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgments about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD011319-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgments about each risk of bias item for each included study." data-id="CD011319-fig-0003" src="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgments about each risk of bias item for each included study. </p> </div> </div> </div> <p>Of the included studies, three were at high risk of bias and were excluded in sensitivity analyses to determine their impact (<a href="./references#CD011319-bbs2-0001" title="A prospective, multi‐centre, randomized controlled, first in man study to assess the safety and performance of the Passeo‐18 Lux paclitaxel releasing PTA balloon catheter vs. the uncoated Passeo 18 balloon catheter in patients with stenosis and occlusion of the femoropopliteal arteries (BIOLUX P‐I). clinicaltrials.gov/ct2/show/NCT01221610 (accessed 15 August 2015). ScheinertD , SchulteKL , ZellerT , LammerJ , TepeG . Paclitaxel‐releasing balloon in femoropopliteal lesions using a BTHC excipient: twelve‐month results from the BIOLUX P‐I randomized trial. Journal of Endovascular Therapy2015;22:14‐21. TepeG , SchulteK‐L , ZellerT , LammerJ , PfaffingerP , SchmidtA , et al. Six‐month results of the BIOLUX P‐I first in man study comparing a paclitaxel‐releasing balloon catheter versus an uncoated balloon catheter in femoropopliteal lesions. Cardiovascular and Interventional Radiology2012; Vol. 35:S264‐5. ZellerT , LammerJ , RastanA , SchulteK , TepeG , ScheinertD . Twelve‐month results of the BIOLUX P‐I first‐in‐man study comparing a paclitaxel‐releasing balloon catheter versus an uncoated catheter in femoropopliteal lesions. Vasa ‐ Journal of Vascular Diseases2013;42(Suppl 84):FV 9.7. ">BIOLUX P‐I</a>; <a href="./references#CD011319-bbs2-0002" title="BIOTONIK's ‐ first in men study of the Passeo‐18 LUX drug releasing PTA balloon catheter vs. the uncoated Passeo 18 balloon catheter in subjects requiring revascularization of infrapopliteal arteries (BIOLUX P‐II). clinicaltrials.gov/ct2/show/NCT01867736 (accessed 15 August 2015). DelooseK , ZellerT , ScheinertD , BeschornerU . BIOLUX P‐II: a randomized clinical trial of Passeo‐18 Lux DRB vs POBA for the treatment of infrapopliteal artery lesions. Journal of the American College of Cardiology2014; Vol. 64, issue Suppl B. ScheinertD , BrodmannM , ZellerT , BosiersM , PeetersP , Karl‐LudwigS , et al. BIOLUX P‐II: a randomized clinical trial of Passeo‐18 lux drug releasing balloon versus plain old balloon angioplasty for the treatment of infrapopliteal artery lesions. Journal of the American College of Cardiology2014;64(11 Suppl 1):B79. ">BIOLUX P‐II</a>; <a href="./references#CD011319-bbs2-0005" title="WerkM , LangnerS , ReinkensmeierB , BoettcherHF , TepeG , DietzU , et al. Inhibition of restenosis in femoropopliteal arteries: paclitaxel‐coated versus uncoated balloon: femoral paclitaxel randomized pilot trial. Circulation2008;118(13):1358‐65. ">FemPac 2008</a>). <a href="./references#CD011319-bbs2-0001" title="A prospective, multi‐centre, randomized controlled, first in man study to assess the safety and performance of the Passeo‐18 Lux paclitaxel releasing PTA balloon catheter vs. the uncoated Passeo 18 balloon catheter in patients with stenosis and occlusion of the femoropopliteal arteries (BIOLUX P‐I). clinicaltrials.gov/ct2/show/NCT01221610 (accessed 15 August 2015). ScheinertD , SchulteKL , ZellerT , LammerJ , TepeG . Paclitaxel‐releasing balloon in femoropopliteal lesions using a BTHC excipient: twelve‐month results from the BIOLUX P‐I randomized trial. Journal of Endovascular Therapy2015;22:14‐21. TepeG , SchulteK‐L , ZellerT , LammerJ , PfaffingerP , SchmidtA , et al. Six‐month results of the BIOLUX P‐I first in man study comparing a paclitaxel‐releasing balloon catheter versus an uncoated balloon catheter in femoropopliteal lesions. Cardiovascular and Interventional Radiology2012; Vol. 35:S264‐5. ZellerT , LammerJ , RastanA , SchulteK , TepeG , ScheinertD . Twelve‐month results of the BIOLUX P‐I first‐in‐man study comparing a paclitaxel‐releasing balloon catheter versus an uncoated catheter in femoropopliteal lesions. Vasa ‐ Journal of Vascular Diseases2013;42(Suppl 84):FV 9.7. ">BIOLUX P‐I</a> was at high risk of bias because of a low follow‐up compliance and a high rate of bailout stenting (26.7%) in the control arm. Furthermore, more than half of the participants in both arms had a history of peripheral vascular interventions, and it is unclear whether the lesions studied in the trial had been previously treated. <a href="./references#CD011319-bbs2-0002" title="BIOTONIK's ‐ first in men study of the Passeo‐18 LUX drug releasing PTA balloon catheter vs. the uncoated Passeo 18 balloon catheter in subjects requiring revascularization of infrapopliteal arteries (BIOLUX P‐II). clinicaltrials.gov/ct2/show/NCT01867736 (accessed 15 August 2015). DelooseK , ZellerT , ScheinertD , BeschornerU . BIOLUX P‐II: a randomized clinical trial of Passeo‐18 Lux DRB vs POBA for the treatment of infrapopliteal artery lesions. Journal of the American College of Cardiology2014; Vol. 64, issue Suppl B. ScheinertD , BrodmannM , ZellerT , BosiersM , PeetersP , Karl‐LudwigS , et al. BIOLUX P‐II: a randomized clinical trial of Passeo‐18 lux drug releasing balloon versus plain old balloon angioplasty for the treatment of infrapopliteal artery lesions. Journal of the American College of Cardiology2014;64(11 Suppl 1):B79. ">BIOLUX P‐II</a> did not blind the operators or the participants to the procedure. Approximately 20% of the participants in the intervention arm were lost to follow‐up, and the rate of technical success in the study was relatively low for both arms (54.5% for the DEB arm and 59.6% for the control arm). <a href="./references#CD011319-bbs2-0005" title="WerkM , LangnerS , ReinkensmeierB , BoettcherHF , TepeG , DietzU , et al. Inhibition of restenosis in femoropopliteal arteries: paclitaxel‐coated versus uncoated balloon: femoral paclitaxel randomized pilot trial. Circulation2008;118(13):1358‐65. ">FemPac 2008</a> similarly did not have adequate follow‐up data on 27% of the DEB arm and 17% of the control arm. Furthermore, approximately 11% of the trial participants were stented, but the outcomes of those participants were not reported separately. </p> <section id="CD011319-sec-0059"> <h4 class="title">Allocation</h4> <p>Most of the included studies were at a low risk for sequence generation selection bias. <a href="./references#CD011319-bbs2-0006" title="ZellerT , BaumgartnerI , ScheinertD , BrodmannM , BosiersM , MicariA , et al. Drug‐eluting balloon versus standard balloon angioplasty for infrapopliteal arterial revascularization in critical limb ischemia: 12‐month results from the IN.PACT DEEP randomized trial. Journal of the American College of Cardiology2014;64(15):1568‐76. ZellerT , BaumgartnerI , ScheinertD , BrodmannM , BosiersM , MicariA , et al. IN.PACT Amphirion paclitaxel eluting balloon versus standard percutaneous transluminal angioplasty for infrapopliteal revascularization of critical limb ischemia: rationale and protocol for an ongoing randomized controlled trial. Trials2014;15:63. ">IN.PACT DEEP 2014</a> randomized participants using "blocks of sealed envelopes" without specifying the methodology for generating those randomization blocks. <a href="./references#CD011319-bbs2-0009" title="RosenfieldK , JaffMR , WhiteCJ , Rocha‐SinghK , Mena‐HurtadoC , MetzgerDC , et al. Trial of a paclitaxel‐coated balloon for femoropopliteal artery disease. New England Journal of Medicine2015;373(2):145‐53. ">LEVANT II 2015</a> did not specify how participants were randomized or allocated to either study arm. </p> <p>Similarly, most studies were at a low risk for allocation concealment selection bias. However, four studies did not specify how allocation concealment bias was addressed (<a href="./references#CD011319-bbs2-0002" title="BIOTONIK's ‐ first in men study of the Passeo‐18 LUX drug releasing PTA balloon catheter vs. the uncoated Passeo 18 balloon catheter in subjects requiring revascularization of infrapopliteal arteries (BIOLUX P‐II). clinicaltrials.gov/ct2/show/NCT01867736 (accessed 15 August 2015). DelooseK , ZellerT , ScheinertD , BeschornerU . BIOLUX P‐II: a randomized clinical trial of Passeo‐18 Lux DRB vs POBA for the treatment of infrapopliteal artery lesions. Journal of the American College of Cardiology2014; Vol. 64, issue Suppl B. ScheinertD , BrodmannM , ZellerT , BosiersM , PeetersP , Karl‐LudwigS , et al. BIOLUX P‐II: a randomized clinical trial of Passeo‐18 lux drug releasing balloon versus plain old balloon angioplasty for the treatment of infrapopliteal artery lesions. Journal of the American College of Cardiology2014;64(11 Suppl 1):B79. ">BIOLUX P‐II</a>; <a href="./references#CD011319-bbs2-0005" title="WerkM , LangnerS , ReinkensmeierB , BoettcherHF , TepeG , DietzU , et al. Inhibition of restenosis in femoropopliteal arteries: paclitaxel‐coated versus uncoated balloon: femoral paclitaxel randomized pilot trial. Circulation2008;118(13):1358‐65. ">FemPac 2008</a>; <a href="./references#CD011319-bbs2-0009" title="RosenfieldK , JaffMR , WhiteCJ , Rocha‐SinghK , Mena‐HurtadoC , MetzgerDC , et al. Trial of a paclitaxel‐coated balloon for femoropopliteal artery disease. New England Journal of Medicine2015;373(2):145‐53. ">LEVANT II 2015</a>; <a href="./references#CD011319-bbs2-0011" title="TepeG , SchnorrB , AlbrechtT , BrechtelK , ClaussenCD , SchellerB , et al. Angioplasty of femoral‐popliteal arteries with drug‐coated balloons: 5‐year follow‐up of the THUNDER trial. JACC. Cardiovascular Interventions2015;8(1):102‐8. TepeG , ZellerT , AlbrechtT , HellerS , SchwarzwälderU , BeregiJP , et al. Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg. New England Journal of Medicine2008;358(7):689‐99. ">THUNDER 2008</a>). </p> </section> <section id="CD011319-sec-0060"> <h4 class="title">Blinding</h4> <p>All of the included studies were at high risk for performance bias because the operators were not blinded to the procedure. In <a href="./references#CD011319-bbs2-0002" title="BIOTONIK's ‐ first in men study of the Passeo‐18 LUX drug releasing PTA balloon catheter vs. the uncoated Passeo 18 balloon catheter in subjects requiring revascularization of infrapopliteal arteries (BIOLUX P‐II). clinicaltrials.gov/ct2/show/NCT01867736 (accessed 15 August 2015). DelooseK , ZellerT , ScheinertD , BeschornerU . BIOLUX P‐II: a randomized clinical trial of Passeo‐18 Lux DRB vs POBA for the treatment of infrapopliteal artery lesions. Journal of the American College of Cardiology2014; Vol. 64, issue Suppl B. ScheinertD , BrodmannM , ZellerT , BosiersM , PeetersP , Karl‐LudwigS , et al. BIOLUX P‐II: a randomized clinical trial of Passeo‐18 lux drug releasing balloon versus plain old balloon angioplasty for the treatment of infrapopliteal artery lesions. Journal of the American College of Cardiology2014;64(11 Suppl 1):B79. ">BIOLUX P‐II</a>, neither the participants nor the operators were blinded. </p> <p>Conversely, the risk of detection bias was low as study authors mostly ensured that outcome assessment was carried out by other blinded investigators. The <a href="./references#CD011319-bbs2-0004" title='FanelliF , CannavaleA , BoattaE , CoronaM , LucatelliP , WlderkA , et al. Lower limb multilevel treatment with drug‐eluting balloons: 6‐month results from the DEBELLUM randomized trial. Journal of Endovascular Therapy2012;19(5):571‐80. FanelliF , CannavaleA , CoronaM , LucatelliP , WlderkA , SalvatoriFM . The "DEBELLUM" ‐ lower limb multilevel treatment with drug eluting balloon ‐ randomized trial: 1‐year results. Journal of Cardiovascular Surgery2014;55(2):207‐16. '>DEBELLUM 2012</a> authors stated that "postoperative evaluation was deferred to different physicians not informed about the assigned intervention", but it was unclear what type of physicians performed those evaluations and what type of qualifications they had. The <a href="./references#CD011319-bbs2-0011" title="TepeG , SchnorrB , AlbrechtT , BrechtelK , ClaussenCD , SchellerB , et al. Angioplasty of femoral‐popliteal arteries with drug‐coated balloons: 5‐year follow‐up of the THUNDER trial. JACC. Cardiovascular Interventions2015;8(1):102‐8. TepeG , ZellerT , AlbrechtT , HellerS , SchwarzwälderU , BeregiJP , et al. Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg. New England Journal of Medicine2008;358(7):689‐99. ">THUNDER 2008</a> authors stated that some of the operators also performed some of the poststudy evaluations. </p> </section> <section id="CD011319-sec-0061"> <h4 class="title">Incomplete outcome data</h4> <p>Six trials were at high risk of attrition bias (<a href="./references#CD011319-bbs2-0001" title="A prospective, multi‐centre, randomized controlled, first in man study to assess the safety and performance of the Passeo‐18 Lux paclitaxel releasing PTA balloon catheter vs. the uncoated Passeo 18 balloon catheter in patients with stenosis and occlusion of the femoropopliteal arteries (BIOLUX P‐I). clinicaltrials.gov/ct2/show/NCT01221610 (accessed 15 August 2015). ScheinertD , SchulteKL , ZellerT , LammerJ , TepeG . Paclitaxel‐releasing balloon in femoropopliteal lesions using a BTHC excipient: twelve‐month results from the BIOLUX P‐I randomized trial. Journal of Endovascular Therapy2015;22:14‐21. TepeG , SchulteK‐L , ZellerT , LammerJ , PfaffingerP , SchmidtA , et al. Six‐month results of the BIOLUX P‐I first in man study comparing a paclitaxel‐releasing balloon catheter versus an uncoated balloon catheter in femoropopliteal lesions. Cardiovascular and Interventional Radiology2012; Vol. 35:S264‐5. ZellerT , LammerJ , RastanA , SchulteK , TepeG , ScheinertD . Twelve‐month results of the BIOLUX P‐I first‐in‐man study comparing a paclitaxel‐releasing balloon catheter versus an uncoated catheter in femoropopliteal lesions. Vasa ‐ Journal of Vascular Diseases2013;42(Suppl 84):FV 9.7. ">BIOLUX P‐I</a>; <a href="./references#CD011319-bbs2-0002" title="BIOTONIK's ‐ first in men study of the Passeo‐18 LUX drug releasing PTA balloon catheter vs. the uncoated Passeo 18 balloon catheter in subjects requiring revascularization of infrapopliteal arteries (BIOLUX P‐II). clinicaltrials.gov/ct2/show/NCT01867736 (accessed 15 August 2015). DelooseK , ZellerT , ScheinertD , BeschornerU . BIOLUX P‐II: a randomized clinical trial of Passeo‐18 Lux DRB vs POBA for the treatment of infrapopliteal artery lesions. Journal of the American College of Cardiology2014; Vol. 64, issue Suppl B. ScheinertD , BrodmannM , ZellerT , BosiersM , PeetersP , Karl‐LudwigS , et al. BIOLUX P‐II: a randomized clinical trial of Passeo‐18 lux drug releasing balloon versus plain old balloon angioplasty for the treatment of infrapopliteal artery lesions. Journal of the American College of Cardiology2014;64(11 Suppl 1):B79. ">BIOLUX P‐II</a>; <a href="./references#CD011319-bbs2-0005" title="WerkM , LangnerS , ReinkensmeierB , BoettcherHF , TepeG , DietzU , et al. Inhibition of restenosis in femoropopliteal arteries: paclitaxel‐coated versus uncoated balloon: femoral paclitaxel randomized pilot trial. Circulation2008;118(13):1358‐65. ">FemPac 2008</a>; <a href="./references#CD011319-bbs2-0006" title="ZellerT , BaumgartnerI , ScheinertD , BrodmannM , BosiersM , MicariA , et al. Drug‐eluting balloon versus standard balloon angioplasty for infrapopliteal arterial revascularization in critical limb ischemia: 12‐month results from the IN.PACT DEEP randomized trial. Journal of the American College of Cardiology2014;64(15):1568‐76. ZellerT , BaumgartnerI , ScheinertD , BrodmannM , BosiersM , MicariA , et al. IN.PACT Amphirion paclitaxel eluting balloon versus standard percutaneous transluminal angioplasty for infrapopliteal revascularization of critical limb ischemia: rationale and protocol for an ongoing randomized controlled trial. Trials2014;15:63. ">IN.PACT DEEP 2014</a>; <a href="./references#CD011319-bbs2-0008" title="ScheinertD , DudaS , ZellerT , KrankenbergH , RickeJ , BosiersM , et al. The LEVANT I (Lutonix paclitaxel‐coated balloon for the prevention of femoropopliteal restenosis) trial for femoropopliteal revascularization: first‐in‐human randomized trial of low‐dose drug‐coated balloon versus uncoated balloon angioplasty. JACC. Cardiovascular Interventions2014;7(1):10‐9. ">LEVANT I 2014</a>; <a href="./references#CD011319-bbs2-0010" title="WerkM , AlbrechtT , MeyerDR , AhmedMN , BehneA , DietzU , et al. Paclitaxel‐coated balloons reduce restenosis after femoro‐popliteal angioplasty: evidence from the randomized PACIFIER trial. Circulation. Cardiovascular Interventions2012;5(6):831‐40. ">PACIFIER 2012</a>). In <a href="./references#CD011319-bbs2-0001" title="A prospective, multi‐centre, randomized controlled, first in man study to assess the safety and performance of the Passeo‐18 Lux paclitaxel releasing PTA balloon catheter vs. the uncoated Passeo 18 balloon catheter in patients with stenosis and occlusion of the femoropopliteal arteries (BIOLUX P‐I). clinicaltrials.gov/ct2/show/NCT01221610 (accessed 15 August 2015). ScheinertD , SchulteKL , ZellerT , LammerJ , TepeG . Paclitaxel‐releasing balloon in femoropopliteal lesions using a BTHC excipient: twelve‐month results from the BIOLUX P‐I randomized trial. Journal of Endovascular Therapy2015;22:14‐21. TepeG , SchulteK‐L , ZellerT , LammerJ , PfaffingerP , SchmidtA , et al. Six‐month results of the BIOLUX P‐I first in man study comparing a paclitaxel‐releasing balloon catheter versus an uncoated balloon catheter in femoropopliteal lesions. Cardiovascular and Interventional Radiology2012; Vol. 35:S264‐5. ZellerT , LammerJ , RastanA , SchulteK , TepeG , ScheinertD . Twelve‐month results of the BIOLUX P‐I first‐in‐man study comparing a paclitaxel‐releasing balloon catheter versus an uncoated catheter in femoropopliteal lesions. Vasa ‐ Journal of Vascular Diseases2013;42(Suppl 84):FV 9.7. ">BIOLUX P‐I</a>, four participants withdrew consent and five participants were lost to follow‐up, which equals a 15% attrition of the study population. Similarly, in <a href="./references#CD011319-bbs2-0002" title="BIOTONIK's ‐ first in men study of the Passeo‐18 LUX drug releasing PTA balloon catheter vs. the uncoated Passeo 18 balloon catheter in subjects requiring revascularization of infrapopliteal arteries (BIOLUX P‐II). clinicaltrials.gov/ct2/show/NCT01867736 (accessed 15 August 2015). DelooseK , ZellerT , ScheinertD , BeschornerU . BIOLUX P‐II: a randomized clinical trial of Passeo‐18 Lux DRB vs POBA for the treatment of infrapopliteal artery lesions. Journal of the American College of Cardiology2014; Vol. 64, issue Suppl B. ScheinertD , BrodmannM , ZellerT , BosiersM , PeetersP , Karl‐LudwigS , et al. BIOLUX P‐II: a randomized clinical trial of Passeo‐18 lux drug releasing balloon versus plain old balloon angioplasty for the treatment of infrapopliteal artery lesions. Journal of the American College of Cardiology2014;64(11 Suppl 1):B79. ">BIOLUX P‐II</a>, 19% of participants of the DEB arm either withdrew from the study or were lost to follow‐up at 12 months. <a href="./references#CD011319-bbs2-0005" title="WerkM , LangnerS , ReinkensmeierB , BoettcherHF , TepeG , DietzU , et al. Inhibition of restenosis in femoropopliteal arteries: paclitaxel‐coated versus uncoated balloon: femoral paclitaxel randomized pilot trial. Circulation2008;118(13):1358‐65. ">FemPac 2008</a> had six‐month data available on only 73% of participants in the intervention arm and 83% of participants in the control arm. In <a href="./references#CD011319-bbs2-0006" title="ZellerT , BaumgartnerI , ScheinertD , BrodmannM , BosiersM , MicariA , et al. Drug‐eluting balloon versus standard balloon angioplasty for infrapopliteal arterial revascularization in critical limb ischemia: 12‐month results from the IN.PACT DEEP randomized trial. Journal of the American College of Cardiology2014;64(15):1568‐76. ZellerT , BaumgartnerI , ScheinertD , BrodmannM , BosiersM , MicariA , et al. IN.PACT Amphirion paclitaxel eluting balloon versus standard percutaneous transluminal angioplasty for infrapopliteal revascularization of critical limb ischemia: rationale and protocol for an ongoing randomized controlled trial. Trials2014;15:63. ">IN.PACT DEEP 2014</a>, the authors stated that low angiographic and wound imaging compliance may have limited the full assessment of the interventions. In <a href="./references#CD011319-bbs2-0008" title="ScheinertD , DudaS , ZellerT , KrankenbergH , RickeJ , BosiersM , et al. The LEVANT I (Lutonix paclitaxel‐coated balloon for the prevention of femoropopliteal restenosis) trial for femoropopliteal revascularization: first‐in‐human randomized trial of low‐dose drug‐coated balloon versus uncoated balloon angioplasty. JACC. Cardiovascular Interventions2014;7(1):10‐9. ">LEVANT I 2014</a>, six‐month angiographic follow‐up was available for 80% of the intervention arm and 69% of the control arm. The <a href="./references#CD011319-bbs2-0010" title="WerkM , AlbrechtT , MeyerDR , AhmedMN , BehneA , DietzU , et al. Paclitaxel‐coated balloons reduce restenosis after femoro‐popliteal angioplasty: evidence from the randomized PACIFIER trial. Circulation. Cardiovascular Interventions2012;5(6):831‐40. ">PACIFIER 2012</a> authors reported missing primary outcome data on 20.5% of the intervention arm and 27.3% of the control arm. </p> </section> <section id="CD011319-sec-0062"> <h4 class="title">Selective reporting</h4> <p>Four trials were at high risk of bias due to incomplete reporting of data (<a href="./references#CD011319-bbs2-0002" title="BIOTONIK's ‐ first in men study of the Passeo‐18 LUX drug releasing PTA balloon catheter vs. the uncoated Passeo 18 balloon catheter in subjects requiring revascularization of infrapopliteal arteries (BIOLUX P‐II). clinicaltrials.gov/ct2/show/NCT01867736 (accessed 15 August 2015). DelooseK , ZellerT , ScheinertD , BeschornerU . BIOLUX P‐II: a randomized clinical trial of Passeo‐18 Lux DRB vs POBA for the treatment of infrapopliteal artery lesions. Journal of the American College of Cardiology2014; Vol. 64, issue Suppl B. ScheinertD , BrodmannM , ZellerT , BosiersM , PeetersP , Karl‐LudwigS , et al. BIOLUX P‐II: a randomized clinical trial of Passeo‐18 lux drug releasing balloon versus plain old balloon angioplasty for the treatment of infrapopliteal artery lesions. Journal of the American College of Cardiology2014;64(11 Suppl 1):B79. ">BIOLUX P‐II</a>; <a href="./references#CD011319-bbs2-0003" title="LiistroF , PortoI , AngioliP , GrottiS , RicciL , DucciK , et al. Drug‐eluting balloon in peripheral intervention for below the knee angioplasty evaluation (DEBATE‐BTK): a randomized trial in diabetic patients with critical limb ischemia. Circulation2013;128(6):615‐21. ">DEBATE‐BTK 2013</a>; <a href="./references#CD011319-bbs2-0005" title="WerkM , LangnerS , ReinkensmeierB , BoettcherHF , TepeG , DietzU , et al. Inhibition of restenosis in femoropopliteal arteries: paclitaxel‐coated versus uncoated balloon: femoral paclitaxel randomized pilot trial. Circulation2008;118(13):1358‐65. ">FemPac 2008</a>; <a href="./references#CD011319-bbs2-0006" title="ZellerT , BaumgartnerI , ScheinertD , BrodmannM , BosiersM , MicariA , et al. Drug‐eluting balloon versus standard balloon angioplasty for infrapopliteal arterial revascularization in critical limb ischemia: 12‐month results from the IN.PACT DEEP randomized trial. Journal of the American College of Cardiology2014;64(15):1568‐76. ZellerT , BaumgartnerI , ScheinertD , BrodmannM , BosiersM , MicariA , et al. IN.PACT Amphirion paclitaxel eluting balloon versus standard percutaneous transluminal angioplasty for infrapopliteal revascularization of critical limb ischemia: rationale and protocol for an ongoing randomized controlled trial. Trials2014;15:63. ">IN.PACT DEEP 2014</a>). In <a href="./references#CD011319-bbs2-0002" title="BIOTONIK's ‐ first in men study of the Passeo‐18 LUX drug releasing PTA balloon catheter vs. the uncoated Passeo 18 balloon catheter in subjects requiring revascularization of infrapopliteal arteries (BIOLUX P‐II). clinicaltrials.gov/ct2/show/NCT01867736 (accessed 15 August 2015). DelooseK , ZellerT , ScheinertD , BeschornerU . BIOLUX P‐II: a randomized clinical trial of Passeo‐18 Lux DRB vs POBA for the treatment of infrapopliteal artery lesions. Journal of the American College of Cardiology2014; Vol. 64, issue Suppl B. ScheinertD , BrodmannM , ZellerT , BosiersM , PeetersP , Karl‐LudwigS , et al. BIOLUX P‐II: a randomized clinical trial of Passeo‐18 lux drug releasing balloon versus plain old balloon angioplasty for the treatment of infrapopliteal artery lesions. Journal of the American College of Cardiology2014;64(11 Suppl 1):B79. ">BIOLUX P‐II</a>, all prespecified outcomes were reported, but the results were not stratified by the type of treated infra‐popliteal vessels (i.e. anterior tibial, posterior tibial, or peroneal arteries). The authors also did not specify whether those participants with more than one target lesion (33.3% of DEB participants and 44.4% of percutaneous transluminal angioplasty (PTA) participants) had several target vessels and whether the outcomes differed by the number of treated lesions and vessels. <a href="./references#CD011319-bbs2-0003" title="LiistroF , PortoI , AngioliP , GrottiS , RicciL , DucciK , et al. Drug‐eluting balloon in peripheral intervention for below the knee angioplasty evaluation (DEBATE‐BTK): a randomized trial in diabetic patients with critical limb ischemia. Circulation2013;128(6):615‐21. ">DEBATE‐BTK 2013</a> was designed to assess infra‐popliteal arterial lesions but some of the participants also received treatment for femoropopliteal lesions. The study authors stated that inflow lesions located in the femoropopliteal segment were "treated by standard techniques during the same session" without elaborating on the nature or number of those techniques. <a href="./references#CD011319-bbs2-0005" title="WerkM , LangnerS , ReinkensmeierB , BoettcherHF , TepeG , DietzU , et al. Inhibition of restenosis in femoropopliteal arteries: paclitaxel‐coated versus uncoated balloon: femoral paclitaxel randomized pilot trial. Circulation2008;118(13):1358‐65. ">FemPac 2008</a> reported that "no Doppler or angiographic information was obtained from 7 patients in the control and 9 patients in the coated balloon group", which amounts to approximately 18% of the study participant population. <a href="./references#CD011319-bbs2-0006" title="ZellerT , BaumgartnerI , ScheinertD , BrodmannM , BosiersM , MicariA , et al. Drug‐eluting balloon versus standard balloon angioplasty for infrapopliteal arterial revascularization in critical limb ischemia: 12‐month results from the IN.PACT DEEP randomized trial. Journal of the American College of Cardiology2014;64(15):1568‐76. ZellerT , BaumgartnerI , ScheinertD , BrodmannM , BosiersM , MicariA , et al. IN.PACT Amphirion paclitaxel eluting balloon versus standard percutaneous transluminal angioplasty for infrapopliteal revascularization of critical limb ischemia: rationale and protocol for an ongoing randomized controlled trial. Trials2014;15:63. ">IN.PACT DEEP 2014</a> did not report several outcomes that were prespecified in the study protocol, such as change in Rutherford classification and QoL scores. </p> </section> <section id="CD011319-sec-0063"> <h4 class="title">Other potential sources of bias</h4> <p>A major source of bias in many of the included studies was the concurrent use of stenting without separate reporting of the outcomes of stented participants. One quarter of the <a href="./references#CD011319-bbs2-0001" title="A prospective, multi‐centre, randomized controlled, first in man study to assess the safety and performance of the Passeo‐18 Lux paclitaxel releasing PTA balloon catheter vs. the uncoated Passeo 18 balloon catheter in patients with stenosis and occlusion of the femoropopliteal arteries (BIOLUX P‐I). clinicaltrials.gov/ct2/show/NCT01221610 (accessed 15 August 2015). ScheinertD , SchulteKL , ZellerT , LammerJ , TepeG . Paclitaxel‐releasing balloon in femoropopliteal lesions using a BTHC excipient: twelve‐month results from the BIOLUX P‐I randomized trial. Journal of Endovascular Therapy2015;22:14‐21. TepeG , SchulteK‐L , ZellerT , LammerJ , PfaffingerP , SchmidtA , et al. Six‐month results of the BIOLUX P‐I first in man study comparing a paclitaxel‐releasing balloon catheter versus an uncoated balloon catheter in femoropopliteal lesions. Cardiovascular and Interventional Radiology2012; Vol. 35:S264‐5. ZellerT , LammerJ , RastanA , SchulteK , TepeG , ScheinertD . Twelve‐month results of the BIOLUX P‐I first‐in‐man study comparing a paclitaxel‐releasing balloon catheter versus an uncoated catheter in femoropopliteal lesions. Vasa ‐ Journal of Vascular Diseases2013;42(Suppl 84):FV 9.7. ">BIOLUX P‐I</a> control arm (26.7%) required bailout stenting. <a href="./references#CD011319-bbs2-0008" title="ScheinertD , DudaS , ZellerT , KrankenbergH , RickeJ , BosiersM , et al. The LEVANT I (Lutonix paclitaxel‐coated balloon for the prevention of femoropopliteal restenosis) trial for femoropopliteal revascularization: first‐in‐human randomized trial of low‐dose drug‐coated balloon versus uncoated balloon angioplasty. JACC. Cardiovascular Interventions2014;7(1):10‐9. ">LEVANT I 2014</a> randomized participants to the intervention or control arms after successful predilation or stenting "based on whether the interventionalist intended to use only balloon dilation of the lesion or intended concomitant stenting". Twenty‐six per cent of trial participants were stented prior to randomization, and a further 3% in the intervention and 16% in the control arm received "bailout stenting" after undergoing the intended therapy. The <a href="./references#CD011319-bbs2-0004" title='FanelliF , CannavaleA , BoattaE , CoronaM , LucatelliP , WlderkA , et al. Lower limb multilevel treatment with drug‐eluting balloons: 6‐month results from the DEBELLUM randomized trial. Journal of Endovascular Therapy2012;19(5):571‐80. FanelliF , CannavaleA , CoronaM , LucatelliP , WlderkA , SalvatoriFM . The "DEBELLUM" ‐ lower limb multilevel treatment with drug eluting balloon ‐ randomized trial: 1‐year results. Journal of Cardiovascular Surgery2014;55(2):207‐16. '>DEBELLUM 2012</a> authors reported that the "decision to implant a nitinol stent in the SFA [superficial femoral artery] territory was left to the judgment of the operator and typically driven by lesion length and presence of severe calcification". However, these stent‐deployment criteria were unclear, and approximately 37% of the treated lesions in the study were stented. The <a href="./references#CD011319-bbs2-0005" title="WerkM , LangnerS , ReinkensmeierB , BoettcherHF , TepeG , DietzU , et al. Inhibition of restenosis in femoropopliteal arteries: paclitaxel‐coated versus uncoated balloon: femoral paclitaxel randomized pilot trial. Circulation2008;118(13):1358‐65. ">FemPac 2008</a> authors similarly reported that 11% of all participants received a stent, the <a href="./references#CD011319-bbs2-0010" title="WerkM , AlbrechtT , MeyerDR , AhmedMN , BehneA , DietzU , et al. Paclitaxel‐coated balloons reduce restenosis after femoro‐popliteal angioplasty: evidence from the randomized PACIFIER trial. Circulation. Cardiovascular Interventions2012;5(6):831‐40. ">PACIFIER 2012</a> authors reported that 21% of intervention and 34% of control participants received a stent, and in <a href="./references#CD011319-bbs2-0011" title="TepeG , SchnorrB , AlbrechtT , BrechtelK , ClaussenCD , SchellerB , et al. Angioplasty of femoral‐popliteal arteries with drug‐coated balloons: 5‐year follow‐up of the THUNDER trial. JACC. Cardiovascular Interventions2015;8(1):102‐8. TepeG , ZellerT , AlbrechtT , HellerS , SchwarzwälderU , BeregiJP , et al. Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg. New England Journal of Medicine2008;358(7):689‐99. ">THUNDER 2008</a>, 4% of intervention and 22% of control participants received a stent. The clinical outcomes of those stented participants were not reported separately. <a href="./references#CD011319-bbs2-0009" title="RosenfieldK , JaffMR , WhiteCJ , Rocha‐SinghK , Mena‐HurtadoC , MetzgerDC , et al. Trial of a paclitaxel‐coated balloon for femoropopliteal artery disease. New England Journal of Medicine2015;373(2):145‐53. ">LEVANT II 2015</a> addressed this potential source of bias by only randomizing participants who did not require a stent after an initial angiogram. </p> <p>In <a href="./references#CD011319-bbs2-0001" title="A prospective, multi‐centre, randomized controlled, first in man study to assess the safety and performance of the Passeo‐18 Lux paclitaxel releasing PTA balloon catheter vs. the uncoated Passeo 18 balloon catheter in patients with stenosis and occlusion of the femoropopliteal arteries (BIOLUX P‐I). clinicaltrials.gov/ct2/show/NCT01221610 (accessed 15 August 2015). ScheinertD , SchulteKL , ZellerT , LammerJ , TepeG . Paclitaxel‐releasing balloon in femoropopliteal lesions using a BTHC excipient: twelve‐month results from the BIOLUX P‐I randomized trial. Journal of Endovascular Therapy2015;22:14‐21. TepeG , SchulteK‐L , ZellerT , LammerJ , PfaffingerP , SchmidtA , et al. Six‐month results of the BIOLUX P‐I first in man study comparing a paclitaxel‐releasing balloon catheter versus an uncoated balloon catheter in femoropopliteal lesions. Cardiovascular and Interventional Radiology2012; Vol. 35:S264‐5. ZellerT , LammerJ , RastanA , SchulteK , TepeG , ScheinertD . Twelve‐month results of the BIOLUX P‐I first‐in‐man study comparing a paclitaxel‐releasing balloon catheter versus an uncoated catheter in femoropopliteal lesions. Vasa ‐ Journal of Vascular Diseases2013;42(Suppl 84):FV 9.7. ">BIOLUX P‐I</a>, predilation was performed more often in DEB than PTA participants (66.7% with DEB versus 30% with PTA, P = 0.01), and technical success was higher in the DEB group (76.7% with DEB versus 46.7% with PTA, P = 0.02). Most of the DEB (56.7%) and PTA (60%) participants had a history of previous peripheral interventions, although the type and location of those interventions was not specified. </p> <p>In <a href="./references#CD011319-bbs2-0002" title="BIOTONIK's ‐ first in men study of the Passeo‐18 LUX drug releasing PTA balloon catheter vs. the uncoated Passeo 18 balloon catheter in subjects requiring revascularization of infrapopliteal arteries (BIOLUX P‐II). clinicaltrials.gov/ct2/show/NCT01867736 (accessed 15 August 2015). DelooseK , ZellerT , ScheinertD , BeschornerU . BIOLUX P‐II: a randomized clinical trial of Passeo‐18 Lux DRB vs POBA for the treatment of infrapopliteal artery lesions. Journal of the American College of Cardiology2014; Vol. 64, issue Suppl B. ScheinertD , BrodmannM , ZellerT , BosiersM , PeetersP , Karl‐LudwigS , et al. BIOLUX P‐II: a randomized clinical trial of Passeo‐18 lux drug releasing balloon versus plain old balloon angioplasty for the treatment of infrapopliteal artery lesions. Journal of the American College of Cardiology2014;64(11 Suppl 1):B79. ">BIOLUX P‐II</a>, while no bailout stenting was required in either treatment arm, the authors had a relatively low technical success rate (defined as less than 30% residual stenosis) in both arms (54.2% with DEB, 59.6% with PTA). </p> <p>Device malfunction in <a href="./references#CD011319-bbs2-0008" title="ScheinertD , DudaS , ZellerT , KrankenbergH , RickeJ , BosiersM , et al. The LEVANT I (Lutonix paclitaxel‐coated balloon for the prevention of femoropopliteal restenosis) trial for femoropopliteal revascularization: first‐in‐human randomized trial of low‐dose drug‐coated balloon versus uncoated balloon angioplasty. JACC. Cardiovascular Interventions2014;7(1):10‐9. ">LEVANT I 2014</a> was another potential source of bias. Eight DEB devices (16%) malfunctioned and failed to deploy. It was unclear how those participants were managed. </p> <p>The approach to antiplatelet therapy also varied between trials. While <a href="./references#CD011319-bbs2-0005" title="WerkM , LangnerS , ReinkensmeierB , BoettcherHF , TepeG , DietzU , et al. Inhibition of restenosis in femoropopliteal arteries: paclitaxel‐coated versus uncoated balloon: femoral paclitaxel randomized pilot trial. Circulation2008;118(13):1358‐65. ">FemPac 2008</a> did not specify the duration of antiplatelet therapy, participants in all the other trials received acetylsalicylic acid (ASA; aspirin) and at least four weeks of a second antiplatelet agent, most commonly clopidogrel. However, in <a href="./references#CD011319-bbs2-0006" title="ZellerT , BaumgartnerI , ScheinertD , BrodmannM , BosiersM , MicariA , et al. Drug‐eluting balloon versus standard balloon angioplasty for infrapopliteal arterial revascularization in critical limb ischemia: 12‐month results from the IN.PACT DEEP randomized trial. Journal of the American College of Cardiology2014;64(15):1568‐76. ZellerT , BaumgartnerI , ScheinertD , BrodmannM , BosiersM , MicariA , et al. IN.PACT Amphirion paclitaxel eluting balloon versus standard percutaneous transluminal angioplasty for infrapopliteal revascularization of critical limb ischemia: rationale and protocol for an ongoing randomized controlled trial. Trials2014;15:63. ">IN.PACT DEEP 2014</a> and <a href="./references#CD011319-bbs2-0007" title="LairdJR , SchneiderP , TepeG , BrodmannM , ZellerT , MetzgerC , et al. Durability of treatment effect using a drug‐coated balloon for femoropopliteal lesions 24‐month results of IN.PACT SFA. Journal of the American College of Cardiology2015;66(21):2329‐38. TepeG , LairdJ , SchneiderP , BrodmannM , KrishnanP , MicariA , et al. Drug‐coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12‐month results from the IN.PACT SFA randomized trial. Circulation2015;131(5):495‐502. ">IN.PACT SFA 2015</a>, the duration of the second antiplatelet agent depended on by whether a stent was deployed. Nonstented participants received a minimum of one month, while stented participants received a minimum of three months of a second antiplatelet agent. </p> <p>While paclitaxel was used in the intervention arm of all the analyzed studies, there was variability in the paclitaxel dose and balloon drug carrier according to the type of DEB device used. </p> <p>Finally, DEB device manufacturers sponsored nine of the 11 included studies (<a href="./references#CD011319-bbs2-0001" title="A prospective, multi‐centre, randomized controlled, first in man study to assess the safety and performance of the Passeo‐18 Lux paclitaxel releasing PTA balloon catheter vs. the uncoated Passeo 18 balloon catheter in patients with stenosis and occlusion of the femoropopliteal arteries (BIOLUX P‐I). clinicaltrials.gov/ct2/show/NCT01221610 (accessed 15 August 2015). ScheinertD , SchulteKL , ZellerT , LammerJ , TepeG . Paclitaxel‐releasing balloon in femoropopliteal lesions using a BTHC excipient: twelve‐month results from the BIOLUX P‐I randomized trial. Journal of Endovascular Therapy2015;22:14‐21. TepeG , SchulteK‐L , ZellerT , LammerJ , PfaffingerP , SchmidtA , et al. Six‐month results of the BIOLUX P‐I first in man study comparing a paclitaxel‐releasing balloon catheter versus an uncoated balloon catheter in femoropopliteal lesions. Cardiovascular and Interventional Radiology2012; Vol. 35:S264‐5. ZellerT , LammerJ , RastanA , SchulteK , TepeG , ScheinertD . Twelve‐month results of the BIOLUX P‐I first‐in‐man study comparing a paclitaxel‐releasing balloon catheter versus an uncoated catheter in femoropopliteal lesions. Vasa ‐ Journal of Vascular Diseases2013;42(Suppl 84):FV 9.7. ">BIOLUX P‐I</a>; <a href="./references#CD011319-bbs2-0002" title="BIOTONIK's ‐ first in men study of the Passeo‐18 LUX drug releasing PTA balloon catheter vs. the uncoated Passeo 18 balloon catheter in subjects requiring revascularization of infrapopliteal arteries (BIOLUX P‐II). clinicaltrials.gov/ct2/show/NCT01867736 (accessed 15 August 2015). DelooseK , ZellerT , ScheinertD , BeschornerU . BIOLUX P‐II: a randomized clinical trial of Passeo‐18 Lux DRB vs POBA for the treatment of infrapopliteal artery lesions. Journal of the American College of Cardiology2014; Vol. 64, issue Suppl B. ScheinertD , BrodmannM , ZellerT , BosiersM , PeetersP , Karl‐LudwigS , et al. BIOLUX P‐II: a randomized clinical trial of Passeo‐18 lux drug releasing balloon versus plain old balloon angioplasty for the treatment of infrapopliteal artery lesions. Journal of the American College of Cardiology2014;64(11 Suppl 1):B79. ">BIOLUX P‐II</a>; <a href="./references#CD011319-bbs2-0005" title="WerkM , LangnerS , ReinkensmeierB , BoettcherHF , TepeG , DietzU , et al. Inhibition of restenosis in femoropopliteal arteries: paclitaxel‐coated versus uncoated balloon: femoral paclitaxel randomized pilot trial. Circulation2008;118(13):1358‐65. ">FemPac 2008</a>; <a href="./references#CD011319-bbs2-0006" title="ZellerT , BaumgartnerI , ScheinertD , BrodmannM , BosiersM , MicariA , et al. Drug‐eluting balloon versus standard balloon angioplasty for infrapopliteal arterial revascularization in critical limb ischemia: 12‐month results from the IN.PACT DEEP randomized trial. Journal of the American College of Cardiology2014;64(15):1568‐76. ZellerT , BaumgartnerI , ScheinertD , BrodmannM , BosiersM , MicariA , et al. IN.PACT Amphirion paclitaxel eluting balloon versus standard percutaneous transluminal angioplasty for infrapopliteal revascularization of critical limb ischemia: rationale and protocol for an ongoing randomized controlled trial. Trials2014;15:63. ">IN.PACT DEEP 2014</a>; <a href="./references#CD011319-bbs2-0007" title="LairdJR , SchneiderP , TepeG , BrodmannM , ZellerT , MetzgerC , et al. Durability of treatment effect using a drug‐coated balloon for femoropopliteal lesions 24‐month results of IN.PACT SFA. Journal of the American College of Cardiology2015;66(21):2329‐38. TepeG , LairdJ , SchneiderP , BrodmannM , KrishnanP , MicariA , et al. Drug‐coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12‐month results from the IN.PACT SFA randomized trial. Circulation2015;131(5):495‐502. ">IN.PACT SFA 2015</a>; <a href="./references#CD011319-bbs2-0008" title="ScheinertD , DudaS , ZellerT , KrankenbergH , RickeJ , BosiersM , et al. The LEVANT I (Lutonix paclitaxel‐coated balloon for the prevention of femoropopliteal restenosis) trial for femoropopliteal revascularization: first‐in‐human randomized trial of low‐dose drug‐coated balloon versus uncoated balloon angioplasty. JACC. Cardiovascular Interventions2014;7(1):10‐9. ">LEVANT I 2014</a>; <a href="./references#CD011319-bbs2-0009" title="RosenfieldK , JaffMR , WhiteCJ , Rocha‐SinghK , Mena‐HurtadoC , MetzgerDC , et al. Trial of a paclitaxel‐coated balloon for femoropopliteal artery disease. New England Journal of Medicine2015;373(2):145‐53. ">LEVANT II 2015</a>; <a href="./references#CD011319-bbs2-0010" title="WerkM , AlbrechtT , MeyerDR , AhmedMN , BehneA , DietzU , et al. Paclitaxel‐coated balloons reduce restenosis after femoro‐popliteal angioplasty: evidence from the randomized PACIFIER trial. Circulation. Cardiovascular Interventions2012;5(6):831‐40. ">PACIFIER 2012</a>; <a href="./references#CD011319-bbs2-0011" title="TepeG , SchnorrB , AlbrechtT , BrechtelK , ClaussenCD , SchellerB , et al. Angioplasty of femoral‐popliteal arteries with drug‐coated balloons: 5‐year follow‐up of the THUNDER trial. JACC. Cardiovascular Interventions2015;8(1):102‐8. TepeG , ZellerT , AlbrechtT , HellerS , SchwarzwälderU , BeregiJP , et al. Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg. New England Journal of Medicine2008;358(7):689‐99. ">THUNDER 2008</a>). In the <a href="./references#CD011319-bbs2-0007" title="LairdJR , SchneiderP , TepeG , BrodmannM , ZellerT , MetzgerC , et al. Durability of treatment effect using a drug‐coated balloon for femoropopliteal lesions 24‐month results of IN.PACT SFA. Journal of the American College of Cardiology2015;66(21):2329‐38. TepeG , LairdJ , SchneiderP , BrodmannM , KrishnanP , MicariA , et al. Drug‐coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12‐month results from the IN.PACT SFA randomized trial. Circulation2015;131(5):495‐502. ">IN.PACT SFA 2015</a> study, every author listed in the published manuscript declared a financial relationship with the DEB device manufacturer. </p> </section> </section> <section id="CD011319-sec-0064"> <h3 class="title" id="CD011319-sec-0064">Effects of interventions</h3> <p>See: <a href="./full#CD011319-tbl-0001"><b>Summary of findings for the main comparison</b> Drug‐eluting balloon versus uncoated balloon angioplasty at 12 months</a> </p> <section id="CD011319-sec-0065"> <h4 class="title">Primary outcomes</h4> <section id="CD011319-sec-0066"> <h5 class="title">Amputation</h5> <p>The incidence of amputation was reported as a secondary endpoint in the included trials. While this outcome was not listed in the study protocol, we included it in the analysis because only one trial reported amputation‐free survival (<a href="./references#CD011319-bbs2-0006" title="ZellerT , BaumgartnerI , ScheinertD , BrodmannM , BosiersM , MicariA , et al. Drug‐eluting balloon versus standard balloon angioplasty for infrapopliteal arterial revascularization in critical limb ischemia: 12‐month results from the IN.PACT DEEP randomized trial. Journal of the American College of Cardiology2014;64(15):1568‐76. ZellerT , BaumgartnerI , ScheinertD , BrodmannM , BosiersM , MicariA , et al. IN.PACT Amphirion paclitaxel eluting balloon versus standard percutaneous transluminal angioplasty for infrapopliteal revascularization of critical limb ischemia: rationale and protocol for an ongoing randomized controlled trial. Trials2014;15:63. ">IN.PACT DEEP 2014</a>). There was no significant difference in the incidence of amputations between DEB and uncoated balloon angioplasty at six months (<a href="./references#CD011319-fig-0005" title="">Analysis 1.1</a>; OR 1.21, 95% CI 0.39 to 3.80; 541 participants; 7 studies); 12 months (<a href="./references#CD011319-fig-0023" title="">Analysis 2.1</a>; OR 1.56, 95% CI 0.73 to 3.33; 1649 participants; 9 studies); two years (<a href="./references#CD011319-fig-0041" title="">Analysis 3.1</a>; OR 0.65, 95% CI 0.11 to 3.88; 493 participants; 3 studies); or five years (<a href="./references#CD011319-fig-0053" title="">Analysis 4.1</a>; OR 4.82, 95% CI 0.52 to 44.70; 102 participants; 1 study). </p> <p>Exclusion of <a href="./references#CD011319-bbs2-0001" title="A prospective, multi‐centre, randomized controlled, first in man study to assess the safety and performance of the Passeo‐18 Lux paclitaxel releasing PTA balloon catheter vs. the uncoated Passeo 18 balloon catheter in patients with stenosis and occlusion of the femoropopliteal arteries (BIOLUX P‐I). clinicaltrials.gov/ct2/show/NCT01221610 (accessed 15 August 2015). ScheinertD , SchulteKL , ZellerT , LammerJ , TepeG . Paclitaxel‐releasing balloon in femoropopliteal lesions using a BTHC excipient: twelve‐month results from the BIOLUX P‐I randomized trial. Journal of Endovascular Therapy2015;22:14‐21. TepeG , SchulteK‐L , ZellerT , LammerJ , PfaffingerP , SchmidtA , et al. Six‐month results of the BIOLUX P‐I first in man study comparing a paclitaxel‐releasing balloon catheter versus an uncoated balloon catheter in femoropopliteal lesions. Cardiovascular and Interventional Radiology2012; Vol. 35:S264‐5. ZellerT , LammerJ , RastanA , SchulteK , TepeG , ScheinertD . Twelve‐month results of the BIOLUX P‐I first‐in‐man study comparing a paclitaxel‐releasing balloon catheter versus an uncoated catheter in femoropopliteal lesions. Vasa ‐ Journal of Vascular Diseases2013;42(Suppl 84):FV 9.7. ">BIOLUX P‐I</a>, <a href="./references#CD011319-bbs2-0002" title="BIOTONIK's ‐ first in men study of the Passeo‐18 LUX drug releasing PTA balloon catheter vs. the uncoated Passeo 18 balloon catheter in subjects requiring revascularization of infrapopliteal arteries (BIOLUX P‐II). clinicaltrials.gov/ct2/show/NCT01867736 (accessed 15 August 2015). DelooseK , ZellerT , ScheinertD , BeschornerU . BIOLUX P‐II: a randomized clinical trial of Passeo‐18 Lux DRB vs POBA for the treatment of infrapopliteal artery lesions. Journal of the American College of Cardiology2014; Vol. 64, issue Suppl B. ScheinertD , BrodmannM , ZellerT , BosiersM , PeetersP , Karl‐LudwigS , et al. BIOLUX P‐II: a randomized clinical trial of Passeo‐18 lux drug releasing balloon versus plain old balloon angioplasty for the treatment of infrapopliteal artery lesions. Journal of the American College of Cardiology2014;64(11 Suppl 1):B79. ">BIOLUX P‐II</a>, and <a href="./references#CD011319-bbs2-0005" title="WerkM , LangnerS , ReinkensmeierB , BoettcherHF , TepeG , DietzU , et al. Inhibition of restenosis in femoropopliteal arteries: paclitaxel‐coated versus uncoated balloon: femoral paclitaxel randomized pilot trial. Circulation2008;118(13):1358‐65. ">FemPac 2008</a> at six and 12 months and two years did not result in any significant differences in amputation outcomes (<a href="./references#CD011319-fig-0015" title="">Analysis 1.11</a>; OR 1.77, 95% CI 0.42 to 7.54; 322 participants; 4 studies at six months; <a href="./references#CD011319-fig-0034" title="">Analysis 2.12</a>; OR 1.78, 95% CI 0.79 to 4.04; 1517 participants; 7 studies at 12 months; <a href="./references#CD011319-fig-0051" title="">Analysis 3.11</a>; OR 3.16, 95% CI 0.12 to 80.19; 406 participants; 2 studies at two years). The sensitivity analysis was carried out due to concerns about participant follow‐up (<a href="./references#CD011319-bbs2-0001" title="A prospective, multi‐centre, randomized controlled, first in man study to assess the safety and performance of the Passeo‐18 Lux paclitaxel releasing PTA balloon catheter vs. the uncoated Passeo 18 balloon catheter in patients with stenosis and occlusion of the femoropopliteal arteries (BIOLUX P‐I). clinicaltrials.gov/ct2/show/NCT01221610 (accessed 15 August 2015). ScheinertD , SchulteKL , ZellerT , LammerJ , TepeG . Paclitaxel‐releasing balloon in femoropopliteal lesions using a BTHC excipient: twelve‐month results from the BIOLUX P‐I randomized trial. Journal of Endovascular Therapy2015;22:14‐21. TepeG , SchulteK‐L , ZellerT , LammerJ , PfaffingerP , SchmidtA , et al. Six‐month results of the BIOLUX P‐I first in man study comparing a paclitaxel‐releasing balloon catheter versus an uncoated balloon catheter in femoropopliteal lesions. Cardiovascular and Interventional Radiology2012; Vol. 35:S264‐5. ZellerT , LammerJ , RastanA , SchulteK , TepeG , ScheinertD . Twelve‐month results of the BIOLUX P‐I first‐in‐man study comparing a paclitaxel‐releasing balloon catheter versus an uncoated catheter in femoropopliteal lesions. Vasa ‐ Journal of Vascular Diseases2013;42(Suppl 84):FV 9.7. ">BIOLUX P‐I</a>; <a href="./references#CD011319-bbs2-0002" title="BIOTONIK's ‐ first in men study of the Passeo‐18 LUX drug releasing PTA balloon catheter vs. the uncoated Passeo 18 balloon catheter in subjects requiring revascularization of infrapopliteal arteries (BIOLUX P‐II). clinicaltrials.gov/ct2/show/NCT01867736 (accessed 15 August 2015). DelooseK , ZellerT , ScheinertD , BeschornerU . BIOLUX P‐II: a randomized clinical trial of Passeo‐18 Lux DRB vs POBA for the treatment of infrapopliteal artery lesions. Journal of the American College of Cardiology2014; Vol. 64, issue Suppl B. ScheinertD , BrodmannM , ZellerT , BosiersM , PeetersP , Karl‐LudwigS , et al. BIOLUX P‐II: a randomized clinical trial of Passeo‐18 lux drug releasing balloon versus plain old balloon angioplasty for the treatment of infrapopliteal artery lesions. Journal of the American College of Cardiology2014;64(11 Suppl 1):B79. ">BIOLUX P‐II</a>; <a href="./references#CD011319-bbs2-0005" title="WerkM , LangnerS , ReinkensmeierB , BoettcherHF , TepeG , DietzU , et al. Inhibition of restenosis in femoropopliteal arteries: paclitaxel‐coated versus uncoated balloon: femoral paclitaxel randomized pilot trial. Circulation2008;118(13):1358‐65. ">FemPac 2008</a>), and technical success rate (<a href="./references#CD011319-bbs2-0002" title="BIOTONIK's ‐ first in men study of the Passeo‐18 LUX drug releasing PTA balloon catheter vs. the uncoated Passeo 18 balloon catheter in subjects requiring revascularization of infrapopliteal arteries (BIOLUX P‐II). clinicaltrials.gov/ct2/show/NCT01867736 (accessed 15 August 2015). DelooseK , ZellerT , ScheinertD , BeschornerU . BIOLUX P‐II: a randomized clinical trial of Passeo‐18 Lux DRB vs POBA for the treatment of infrapopliteal artery lesions. Journal of the American College of Cardiology2014; Vol. 64, issue Suppl B. ScheinertD , BrodmannM , ZellerT , BosiersM , PeetersP , Karl‐LudwigS , et al. BIOLUX P‐II: a randomized clinical trial of Passeo‐18 lux drug releasing balloon versus plain old balloon angioplasty for the treatment of infrapopliteal artery lesions. Journal of the American College of Cardiology2014;64(11 Suppl 1):B79. ">BIOLUX P‐II</a>) in the study population. </p> <section id="CD011319-sec-0067"> <h6 class="title">Amputation‐free survival</h6> <p>Only <a href="./references#CD011319-bbs2-0006" title="ZellerT , BaumgartnerI , ScheinertD , BrodmannM , BosiersM , MicariA , et al. Drug‐eluting balloon versus standard balloon angioplasty for infrapopliteal arterial revascularization in critical limb ischemia: 12‐month results from the IN.PACT DEEP randomized trial. Journal of the American College of Cardiology2014;64(15):1568‐76. ZellerT , BaumgartnerI , ScheinertD , BrodmannM , BosiersM , MicariA , et al. IN.PACT Amphirion paclitaxel eluting balloon versus standard percutaneous transluminal angioplasty for infrapopliteal revascularization of critical limb ischemia: rationale and protocol for an ongoing randomized controlled trial. Trials2014;15:63. ">IN.PACT DEEP 2014</a> reported amputation‐free survival at 12 months in (<a href="./references#CD011319-fig-0024" title="">Analysis 2.2</a>; OR 0.68, 95% CI 0.38 to 1.19; 358 participants; 1 study). The trial showed a trend towards improved amputation‐free survival among control arm participants compared with the DEB arm, although this difference did not reach statistical significance. </p> </section> <section id="CD011319-sec-0068"> <h6 class="title">Amputation‐free rate</h6> <p>None of the included studies reported amputation‐free rate.</p> </section> </section> <section id="CD011319-sec-0069"> <h5 class="title">Vessel patency</h5> <section id="CD011319-sec-0070"> <h6 class="title">Primary vessel patency</h6> <p>There was no significant difference in primary vessel patency between DEB and uncoated balloon angioplasty at six months (<a href="./references#CD011319-fig-0006" title="">Analysis 1.2</a>; OR 1.47, 95% CI 0.22 to 9.57; 162 participants; 2 studies). However, exclusion of <a href="./references#CD011319-bbs2-0005" title="WerkM , LangnerS , ReinkensmeierB , BoettcherHF , TepeG , DietzU , et al. Inhibition of restenosis in femoropopliteal arteries: paclitaxel‐coated versus uncoated balloon: femoral paclitaxel randomized pilot trial. Circulation2008;118(13):1358‐65. ">FemPac 2008</a> resulted in a significant advantage for DEB compared with uncoated balloon angioplasty at six months (<a href="./references#CD011319-fig-0016" title="">Analysis 1.12</a>; OR 3.84, 95% CI 1.43 to 10.31; 75 participants; 1 study). <a href="./references#CD011319-bbs2-0005" title="WerkM , LangnerS , ReinkensmeierB , BoettcherHF , TepeG , DietzU , et al. Inhibition of restenosis in femoropopliteal arteries: paclitaxel‐coated versus uncoated balloon: femoral paclitaxel randomized pilot trial. Circulation2008;118(13):1358‐65. ">FemPac 2008</a> was excluded due to concerns about incomplete participant follow‐up. DEBs were associated with significantly greater odds of primary vessel patency at 12 months (<a href="./references#CD011319-fig-0025" title="">Analysis 2.3</a>; OR 1.92, 95% CI 1.45 to 2.56; 882 participants; 3 studies) and two years (<a href="./references#CD011319-fig-0042" title="">Analysis 3.2</a>; OR 3.51, 95% CI 2.26 to 5.46; 406 participants; 2 studies). </p> </section> <section id="CD011319-sec-0071"> <h6 class="title">Secondary vessel patency</h6> <p>None of the included trials reported secondary vessel patency rates.</p> </section> <section id="CD011319-sec-0072"> <h6 class="title">Late lumen loss</h6> <p>Participants treated with DEB were less likely to develop late lumen loss at six months compared with the control participants (<a href="./references#CD011319-fig-0007" title="">Analysis 1.3</a>; MD ‐0.64 mm, 95% CI ‐1.00 to ‐0.28; 603 participants; 7 studies). However, this advantage was lost after 12 months, primarily due to the inclusion of <a href="./references#CD011319-bbs2-0006" title="ZellerT , BaumgartnerI , ScheinertD , BrodmannM , BosiersM , MicariA , et al. Drug‐eluting balloon versus standard balloon angioplasty for infrapopliteal arterial revascularization in critical limb ischemia: 12‐month results from the IN.PACT DEEP randomized trial. Journal of the American College of Cardiology2014;64(15):1568‐76. ZellerT , BaumgartnerI , ScheinertD , BrodmannM , BosiersM , MicariA , et al. IN.PACT Amphirion paclitaxel eluting balloon versus standard percutaneous transluminal angioplasty for infrapopliteal revascularization of critical limb ischemia: rationale and protocol for an ongoing randomized controlled trial. Trials2014;15:63. ">IN.PACT DEEP 2014</a> (<a href="./references#CD011319-fig-0026" title="">Analysis 2.4</a>; MD ‐0.73 mm, 95% CI ‐1.59 to 0.13; 535 participants; 3 studies), which was limited to infra‐popliteal vessels that were smaller than the femoropopliteal vessels studied in the other trials. When the analysis excluded <a href="./references#CD011319-bbs2-0006" title="ZellerT , BaumgartnerI , ScheinertD , BrodmannM , BosiersM , MicariA , et al. Drug‐eluting balloon versus standard balloon angioplasty for infrapopliteal arterial revascularization in critical limb ischemia: 12‐month results from the IN.PACT DEEP randomized trial. Journal of the American College of Cardiology2014;64(15):1568‐76. ZellerT , BaumgartnerI , ScheinertD , BrodmannM , BosiersM , MicariA , et al. IN.PACT Amphirion paclitaxel eluting balloon versus standard percutaneous transluminal angioplasty for infrapopliteal revascularization of critical limb ischemia: rationale and protocol for an ongoing randomized controlled trial. Trials2014;15:63. ">IN.PACT DEEP 2014</a>, there was less late lumen loss with DEBs compared with uncoated balloon angioplasty (<a href="./references#CD011319-fig-0037" title="">Analysis 2.15</a>; MD ‐1.10 mm, 95% CI ‐1.41 to ‐0.79; 177 participants; 2 studies). There was an advantage for DEB compared with uncoated balloon angioplasty at two years (<a href="./references#CD011319-fig-0043" title="">Analysis 3.3</a>; MD ‐0.80 mm, 95% CI ‐1.44 to ‐0.16; 102 participants; 1 study). </p> <p>Exclusion of <a href="./references#CD011319-bbs2-0005" title="WerkM , LangnerS , ReinkensmeierB , BoettcherHF , TepeG , DietzU , et al. Inhibition of restenosis in femoropopliteal arteries: paclitaxel‐coated versus uncoated balloon: femoral paclitaxel randomized pilot trial. Circulation2008;118(13):1358‐65. ">FemPac 2008</a>, which reported late lumen losses as medians, and the <a href="./references#CD011319-bbs2-0001" title="A prospective, multi‐centre, randomized controlled, first in man study to assess the safety and performance of the Passeo‐18 Lux paclitaxel releasing PTA balloon catheter vs. the uncoated Passeo 18 balloon catheter in patients with stenosis and occlusion of the femoropopliteal arteries (BIOLUX P‐I). clinicaltrials.gov/ct2/show/NCT01221610 (accessed 15 August 2015). ScheinertD , SchulteKL , ZellerT , LammerJ , TepeG . Paclitaxel‐releasing balloon in femoropopliteal lesions using a BTHC excipient: twelve‐month results from the BIOLUX P‐I randomized trial. Journal of Endovascular Therapy2015;22:14‐21. TepeG , SchulteK‐L , ZellerT , LammerJ , PfaffingerP , SchmidtA , et al. Six‐month results of the BIOLUX P‐I first in man study comparing a paclitaxel‐releasing balloon catheter versus an uncoated balloon catheter in femoropopliteal lesions. Cardiovascular and Interventional Radiology2012; Vol. 35:S264‐5. ZellerT , LammerJ , RastanA , SchulteK , TepeG , ScheinertD . Twelve‐month results of the BIOLUX P‐I first‐in‐man study comparing a paclitaxel‐releasing balloon catheter versus an uncoated catheter in femoropopliteal lesions. Vasa ‐ Journal of Vascular Diseases2013;42(Suppl 84):FV 9.7. ">BIOLUX P‐I</a> and <a href="./references#CD011319-bbs2-0002" title="BIOTONIK's ‐ first in men study of the Passeo‐18 LUX drug releasing PTA balloon catheter vs. the uncoated Passeo 18 balloon catheter in subjects requiring revascularization of infrapopliteal arteries (BIOLUX P‐II). clinicaltrials.gov/ct2/show/NCT01867736 (accessed 15 August 2015). DelooseK , ZellerT , ScheinertD , BeschornerU . BIOLUX P‐II: a randomized clinical trial of Passeo‐18 Lux DRB vs POBA for the treatment of infrapopliteal artery lesions. Journal of the American College of Cardiology2014; Vol. 64, issue Suppl B. ScheinertD , BrodmannM , ZellerT , BosiersM , PeetersP , Karl‐LudwigS , et al. BIOLUX P‐II: a randomized clinical trial of Passeo‐18 lux drug releasing balloon versus plain old balloon angioplasty for the treatment of infrapopliteal artery lesions. Journal of the American College of Cardiology2014;64(11 Suppl 1):B79. ">BIOLUX P‐II</a> studies did not impact the late lumen loss advantage of DEB compared with uncoated balloon angioplasty at six months (<a href="./references#CD011319-fig-0017" title="">Analysis 1.13</a>; MD ‐0.96 mm, 95% CI ‐1.21 to ‐0.71; 343 participants; 4 studies). </p> </section> <section id="CD011319-sec-0073"> <h6 class="title">Target lesion revascularization</h6> <p>The DEB arm of the trials had a clear advantage in target lesion revascularization compared with uncoated balloon angioplasty at six months (<a href="./references#CD011319-fig-0008" title="">Analysis 1.4</a>; OR 0.28, 95% CI 0.17 to 0.47; 603 participants; 7 studies), 12 months (<a href="./references#CD011319-fig-0027" title="">Analysis 2.5</a>; OR 0.40, 95% CI 0.31 to 0.51; 1900 participants; 11 studies), two years (<a href="./references#CD011319-fig-0044" title="">Analysis 3.4</a>; OR 0.28, 95% CI 0.18 to 0.44; 508 participants; 3 studies), and five years (<a href="./references#CD011319-fig-0054" title="">Analysis 4.2</a>; OR 0.21, 95% CI 0.09 to 0.51; 102 participants; 1 study). </p> <p>Exclusion of <a href="./references#CD011319-bbs2-0001" title="A prospective, multi‐centre, randomized controlled, first in man study to assess the safety and performance of the Passeo‐18 Lux paclitaxel releasing PTA balloon catheter vs. the uncoated Passeo 18 balloon catheter in patients with stenosis and occlusion of the femoropopliteal arteries (BIOLUX P‐I). clinicaltrials.gov/ct2/show/NCT01221610 (accessed 15 August 2015). ScheinertD , SchulteKL , ZellerT , LammerJ , TepeG . Paclitaxel‐releasing balloon in femoropopliteal lesions using a BTHC excipient: twelve‐month results from the BIOLUX P‐I randomized trial. Journal of Endovascular Therapy2015;22:14‐21. TepeG , SchulteK‐L , ZellerT , LammerJ , PfaffingerP , SchmidtA , et al. Six‐month results of the BIOLUX P‐I first in man study comparing a paclitaxel‐releasing balloon catheter versus an uncoated balloon catheter in femoropopliteal lesions. Cardiovascular and Interventional Radiology2012; Vol. 35:S264‐5. ZellerT , LammerJ , RastanA , SchulteK , TepeG , ScheinertD . Twelve‐month results of the BIOLUX P‐I first‐in‐man study comparing a paclitaxel‐releasing balloon catheter versus an uncoated catheter in femoropopliteal lesions. Vasa ‐ Journal of Vascular Diseases2013;42(Suppl 84):FV 9.7. ">BIOLUX P‐I</a>, <a href="./references#CD011319-bbs2-0002" title="BIOTONIK's ‐ first in men study of the Passeo‐18 LUX drug releasing PTA balloon catheter vs. the uncoated Passeo 18 balloon catheter in subjects requiring revascularization of infrapopliteal arteries (BIOLUX P‐II). clinicaltrials.gov/ct2/show/NCT01867736 (accessed 15 August 2015). DelooseK , ZellerT , ScheinertD , BeschornerU . BIOLUX P‐II: a randomized clinical trial of Passeo‐18 Lux DRB vs POBA for the treatment of infrapopliteal artery lesions. Journal of the American College of Cardiology2014; Vol. 64, issue Suppl B. ScheinertD , BrodmannM , ZellerT , BosiersM , PeetersP , Karl‐LudwigS , et al. BIOLUX P‐II: a randomized clinical trial of Passeo‐18 lux drug releasing balloon versus plain old balloon angioplasty for the treatment of infrapopliteal artery lesions. Journal of the American College of Cardiology2014;64(11 Suppl 1):B79. ">BIOLUX P‐II</a>, and <a href="./references#CD011319-bbs2-0005" title="WerkM , LangnerS , ReinkensmeierB , BoettcherHF , TepeG , DietzU , et al. Inhibition of restenosis in femoropopliteal arteries: paclitaxel‐coated versus uncoated balloon: femoral paclitaxel randomized pilot trial. Circulation2008;118(13):1358‐65. ">FemPac 2008</a> at six and 12 months did not impact the target lesion revascularization advantage of DEB compared with uncoated balloon angioplasty (<a href="./references#CD011319-fig-0018" title="">Analysis 1.14</a>; OR 0.22, 95% CI 0.11 to 0.44; 343 participants; 4 studies at six months; <a href="./references#CD011319-fig-0035" title="">Analysis 2.13</a>; OR 0.33, 95% CI 0.18 to 0.61; 1640 participants; 8 studies at 12 months). </p> <p>A funnel plot constructed to test for publication bias in target lesion revascularization at 12 months demonstrated asymmetry, which was consistent with the heterogeneity observed in the analysis (Chi<sup>2</sup> test for heterogeneity P &lt; 0.0001) (<a href="#CD011319-fig-0004">Figure 4</a>). </p> <div class="figure" id="CD011319-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: 2 Drug‐eluting balloon versus uncoated balloon angioplasty at 12 months, outcome: 2.5 Target lesion revascularization." data-id="CD011319-fig-0004" src="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-AFig-FIG04.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: 2 Drug‐eluting balloon versus uncoated balloon angioplasty at 12 months, outcome: 2.5 Target lesion revascularization. </p> </div> </div> </div> </section> <section id="CD011319-sec-0074"> <h6 class="title">Binary restenosis rate</h6> <p>Participants treated with DEBs had significantly lower odds of developing binary restenosis compared with participants in the control group at six months (<a href="./references#CD011319-fig-0009" title="">Analysis 1.5</a>; OR 0.44, 95% CI 0.29 to 0.67; 528 participants; 6 studies), 12 months (<a href="./references#CD011319-fig-0028" title="">Analysis 2.6</a>; OR 0.38, 95% CI 0.15 to 0.98; 1094 participants; 4 studies), two years (<a href="./references#CD011319-fig-0045" title="">Analysis 3.5</a>; OR 0.26, 95% CI 0.10 to 0.66; 87 participants; 1 stud), and five years (<a href="./references#CD011319-fig-0055" title="">Analysis 4.3</a>; OR 0.12, 95% CI 0.05 to 0.30; 102 participants; 1 study). </p> <p>Exclusion of <a href="./references#CD011319-bbs2-0001" title="A prospective, multi‐centre, randomized controlled, first in man study to assess the safety and performance of the Passeo‐18 Lux paclitaxel releasing PTA balloon catheter vs. the uncoated Passeo 18 balloon catheter in patients with stenosis and occlusion of the femoropopliteal arteries (BIOLUX P‐I). clinicaltrials.gov/ct2/show/NCT01221610 (accessed 15 August 2015). ScheinertD , SchulteKL , ZellerT , LammerJ , TepeG . Paclitaxel‐releasing balloon in femoropopliteal lesions using a BTHC excipient: twelve‐month results from the BIOLUX P‐I randomized trial. Journal of Endovascular Therapy2015;22:14‐21. TepeG , SchulteK‐L , ZellerT , LammerJ , PfaffingerP , SchmidtA , et al. Six‐month results of the BIOLUX P‐I first in man study comparing a paclitaxel‐releasing balloon catheter versus an uncoated balloon catheter in femoropopliteal lesions. Cardiovascular and Interventional Radiology2012; Vol. 35:S264‐5. ZellerT , LammerJ , RastanA , SchulteK , TepeG , ScheinertD . Twelve‐month results of the BIOLUX P‐I first‐in‐man study comparing a paclitaxel‐releasing balloon catheter versus an uncoated catheter in femoropopliteal lesions. Vasa ‐ Journal of Vascular Diseases2013;42(Suppl 84):FV 9.7. ">BIOLUX P‐I</a>, <a href="./references#CD011319-bbs2-0002" title="BIOTONIK's ‐ first in men study of the Passeo‐18 LUX drug releasing PTA balloon catheter vs. the uncoated Passeo 18 balloon catheter in subjects requiring revascularization of infrapopliteal arteries (BIOLUX P‐II). clinicaltrials.gov/ct2/show/NCT01867736 (accessed 15 August 2015). DelooseK , ZellerT , ScheinertD , BeschornerU . BIOLUX P‐II: a randomized clinical trial of Passeo‐18 Lux DRB vs POBA for the treatment of infrapopliteal artery lesions. Journal of the American College of Cardiology2014; Vol. 64, issue Suppl B. ScheinertD , BrodmannM , ZellerT , BosiersM , PeetersP , Karl‐LudwigS , et al. BIOLUX P‐II: a randomized clinical trial of Passeo‐18 lux drug releasing balloon versus plain old balloon angioplasty for the treatment of infrapopliteal artery lesions. Journal of the American College of Cardiology2014;64(11 Suppl 1):B79. ">BIOLUX P‐II</a>, and <a href="./references#CD011319-bbs2-0005" title="WerkM , LangnerS , ReinkensmeierB , BoettcherHF , TepeG , DietzU , et al. Inhibition of restenosis in femoropopliteal arteries: paclitaxel‐coated versus uncoated balloon: femoral paclitaxel randomized pilot trial. Circulation2008;118(13):1358‐65. ">FemPac 2008</a> at six months did not impact the binary restenosis rate advantage of DEB compared with uncoated balloon angioplasty (<a href="./references#CD011319-fig-0019" title="">Analysis 1.15</a>; OR 0.25, 95% CI 0.13 to 0.50; 268 participants; 3 studies). </p> </section> </section> <section id="CD011319-sec-0075"> <h5 class="title">Death</h5> <p>There was no significant difference in mortality between participants who underwent DEB or uncoated balloon angioplasty at six months (<a href="./references#CD011319-fig-0010" title="">Analysis 1.6</a>; OR 0.81, 95% CI 0.31 to 2.14; 541 participants; 7 studies), 12 months (<a href="./references#CD011319-fig-0029" title="">Analysis 2.7</a>; OR 1.04, 95% CI 0.64 to 1.71; 1649 participants; 9 studies), and five years (<a href="./references#CD011319-fig-0056" title="">Analysis 4.4</a>; OR 1.92, 95% CI 0.71 to 5.19; 102 participants; 1 study). At two years, uncoated balloon angioplasty had a slight mortality advantage compared with DEB (<a href="./references#CD011319-fig-0046" title="">Analysis 3.6</a>; OR 2.13, 95% CI 1.08 to 4.20; 595 participants; 4 studies). </p> <p>Exclusion of <a href="./references#CD011319-bbs2-0001" title="A prospective, multi‐centre, randomized controlled, first in man study to assess the safety and performance of the Passeo‐18 Lux paclitaxel releasing PTA balloon catheter vs. the uncoated Passeo 18 balloon catheter in patients with stenosis and occlusion of the femoropopliteal arteries (BIOLUX P‐I). clinicaltrials.gov/ct2/show/NCT01221610 (accessed 15 August 2015). ScheinertD , SchulteKL , ZellerT , LammerJ , TepeG . Paclitaxel‐releasing balloon in femoropopliteal lesions using a BTHC excipient: twelve‐month results from the BIOLUX P‐I randomized trial. Journal of Endovascular Therapy2015;22:14‐21. TepeG , SchulteK‐L , ZellerT , LammerJ , PfaffingerP , SchmidtA , et al. Six‐month results of the BIOLUX P‐I first in man study comparing a paclitaxel‐releasing balloon catheter versus an uncoated balloon catheter in femoropopliteal lesions. Cardiovascular and Interventional Radiology2012; Vol. 35:S264‐5. ZellerT , LammerJ , RastanA , SchulteK , TepeG , ScheinertD . Twelve‐month results of the BIOLUX P‐I first‐in‐man study comparing a paclitaxel‐releasing balloon catheter versus an uncoated catheter in femoropopliteal lesions. Vasa ‐ Journal of Vascular Diseases2013;42(Suppl 84):FV 9.7. ">BIOLUX P‐I</a>, <a href="./references#CD011319-bbs2-0002" title="BIOTONIK's ‐ first in men study of the Passeo‐18 LUX drug releasing PTA balloon catheter vs. the uncoated Passeo 18 balloon catheter in subjects requiring revascularization of infrapopliteal arteries (BIOLUX P‐II). clinicaltrials.gov/ct2/show/NCT01867736 (accessed 15 August 2015). DelooseK , ZellerT , ScheinertD , BeschornerU . BIOLUX P‐II: a randomized clinical trial of Passeo‐18 Lux DRB vs POBA for the treatment of infrapopliteal artery lesions. Journal of the American College of Cardiology2014; Vol. 64, issue Suppl B. ScheinertD , BrodmannM , ZellerT , BosiersM , PeetersP , Karl‐LudwigS , et al. BIOLUX P‐II: a randomized clinical trial of Passeo‐18 lux drug releasing balloon versus plain old balloon angioplasty for the treatment of infrapopliteal artery lesions. Journal of the American College of Cardiology2014;64(11 Suppl 1):B79. ">BIOLUX P‐II</a>, and <a href="./references#CD011319-bbs2-0005" title="WerkM , LangnerS , ReinkensmeierB , BoettcherHF , TepeG , DietzU , et al. Inhibition of restenosis in femoropopliteal arteries: paclitaxel‐coated versus uncoated balloon: femoral paclitaxel randomized pilot trial. Circulation2008;118(13):1358‐65. ">FemPac 2008</a> at six months, 12 months, and two years did not result in a significant difference in mortality between the treatment groups (<a href="./references#CD011319-fig-0020" title="">Analysis 1.16</a>; OR 0.57, 95% CI 0.15 to 2.11; 322 participants; 4 studies at six months; <a href="./references#CD011319-fig-0036" title="">Analysis 2.14</a>; OR 1.09, 95% CI 0.64 to 1.85; 1517 participants; 7 studies at 12 months; <a href="./references#CD011319-fig-0052" title="">Analysis 3.12</a>; OR 2.16, 95% CI 1.00 to 4.67; 508 participants; 3 studies at two years). </p> </section> </section> <section id="CD011319-sec-0076"> <h4 class="title">Secondary outcomes</h4> <section id="CD011319-sec-0077"> <h5 class="title">Change in Fontaine stage or Rutherford category of peripheral arterial disease</h5> <p>There was no significant difference in the change in Rutherford category between the DEB and uncoated balloon angioplasty arms at six months (<a href="./references#CD011319-fig-0011" title="">Analysis 1.7</a>; MD ‐0.07, 95% CI ‐0.49 to 0.36; 249 participants; 3 studies), 12 months (<a href="./references#CD011319-fig-0030" title="">Analysis 2.8</a>; MD ‐0.10, 95% CI ‐0.29 to 0.10; 623 participants; 3 studies), and two years (<a href="./references#CD011319-fig-0047" title="">Analysis 3.7</a>; MD ‐0.30, 95% CI ‐0.80 to 0.20; 75 participants; 1 study). </p> <p>Exclusion of <a href="./references#CD011319-bbs2-0002" title="BIOTONIK's ‐ first in men study of the Passeo‐18 LUX drug releasing PTA balloon catheter vs. the uncoated Passeo 18 balloon catheter in subjects requiring revascularization of infrapopliteal arteries (BIOLUX P‐II). clinicaltrials.gov/ct2/show/NCT01867736 (accessed 15 August 2015). DelooseK , ZellerT , ScheinertD , BeschornerU . BIOLUX P‐II: a randomized clinical trial of Passeo‐18 Lux DRB vs POBA for the treatment of infrapopliteal artery lesions. Journal of the American College of Cardiology2014; Vol. 64, issue Suppl B. ScheinertD , BrodmannM , ZellerT , BosiersM , PeetersP , Karl‐LudwigS , et al. BIOLUX P‐II: a randomized clinical trial of Passeo‐18 lux drug releasing balloon versus plain old balloon angioplasty for the treatment of infrapopliteal artery lesions. Journal of the American College of Cardiology2014;64(11 Suppl 1):B79. ">BIOLUX P‐II</a> at six and 12 months did not result in a significant change in Rutherford category from baseline between the two treatment groups (<a href="./references#CD011319-fig-0021" title="">Analysis 1.17</a>; MD 0.04, 95% CI ‐0.42 to 0.50; 177 participants; 2 studies at six months; <a href="./references#CD011319-fig-0038" title="">Analysis 2.16</a>; MD 0.09, 95% CI ‐0.58 to 0.77; 551 participants; 2 studies at 12 months). </p> <p>One trial reported the Fontaine stage rather than the Rutherford classification system (<a href="./references#CD011319-bbs2-0004" title='FanelliF , CannavaleA , BoattaE , CoronaM , LucatelliP , WlderkA , et al. Lower limb multilevel treatment with drug‐eluting balloons: 6‐month results from the DEBELLUM randomized trial. Journal of Endovascular Therapy2012;19(5):571‐80. FanelliF , CannavaleA , CoronaM , LucatelliP , WlderkA , SalvatoriFM . The "DEBELLUM" ‐ lower limb multilevel treatment with drug eluting balloon ‐ randomized trial: 1‐year results. Journal of Cardiovascular Surgery2014;55(2):207‐16. '>DEBELLUM 2012</a>). Our analysis did not include these data, however, because the authors reported the Fontaine class at six and 12 months rather than the change in Fontaine class from baseline. At six months, the DEB participants were 92% Fontaine class I, 8% class IIa, and 0% class IIb or III, versus uncoated balloon angioplasty participants who were 67% class I, 13% class IIa, 7% class IIb, and 13% class III. At 12 months, the DEB participants were 77% class I, 8% class IIa, 15% class IIb, and 0% class III, versus uncoated balloon angioplasty participants who were 60% class I, 13% class IIa, 13% class IIb, and 13% class III. </p> </section> <section id="CD011319-sec-0078"> <h5 class="title">Change in ankle‐brachial index</h5> <p>There was no significant advantage for DEB when evaluating change in ABI at six months (<a href="./references#CD011319-fig-0012" title="">Analysis 1.8</a>; MD ‐0.00, 95% CI ‐0.19 to 0.18; 369 participants; 4 studies), 12 months (<a href="./references#CD011319-fig-0031" title="">Analysis 2.9</a>; MD ‐0.03, 95% CI ‐0.07 to 0.01; 656 participants; 3 studies), and two years (<a href="./references#CD011319-fig-0048" title="">Analysis 3.8</a>; MD 0.02, 95% CI ‐0.12 to 0.16; 83 participants; 1 study). </p> <p>Exclusion of <a href="./references#CD011319-bbs2-0005" title="WerkM , LangnerS , ReinkensmeierB , BoettcherHF , TepeG , DietzU , et al. Inhibition of restenosis in femoropopliteal arteries: paclitaxel‐coated versus uncoated balloon: femoral paclitaxel randomized pilot trial. Circulation2008;118(13):1358‐65. ">FemPac 2008</a>, which reported changes in ABI as medians, and <a href="./references#CD011319-bbs2-0002" title="BIOTONIK's ‐ first in men study of the Passeo‐18 LUX drug releasing PTA balloon catheter vs. the uncoated Passeo 18 balloon catheter in subjects requiring revascularization of infrapopliteal arteries (BIOLUX P‐II). clinicaltrials.gov/ct2/show/NCT01867736 (accessed 15 August 2015). DelooseK , ZellerT , ScheinertD , BeschornerU . BIOLUX P‐II: a randomized clinical trial of Passeo‐18 Lux DRB vs POBA for the treatment of infrapopliteal artery lesions. Journal of the American College of Cardiology2014; Vol. 64, issue Suppl B. ScheinertD , BrodmannM , ZellerT , BosiersM , PeetersP , Karl‐LudwigS , et al. BIOLUX P‐II: a randomized clinical trial of Passeo‐18 lux drug releasing balloon versus plain old balloon angioplasty for the treatment of infrapopliteal artery lesions. Journal of the American College of Cardiology2014;64(11 Suppl 1):B79. ">BIOLUX P‐II</a> demonstrated no advantage in ABI change for DEB compared with uncoated balloon angioplasty at six and 12 months (<a href="./references#CD011319-fig-0022" title="">Analysis 1.18</a>; MD ‐0.01, 95% CI ‐0.09 to 0.08; 177 participants; 2 studies at six months; <a href="./references#CD011319-fig-0039" title="">Analysis 2.17</a>; MD ‐0.01, 95% CI ‐0.05 to 0.03; 551 participants; 2 studies at 12 months). </p> </section> <section id="CD011319-sec-0079"> <h5 class="title">Change in quality of life scores</h5> <p>The Euro‐Qol Group 5‐Dimension Self‐Report Questionnaire (EQ‐5D) QoL scores were reported at six months (<a href="./references#CD011319-bbs2-0002" title="BIOTONIK's ‐ first in men study of the Passeo‐18 LUX drug releasing PTA balloon catheter vs. the uncoated Passeo 18 balloon catheter in subjects requiring revascularization of infrapopliteal arteries (BIOLUX P‐II). clinicaltrials.gov/ct2/show/NCT01867736 (accessed 15 August 2015). DelooseK , ZellerT , ScheinertD , BeschornerU . BIOLUX P‐II: a randomized clinical trial of Passeo‐18 Lux DRB vs POBA for the treatment of infrapopliteal artery lesions. Journal of the American College of Cardiology2014; Vol. 64, issue Suppl B. ScheinertD , BrodmannM , ZellerT , BosiersM , PeetersP , Karl‐LudwigS , et al. BIOLUX P‐II: a randomized clinical trial of Passeo‐18 lux drug releasing balloon versus plain old balloon angioplasty for the treatment of infrapopliteal artery lesions. Journal of the American College of Cardiology2014;64(11 Suppl 1):B79. ">BIOLUX P‐II</a>), 12 months (<a href="./references#CD011319-bbs2-0002" title="BIOTONIK's ‐ first in men study of the Passeo‐18 LUX drug releasing PTA balloon catheter vs. the uncoated Passeo 18 balloon catheter in subjects requiring revascularization of infrapopliteal arteries (BIOLUX P‐II). clinicaltrials.gov/ct2/show/NCT01867736 (accessed 15 August 2015). DelooseK , ZellerT , ScheinertD , BeschornerU . BIOLUX P‐II: a randomized clinical trial of Passeo‐18 Lux DRB vs POBA for the treatment of infrapopliteal artery lesions. Journal of the American College of Cardiology2014; Vol. 64, issue Suppl B. ScheinertD , BrodmannM , ZellerT , BosiersM , PeetersP , Karl‐LudwigS , et al. BIOLUX P‐II: a randomized clinical trial of Passeo‐18 lux drug releasing balloon versus plain old balloon angioplasty for the treatment of infrapopliteal artery lesions. Journal of the American College of Cardiology2014;64(11 Suppl 1):B79. ">BIOLUX P‐II</a>; <a href="./references#CD011319-bbs2-0007" title="LairdJR , SchneiderP , TepeG , BrodmannM , ZellerT , MetzgerC , et al. Durability of treatment effect using a drug‐coated balloon for femoropopliteal lesions 24‐month results of IN.PACT SFA. Journal of the American College of Cardiology2015;66(21):2329‐38. TepeG , LairdJ , SchneiderP , BrodmannM , KrishnanP , MicariA , et al. Drug‐coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12‐month results from the IN.PACT SFA randomized trial. Circulation2015;131(5):495‐502. ">IN.PACT SFA 2015</a>; <a href="./references#CD011319-bbs2-0009" title="RosenfieldK , JaffMR , WhiteCJ , Rocha‐SinghK , Mena‐HurtadoC , MetzgerDC , et al. Trial of a paclitaxel‐coated balloon for femoropopliteal artery disease. New England Journal of Medicine2015;373(2):145‐53. ">LEVANT II 2015</a>) and two years (<a href="./references#CD011319-bbs2-0007" title="LairdJR , SchneiderP , TepeG , BrodmannM , ZellerT , MetzgerC , et al. Durability of treatment effect using a drug‐coated balloon for femoropopliteal lesions 24‐month results of IN.PACT SFA. Journal of the American College of Cardiology2015;66(21):2329‐38. TepeG , LairdJ , SchneiderP , BrodmannM , KrishnanP , MicariA , et al. Drug‐coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12‐month results from the IN.PACT SFA randomized trial. Circulation2015;131(5):495‐502. ">IN.PACT SFA 2015</a>). There was no significant difference in the change of EQ‐5D scores between the DEB and uncoated balloon angioplasty arms (<a href="./references#CD011319-fig-0013" title="">Analysis 1.9</a>; MD ‐0.10, 95% CI ‐0.22 to 0.02; 72 participants; 1 study at six months, <a href="./references#CD011319-fig-0032" title="">Analysis 2.10</a>; MD 0.01, 95% CI ‐0.02 to 0.04; 879 participants; 3 studies at 12 months; <a href="./references#CD011319-fig-0049" title="">Analysis 3.9</a>; MD 0.04; 95% CI ‐0.01 to 0.09; 331 participants; 1 study at two years). </p> <p>Exclusion of <a href="./references#CD011319-bbs2-0002" title="BIOTONIK's ‐ first in men study of the Passeo‐18 LUX drug releasing PTA balloon catheter vs. the uncoated Passeo 18 balloon catheter in subjects requiring revascularization of infrapopliteal arteries (BIOLUX P‐II). clinicaltrials.gov/ct2/show/NCT01867736 (accessed 15 August 2015). DelooseK , ZellerT , ScheinertD , BeschornerU . BIOLUX P‐II: a randomized clinical trial of Passeo‐18 Lux DRB vs POBA for the treatment of infrapopliteal artery lesions. Journal of the American College of Cardiology2014; Vol. 64, issue Suppl B. ScheinertD , BrodmannM , ZellerT , BosiersM , PeetersP , Karl‐LudwigS , et al. BIOLUX P‐II: a randomized clinical trial of Passeo‐18 lux drug releasing balloon versus plain old balloon angioplasty for the treatment of infrapopliteal artery lesions. Journal of the American College of Cardiology2014;64(11 Suppl 1):B79. ">BIOLUX P‐II</a> at 12 months did not result in a significant change in QoL scores from baseline between the two treatment groups (<a href="./references#CD011319-fig-0040" title="">Analysis 2.18</a>; MD 0.02, 95% CI ‐0.01 to 0.05; 807 participants; 2 studies). </p> <p><a href="./references#CD011319-bbs2-0009" title="RosenfieldK , JaffMR , WhiteCJ , Rocha‐SinghK , Mena‐HurtadoC , MetzgerDC , et al. Trial of a paclitaxel‐coated balloon for femoropopliteal artery disease. New England Journal of Medicine2015;373(2):145‐53. ">LEVANT II 2015</a> also reported 36‐item Short Form (SF‐36) Physical and Mental component scores at 12 months but demonstrated no significant difference. The MD and standard deviation (SD) in the Physical component score between the intervention and control arms was 0.6 ± 11 (95% CI ‐1.7 to 2.9). Similarly, the difference in the Mental component score between the intervention and control arms was ‐0.2 ± 12.8 (95% CI ‐2.9 to 2.5). </p> </section> <section id="CD011319-sec-0080"> <h5 class="title">Change in functional walking ability</h5> <p>Two trials assessed the change in functional walking ability using the WIQ (<a href="./references#CD011319-bbs2-0008" title="ScheinertD , DudaS , ZellerT , KrankenbergH , RickeJ , BosiersM , et al. The LEVANT I (Lutonix paclitaxel‐coated balloon for the prevention of femoropopliteal restenosis) trial for femoropopliteal revascularization: first‐in‐human randomized trial of low‐dose drug‐coated balloon versus uncoated balloon angioplasty. JACC. Cardiovascular Interventions2014;7(1):10‐9. ">LEVANT I 2014</a>; <a href="./references#CD011319-bbs2-0009" title="RosenfieldK , JaffMR , WhiteCJ , Rocha‐SinghK , Mena‐HurtadoC , MetzgerDC , et al. Trial of a paclitaxel‐coated balloon for femoropopliteal artery disease. New England Journal of Medicine2015;373(2):145‐53. ">LEVANT II 2015</a>). There were no significant differences in WIQ scores between DEB and uncoated balloon angioplasty at six months (<a href="./references#CD011319-fig-0014" title="">Analysis 1.10</a>; MD ‐0.70, 95% CI ‐16.00 to 14.60; 75 participants; 1 study), 12 months (<a href="./references#CD011319-fig-0033" title="">Analysis 2.11</a>; MD 3.57, 95% CI ‐1.23 to 8.38; 513 participants; 2 studies), and two years (<a href="./references#CD011319-fig-0050" title="">Analysis 3.10</a>; MD 0.50, 95% CI ‐13.42 to 14.42; 75 participants; 1 study). </p> </section> </section> <section id="CD011319-sec-0081"> <h4 class="title">Subgroup analysis</h4> <section id="CD011319-sec-0082"> <h5 class="title">Arterial segments</h5> <p>Seven trials included only femoropopliteal arterial lesions (<a href="./references#CD011319-bbs2-0001" title="A prospective, multi‐centre, randomized controlled, first in man study to assess the safety and performance of the Passeo‐18 Lux paclitaxel releasing PTA balloon catheter vs. the uncoated Passeo 18 balloon catheter in patients with stenosis and occlusion of the femoropopliteal arteries (BIOLUX P‐I). clinicaltrials.gov/ct2/show/NCT01221610 (accessed 15 August 2015). ScheinertD , SchulteKL , ZellerT , LammerJ , TepeG . Paclitaxel‐releasing balloon in femoropopliteal lesions using a BTHC excipient: twelve‐month results from the BIOLUX P‐I randomized trial. Journal of Endovascular Therapy2015;22:14‐21. TepeG , SchulteK‐L , ZellerT , LammerJ , PfaffingerP , SchmidtA , et al. Six‐month results of the BIOLUX P‐I first in man study comparing a paclitaxel‐releasing balloon catheter versus an uncoated balloon catheter in femoropopliteal lesions. Cardiovascular and Interventional Radiology2012; Vol. 35:S264‐5. ZellerT , LammerJ , RastanA , SchulteK , TepeG , ScheinertD . Twelve‐month results of the BIOLUX P‐I first‐in‐man study comparing a paclitaxel‐releasing balloon catheter versus an uncoated catheter in femoropopliteal lesions. Vasa ‐ Journal of Vascular Diseases2013;42(Suppl 84):FV 9.7. ">BIOLUX P‐I</a>; <a href="./references#CD011319-bbs2-0005" title="WerkM , LangnerS , ReinkensmeierB , BoettcherHF , TepeG , DietzU , et al. Inhibition of restenosis in femoropopliteal arteries: paclitaxel‐coated versus uncoated balloon: femoral paclitaxel randomized pilot trial. Circulation2008;118(13):1358‐65. ">FemPac 2008</a>; <a href="./references#CD011319-bbs2-0007" title="LairdJR , SchneiderP , TepeG , BrodmannM , ZellerT , MetzgerC , et al. Durability of treatment effect using a drug‐coated balloon for femoropopliteal lesions 24‐month results of IN.PACT SFA. Journal of the American College of Cardiology2015;66(21):2329‐38. TepeG , LairdJ , SchneiderP , BrodmannM , KrishnanP , MicariA , et al. Drug‐coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12‐month results from the IN.PACT SFA randomized trial. Circulation2015;131(5):495‐502. ">IN.PACT SFA 2015</a>; <a href="./references#CD011319-bbs2-0008" title="ScheinertD , DudaS , ZellerT , KrankenbergH , RickeJ , BosiersM , et al. The LEVANT I (Lutonix paclitaxel‐coated balloon for the prevention of femoropopliteal restenosis) trial for femoropopliteal revascularization: first‐in‐human randomized trial of low‐dose drug‐coated balloon versus uncoated balloon angioplasty. JACC. Cardiovascular Interventions2014;7(1):10‐9. ">LEVANT I 2014</a>; <a href="./references#CD011319-bbs2-0009" title="RosenfieldK , JaffMR , WhiteCJ , Rocha‐SinghK , Mena‐HurtadoC , MetzgerDC , et al. Trial of a paclitaxel‐coated balloon for femoropopliteal artery disease. New England Journal of Medicine2015;373(2):145‐53. ">LEVANT II 2015</a>; <a href="./references#CD011319-bbs2-0010" title="WerkM , AlbrechtT , MeyerDR , AhmedMN , BehneA , DietzU , et al. Paclitaxel‐coated balloons reduce restenosis after femoro‐popliteal angioplasty: evidence from the randomized PACIFIER trial. Circulation. Cardiovascular Interventions2012;5(6):831‐40. ">PACIFIER 2012</a>; <a href="./references#CD011319-bbs2-0011" title="TepeG , SchnorrB , AlbrechtT , BrechtelK , ClaussenCD , SchellerB , et al. Angioplasty of femoral‐popliteal arteries with drug‐coated balloons: 5‐year follow‐up of the THUNDER trial. JACC. Cardiovascular Interventions2015;8(1):102‐8. TepeG , ZellerT , AlbrechtT , HellerS , SchwarzwälderU , BeregiJP , et al. Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg. New England Journal of Medicine2008;358(7):689‐99. ">THUNDER 2008</a>), and three trials included only tibial arterial lesions (<a href="./references#CD011319-bbs2-0002" title="BIOTONIK's ‐ first in men study of the Passeo‐18 LUX drug releasing PTA balloon catheter vs. the uncoated Passeo 18 balloon catheter in subjects requiring revascularization of infrapopliteal arteries (BIOLUX P‐II). clinicaltrials.gov/ct2/show/NCT01867736 (accessed 15 August 2015). DelooseK , ZellerT , ScheinertD , BeschornerU . BIOLUX P‐II: a randomized clinical trial of Passeo‐18 Lux DRB vs POBA for the treatment of infrapopliteal artery lesions. Journal of the American College of Cardiology2014; Vol. 64, issue Suppl B. ScheinertD , BrodmannM , ZellerT , BosiersM , PeetersP , Karl‐LudwigS , et al. BIOLUX P‐II: a randomized clinical trial of Passeo‐18 lux drug releasing balloon versus plain old balloon angioplasty for the treatment of infrapopliteal artery lesions. Journal of the American College of Cardiology2014;64(11 Suppl 1):B79. ">BIOLUX P‐II</a>; <a href="./references#CD011319-bbs2-0003" title="LiistroF , PortoI , AngioliP , GrottiS , RicciL , DucciK , et al. Drug‐eluting balloon in peripheral intervention for below the knee angioplasty evaluation (DEBATE‐BTK): a randomized trial in diabetic patients with critical limb ischemia. Circulation2013;128(6):615‐21. ">DEBATE‐BTK 2013</a>; <a href="./references#CD011319-bbs2-0006" title="ZellerT , BaumgartnerI , ScheinertD , BrodmannM , BosiersM , MicariA , et al. Drug‐eluting balloon versus standard balloon angioplasty for infrapopliteal arterial revascularization in critical limb ischemia: 12‐month results from the IN.PACT DEEP randomized trial. Journal of the American College of Cardiology2014;64(15):1568‐76. ZellerT , BaumgartnerI , ScheinertD , BrodmannM , BosiersM , MicariA , et al. IN.PACT Amphirion paclitaxel eluting balloon versus standard percutaneous transluminal angioplasty for infrapopliteal revascularization of critical limb ischemia: rationale and protocol for an ongoing randomized controlled trial. Trials2014;15:63. ">IN.PACT DEEP 2014</a>). <a href="./references#CD011319-bbs2-0004" title='FanelliF , CannavaleA , BoattaE , CoronaM , LucatelliP , WlderkA , et al. Lower limb multilevel treatment with drug‐eluting balloons: 6‐month results from the DEBELLUM randomized trial. Journal of Endovascular Therapy2012;19(5):571‐80. FanelliF , CannavaleA , CoronaM , LucatelliP , WlderkA , SalvatoriFM . The "DEBELLUM" ‐ lower limb multilevel treatment with drug eluting balloon ‐ randomized trial: 1‐year results. Journal of Cardiovascular Surgery2014;55(2):207‐16. '>DEBELLUM 2012</a> included both femoropopliteal and tibial lesions, but did not stratify the outcomes by type of arterial segment and as such was excluded from this subgroup analysis. Data were available to permit subgroup analysis by arterial segment at six and 12 months for the following outcomes: amputation, late lumen loss, target lesion revascularization, binary restenosis, death, change in Rutherford category, and change in ABI. </p> <section id="CD011319-sec-0083"> <h6 class="title">Amputation</h6> <p>There was no significant difference in the incidence of amputation by arterial segment at six months (<a href="./references#CD011319-fig-0057" title="">Analysis 5.1</a>; OR 1.87, 95% CI 0.40 to 8.75; 415 participants; 5 studies for femoropopliteal vessels versus OR 1.00, 95% CI 0.06 to 16.63; 72 participants; 1 study for tibial vessels; P = 0.70) or 12 months (<a href="./references#CD011319-fig-0070" title="">Analysis 6.1</a>; OR 2.21, 95% CI 0.23 to 21.51; 1033 participants; 5 studies for femoropopliteal vessels versus OR 1.95, 95% CI 0.78 to 4.89; 562 participants; 3 studies for tibial vessels; P = 0.92). </p> <p>Exclusion of <a href="./references#CD011319-bbs2-0001" title="A prospective, multi‐centre, randomized controlled, first in man study to assess the safety and performance of the Passeo‐18 Lux paclitaxel releasing PTA balloon catheter vs. the uncoated Passeo 18 balloon catheter in patients with stenosis and occlusion of the femoropopliteal arteries (BIOLUX P‐I). clinicaltrials.gov/ct2/show/NCT01221610 (accessed 15 August 2015). ScheinertD , SchulteKL , ZellerT , LammerJ , TepeG . Paclitaxel‐releasing balloon in femoropopliteal lesions using a BTHC excipient: twelve‐month results from the BIOLUX P‐I randomized trial. Journal of Endovascular Therapy2015;22:14‐21. TepeG , SchulteK‐L , ZellerT , LammerJ , PfaffingerP , SchmidtA , et al. Six‐month results of the BIOLUX P‐I first in man study comparing a paclitaxel‐releasing balloon catheter versus an uncoated balloon catheter in femoropopliteal lesions. Cardiovascular and Interventional Radiology2012; Vol. 35:S264‐5. ZellerT , LammerJ , RastanA , SchulteK , TepeG , ScheinertD . Twelve‐month results of the BIOLUX P‐I first‐in‐man study comparing a paclitaxel‐releasing balloon catheter versus an uncoated catheter in femoropopliteal lesions. Vasa ‐ Journal of Vascular Diseases2013;42(Suppl 84):FV 9.7. ">BIOLUX P‐I</a> and <a href="./references#CD011319-bbs2-0005" title="WerkM , LangnerS , ReinkensmeierB , BoettcherHF , TepeG , DietzU , et al. Inhibition of restenosis in femoropopliteal arteries: paclitaxel‐coated versus uncoated balloon: femoral paclitaxel randomized pilot trial. Circulation2008;118(13):1358‐65. ">FemPac 2008</a> did not result in a significant change in the incidence of amputation for DEB compared with uncoated balloon angioplasty at six months (<a href="./references#CD011319-fig-0064" title="">Analysis 5.8</a>; OR 4.47, 95% CI 0.49 to 40.67; 268 participants; 3 studies for femoropopliteal vessels) and 12 months (<a href="./references#CD011319-fig-0078" title="">Analysis 6.9</a>; OR 2.21, 95% CI 0.23 to 21.51; 973 participants; 4 studies for femoropopliteal vessels versus OR 2.10, 95% CI 0.79 to 5.59; 490 participants; 2 studies for tibial vessels). </p> </section> <section id="CD011319-sec-0084"> <h6 class="title">Late lumen loss</h6> <p>Comparison of the arterial segment subgroups demonstrated a significant difference in late lumen loss favoring the DEB arm of the femoropopliteal group at six months (<a href="./references#CD011319-fig-0058" title="">Analysis 5.2</a>; MD ‐0.65 mm, 95% CI ‐0.86 to ‐0.45; 423 participants; 5 studies for femoropopliteal vessels versus MD 0.02 mm, 95% CI ‐0.23 to 0.27; 105 participants; 1 study tibial vessels; P &lt; 0.0001) and 12 months (<a href="./references#CD011319-fig-0071" title="">Analysis 6.2</a>; MD ‐1.20 mm, 95% CI ‐1.86 to ‐0.54; 102 participants; 1 study for femoropopliteal vessels versus MD ‐0.01 mm, 95% CI ‐0.18 to 0.16; 358 participants; 1 study for tibial vessels; P = 0.0006). </p> <p>Exclusion of <a href="./references#CD011319-bbs2-0001" title="A prospective, multi‐centre, randomized controlled, first in man study to assess the safety and performance of the Passeo‐18 Lux paclitaxel releasing PTA balloon catheter vs. the uncoated Passeo 18 balloon catheter in patients with stenosis and occlusion of the femoropopliteal arteries (BIOLUX P‐I). clinicaltrials.gov/ct2/show/NCT01221610 (accessed 15 August 2015). ScheinertD , SchulteKL , ZellerT , LammerJ , TepeG . Paclitaxel‐releasing balloon in femoropopliteal lesions using a BTHC excipient: twelve‐month results from the BIOLUX P‐I randomized trial. Journal of Endovascular Therapy2015;22:14‐21. TepeG , SchulteK‐L , ZellerT , LammerJ , PfaffingerP , SchmidtA , et al. Six‐month results of the BIOLUX P‐I first in man study comparing a paclitaxel‐releasing balloon catheter versus an uncoated balloon catheter in femoropopliteal lesions. Cardiovascular and Interventional Radiology2012; Vol. 35:S264‐5. ZellerT , LammerJ , RastanA , SchulteK , TepeG , ScheinertD . Twelve‐month results of the BIOLUX P‐I first‐in‐man study comparing a paclitaxel‐releasing balloon catheter versus an uncoated catheter in femoropopliteal lesions. Vasa ‐ Journal of Vascular Diseases2013;42(Suppl 84):FV 9.7. ">BIOLUX P‐I</a> and <a href="./references#CD011319-bbs2-0005" title="WerkM , LangnerS , ReinkensmeierB , BoettcherHF , TepeG , DietzU , et al. Inhibition of restenosis in femoropopliteal arteries: paclitaxel‐coated versus uncoated balloon: femoral paclitaxel randomized pilot trial. Circulation2008;118(13):1358‐65. ">FemPac 2008</a> did not result in a significant change in the late lumen loss advantage of DEB compared with uncoated balloon angioplasty at six months (<a href="./references#CD011319-fig-0065" title="">Analysis 5.9</a>; MD ‐0.92 mm, 95% CI ‐1.27 to ‐0.57; 268 participants; 3 studies for femoropopliteal vessels). </p> <p>Given the intrinsic lumen diameter differences between femoropopliteal and tibial vessels, the implications of this analysis are limited. </p> </section> <section id="CD011319-sec-0085"> <h6 class="title">Target lesion revascularization</h6> <p>Comparison of the arterial segment subgroups demonstrated a significant advantage in target lesion revascularization for the DEB arm of the femoropopliteal subgroup, but there was no significant difference between the DEB and control arms of the tibial subgroup at six months (<a href="./references#CD011319-fig-0059" title="">Analysis 5.3</a>; OR 0.22, 95% CI 0.12 to 0.41; 423 participants; 5 studies for femoropopliteal vessels versus OR 0.91, 95% CI 0.26 to 3.18; 105 participants; 1 study for tibial vessels; P = 0.05) and 12 months (<a href="./references#CD011319-fig-0072" title="">Analysis 6.3</a>; OR 0.26, 95% CI 0.13 to 0.56; 1230 participants; 7 studies for femoropopliteal vessels versus OR 0.65, 95% CI 0.30 to 1.44; 595 participants; 3 studies for tibial vessels; P = 0.10). </p> <p>Exclusion of <a href="./references#CD011319-bbs2-0001" title="A prospective, multi‐centre, randomized controlled, first in man study to assess the safety and performance of the Passeo‐18 Lux paclitaxel releasing PTA balloon catheter vs. the uncoated Passeo 18 balloon catheter in patients with stenosis and occlusion of the femoropopliteal arteries (BIOLUX P‐I). clinicaltrials.gov/ct2/show/NCT01221610 (accessed 15 August 2015). ScheinertD , SchulteKL , ZellerT , LammerJ , TepeG . Paclitaxel‐releasing balloon in femoropopliteal lesions using a BTHC excipient: twelve‐month results from the BIOLUX P‐I randomized trial. Journal of Endovascular Therapy2015;22:14‐21. TepeG , SchulteK‐L , ZellerT , LammerJ , PfaffingerP , SchmidtA , et al. Six‐month results of the BIOLUX P‐I first in man study comparing a paclitaxel‐releasing balloon catheter versus an uncoated balloon catheter in femoropopliteal lesions. Cardiovascular and Interventional Radiology2012; Vol. 35:S264‐5. ZellerT , LammerJ , RastanA , SchulteK , TepeG , ScheinertD . Twelve‐month results of the BIOLUX P‐I first‐in‐man study comparing a paclitaxel‐releasing balloon catheter versus an uncoated catheter in femoropopliteal lesions. Vasa ‐ Journal of Vascular Diseases2013;42(Suppl 84):FV 9.7. ">BIOLUX P‐I</a>, <a href="./references#CD011319-bbs2-0002" title="BIOTONIK's ‐ first in men study of the Passeo‐18 LUX drug releasing PTA balloon catheter vs. the uncoated Passeo 18 balloon catheter in subjects requiring revascularization of infrapopliteal arteries (BIOLUX P‐II). clinicaltrials.gov/ct2/show/NCT01867736 (accessed 15 August 2015). DelooseK , ZellerT , ScheinertD , BeschornerU . BIOLUX P‐II: a randomized clinical trial of Passeo‐18 Lux DRB vs POBA for the treatment of infrapopliteal artery lesions. Journal of the American College of Cardiology2014; Vol. 64, issue Suppl B. ScheinertD , BrodmannM , ZellerT , BosiersM , PeetersP , Karl‐LudwigS , et al. BIOLUX P‐II: a randomized clinical trial of Passeo‐18 lux drug releasing balloon versus plain old balloon angioplasty for the treatment of infrapopliteal artery lesions. Journal of the American College of Cardiology2014;64(11 Suppl 1):B79. ">BIOLUX P‐II</a>, and <a href="./references#CD011319-bbs2-0005" title="WerkM , LangnerS , ReinkensmeierB , BoettcherHF , TepeG , DietzU , et al. Inhibition of restenosis in femoropopliteal arteries: paclitaxel‐coated versus uncoated balloon: femoral paclitaxel randomized pilot trial. Circulation2008;118(13):1358‐65. ">FemPac 2008</a> did not result in a significant change in the target lesion revascularization advantage of DEB compared with uncoated balloon angioplasty at six months (<a href="./references#CD011319-fig-0066" title="">Analysis 5.10</a>; OR 0.23, 95% CI 0.11 to 0.48; 268 participants; 3 studies for femoropopliteal vessels) and 12 months (<a href="./references#CD011319-fig-0079" title="">Analysis 6.10</a>; OR 0.28, 95% CI 0.10 to 0.73; 1075 participants; 5 studies for femoropopliteal vessels versus OR 0.52, 95% CI 0.18 to 1.52; 490 participants; 2 studies for tibial vessels; P = 0.23). </p> </section> <section id="CD011319-sec-0086"> <h6 class="title">Binary restenosis</h6> <p>There was a significant advantage for DEB in the incidence of binary femoropopliteal vessel restenosis compared with uncoated balloon angioplasty at six months (<a href="./references#CD011319-fig-0060" title="">Analysis 5.4</a>; OR 0.26, 95% CI 0.15 to 0.46; 348 participants; 4 studies for femoropopliteal vessels versus OR 1.85, 95% CI 0.78 to 4.39; 105 participants; 1 study for tibial vessels; P = 0.0002). However, this effect was not sustained at 12 months (<a href="./references#CD011319-fig-0073" title="">Analysis 6.4</a>; OR 0.37, 95% CI 0.11 to 1.26; 578 participants; 2 studies for femoropopliteal vessels versus OR 0.40, 95% CI 0.05 to 3.14; 516 participants; 2 studies for tibial vessels; P = 0.96). </p> <p>Exclusion of <a href="./references#CD011319-bbs2-0001" title="A prospective, multi‐centre, randomized controlled, first in man study to assess the safety and performance of the Passeo‐18 Lux paclitaxel releasing PTA balloon catheter vs. the uncoated Passeo 18 balloon catheter in patients with stenosis and occlusion of the femoropopliteal arteries (BIOLUX P‐I). clinicaltrials.gov/ct2/show/NCT01221610 (accessed 15 August 2015). ScheinertD , SchulteKL , ZellerT , LammerJ , TepeG . Paclitaxel‐releasing balloon in femoropopliteal lesions using a BTHC excipient: twelve‐month results from the BIOLUX P‐I randomized trial. Journal of Endovascular Therapy2015;22:14‐21. TepeG , SchulteK‐L , ZellerT , LammerJ , PfaffingerP , SchmidtA , et al. Six‐month results of the BIOLUX P‐I first in man study comparing a paclitaxel‐releasing balloon catheter versus an uncoated balloon catheter in femoropopliteal lesions. Cardiovascular and Interventional Radiology2012; Vol. 35:S264‐5. ZellerT , LammerJ , RastanA , SchulteK , TepeG , ScheinertD . Twelve‐month results of the BIOLUX P‐I first‐in‐man study comparing a paclitaxel‐releasing balloon catheter versus an uncoated catheter in femoropopliteal lesions. Vasa ‐ Journal of Vascular Diseases2013;42(Suppl 84):FV 9.7. ">BIOLUX P‐I</a> and <a href="./references#CD011319-bbs2-0005" title="WerkM , LangnerS , ReinkensmeierB , BoettcherHF , TepeG , DietzU , et al. Inhibition of restenosis in femoropopliteal arteries: paclitaxel‐coated versus uncoated balloon: femoral paclitaxel randomized pilot trial. Circulation2008;118(13):1358‐65. ">FemPac 2008</a> did not result in a significant change in the binary restenosis advantage of DEB compared with uncoated balloon angioplasty at six months (<a href="./references#CD011319-fig-0067" title="">Analysis 5.11</a>; OR 0.26, 95% CI 0.12 to 0.57; 193 participants; 2 studies). </p> </section> <section id="CD011319-sec-0087"> <h6 class="title">Death</h6> <p>Comparison of the arterial segment subgroups demonstrated no difference in mortality between DEB and uncoated balloon angioplasty at six months (<a href="./references#CD011319-fig-0061" title="">Analysis 5.5</a>; OR 0.66, 95% CI 0.22 to 1.97; 415 participants; 5 studies for femoropopliteal vessels versus OR 2.06, 95% CI 0.18 to 23.77; 72 participants; 1 study for tibial vessels; P = 0.41) and 12 months (<a href="./references#CD011319-fig-0074" title="">Analysis 6.5</a>; OR 0.67, 95% CI 0.31 to 1.46; 1033 participants; 5 studies for femoropopliteal vessels versus OR 1.41, 95% CI 0.73 to 2.74; 562 participants; 3 studies for tibial vessels; P = 0.15). </p> <p>Exclusion of <a href="./references#CD011319-bbs2-0001" title="A prospective, multi‐centre, randomized controlled, first in man study to assess the safety and performance of the Passeo‐18 Lux paclitaxel releasing PTA balloon catheter vs. the uncoated Passeo 18 balloon catheter in patients with stenosis and occlusion of the femoropopliteal arteries (BIOLUX P‐I). clinicaltrials.gov/ct2/show/NCT01221610 (accessed 15 August 2015). ScheinertD , SchulteKL , ZellerT , LammerJ , TepeG . Paclitaxel‐releasing balloon in femoropopliteal lesions using a BTHC excipient: twelve‐month results from the BIOLUX P‐I randomized trial. Journal of Endovascular Therapy2015;22:14‐21. TepeG , SchulteK‐L , ZellerT , LammerJ , PfaffingerP , SchmidtA , et al. Six‐month results of the BIOLUX P‐I first in man study comparing a paclitaxel‐releasing balloon catheter versus an uncoated balloon catheter in femoropopliteal lesions. Cardiovascular and Interventional Radiology2012; Vol. 35:S264‐5. ZellerT , LammerJ , RastanA , SchulteK , TepeG , ScheinertD . Twelve‐month results of the BIOLUX P‐I first‐in‐man study comparing a paclitaxel‐releasing balloon catheter versus an uncoated catheter in femoropopliteal lesions. Vasa ‐ Journal of Vascular Diseases2013;42(Suppl 84):FV 9.7. ">BIOLUX P‐I</a>, <a href="./references#CD011319-bbs2-0002" title="BIOTONIK's ‐ first in men study of the Passeo‐18 LUX drug releasing PTA balloon catheter vs. the uncoated Passeo 18 balloon catheter in subjects requiring revascularization of infrapopliteal arteries (BIOLUX P‐II). clinicaltrials.gov/ct2/show/NCT01867736 (accessed 15 August 2015). DelooseK , ZellerT , ScheinertD , BeschornerU . BIOLUX P‐II: a randomized clinical trial of Passeo‐18 Lux DRB vs POBA for the treatment of infrapopliteal artery lesions. Journal of the American College of Cardiology2014; Vol. 64, issue Suppl B. ScheinertD , BrodmannM , ZellerT , BosiersM , PeetersP , Karl‐LudwigS , et al. BIOLUX P‐II: a randomized clinical trial of Passeo‐18 lux drug releasing balloon versus plain old balloon angioplasty for the treatment of infrapopliteal artery lesions. Journal of the American College of Cardiology2014;64(11 Suppl 1):B79. ">BIOLUX P‐II</a>, and <a href="./references#CD011319-bbs2-0005" title="WerkM , LangnerS , ReinkensmeierB , BoettcherHF , TepeG , DietzU , et al. Inhibition of restenosis in femoropopliteal arteries: paclitaxel‐coated versus uncoated balloon: femoral paclitaxel randomized pilot trial. Circulation2008;118(13):1358‐65. ">FemPac 2008</a> did not result in a significant change in mortality for DEB compared with uncoated balloon angioplasty at six months (<a href="./references#CD011319-fig-0068" title="">Analysis 5.12</a>; OR 0.57, 95% CI 0.15 to 2.11; 268 participants; 3 studies for femoropopliteal vessels) and 12 months (<a href="./references#CD011319-fig-0080" title="">Analysis 6.11</a>; OR 0.77, 95% CI 0.34 to 1.73; 973 participants; 4 studies for femoropopliteal vessels versus OR 1.40, 95% CI 0.69 to 2.83; 490 participants; 2 studies for tibial vessels; P = 0.27). </p> </section> <section id="CD011319-sec-0088"> <h6 class="title">Change in Rutherford category</h6> <p>Comparison of the arterial segment subgroups demonstrated no difference in Rutherford category between DEB and uncoated balloon angioplasty at six months (<a href="./references#CD011319-fig-0062" title="">Analysis 5.6</a>; MD 0.04, 95% CI ‐0.42 to 0.50; 177 participants; 2 studies for femoropopliteal vessels versus MD ‐0.60, 95% CI ‐1.64 to 0.44; 72 participants; 1 study for tibial vessels; P = 0.27) and 12 months (<a href="./references#CD011319-fig-0075" title="">Analysis 6.6</a>; MD 0.09, 95% CI ‐0.58 to 0.77; 551 participants; 2 studies for femoropopliteal vessels versus MD 0.60, 95% CI ‐0.46 to 1.66; 72 participants; 1 study for tibial vessels; P = 0.43). </p> <p>Exclusion of <a href="./references#CD011319-bbs2-0005" title="WerkM , LangnerS , ReinkensmeierB , BoettcherHF , TepeG , DietzU , et al. Inhibition of restenosis in femoropopliteal arteries: paclitaxel‐coated versus uncoated balloon: femoral paclitaxel randomized pilot trial. Circulation2008;118(13):1358‐65. ">FemPac 2008</a> did not result in a significant change in Rutherford category between DEB and uncoated balloon angioplasty at six months (<a href="./references#CD011319-fig-0069" title="">Analysis 5.13</a>; MD ‐0.01, 95% CI ‐0.09 to 0.08; 177 participants; 2 studies for femoropopliteal vessels). </p> </section> <section id="CD011319-sec-0089"> <h6 class="title">Change in ankle‐brachial index</h6> <p>There was a significant change in ABI advantage for uncoated balloon angioplasty compared with DEB in tibial vessels, but this advantage was not seen in femoropopliteal vessels at six months (<a href="./references#CD011319-fig-0063" title="">Analysis 5.7</a>; MD 0.07, 95% CI ‐0.09 to 0.22; 264 participants; 3 studies for femoropopliteal vessels versus MD ‐0.20, 95% CI ‐0.31 to ‐0.09; 105 participants; 1 study for tibial vessels; P = 0.007) and 12 months (<a href="./references#CD011319-fig-0076" title="">Analysis 6.7</a>; MD ‐0.01, 95% CI ‐0.05 to 0.03; 551 participants; 2 studies for femoropopliteal vessels versus MD ‐0.20, 95% CI ‐0.31 to ‐0.09; 105 participants; 1 study for tibial vessels; P = 0.003). </p> <p>Exclusion of <a href="./references#CD011319-bbs2-0005" title="WerkM , LangnerS , ReinkensmeierB , BoettcherHF , TepeG , DietzU , et al. Inhibition of restenosis in femoropopliteal arteries: paclitaxel‐coated versus uncoated balloon: femoral paclitaxel randomized pilot trial. Circulation2008;118(13):1358‐65. ">FemPac 2008</a> did not result in a significant change in ABI between DEB and uncoated balloon angioplasty for femoropopliteal vessels at six months (<a href="./references#CD011319-fig-0069" title="">Analysis 5.13</a>; MD ‐0.01, 95% CI ‐0.09 to 0.08; 177 participants; 2 studies for femoropopliteal vessels). </p> </section> </section> <section id="CD011319-sec-0090"> <h5 class="title">Severity of peripheral arterial disease</h5> <p>Two trials included only participants with CLI (Rutherford class 4 or greater) (<a href="./references#CD011319-bbs2-0003" title="LiistroF , PortoI , AngioliP , GrottiS , RicciL , DucciK , et al. Drug‐eluting balloon in peripheral intervention for below the knee angioplasty evaluation (DEBATE‐BTK): a randomized trial in diabetic patients with critical limb ischemia. Circulation2013;128(6):615‐21. ">DEBATE‐BTK 2013</a>; <a href="./references#CD011319-bbs2-0006" title="ZellerT , BaumgartnerI , ScheinertD , BrodmannM , BosiersM , MicariA , et al. Drug‐eluting balloon versus standard balloon angioplasty for infrapopliteal arterial revascularization in critical limb ischemia: 12‐month results from the IN.PACT DEEP randomized trial. Journal of the American College of Cardiology2014;64(15):1568‐76. ZellerT , BaumgartnerI , ScheinertD , BrodmannM , BosiersM , MicariA , et al. IN.PACT Amphirion paclitaxel eluting balloon versus standard percutaneous transluminal angioplasty for infrapopliteal revascularization of critical limb ischemia: rationale and protocol for an ongoing randomized controlled trial. Trials2014;15:63. ">IN.PACT DEEP 2014</a>). The other trials included participants with varying degrees of PAD but did not stratify the outcomes by severity of PAD and as such were excluded from this subgroup analysis. Data were only available to permit subgroup analysis for participants with CLI at 12 months for the following outcomes: amputation, late lumen loss, target lesion revascularization, binary restenosis, and death. </p> <p>There was no significant difference in the incidence of amputation between the DEB and control arms in participants with CLI (<a href="./references#CD011319-fig-0081" title="">Analysis 7.1</a>; OR 2.10, 95% CI 0.79 to 5.59; 490 participants; 2 studies). Similarly, there was no difference in late lumen loss (<a href="./references#CD011319-fig-0082" title="">Analysis 7.2</a>; MD ‐0.01 mm, 95% CI ‐0.18 to 0.16; 358 participants; 1 study), target lesion revascularization (<a href="./references#CD011319-fig-0083" title="">Analysis 7.3</a>; OR 0.52, 95% CI 0.18 to 1.52; 490 participants; 2 studies); binary restenosis (<a href="./references#CD011319-fig-0084" title="">Analysis 7.4</a>; OR 0.40, 95% CI 0.05 to 3.14; 516 participants; 2 studies); or death (<a href="./references#CD011319-fig-0085" title="">Analysis 7.5</a>; OR 1.40, 95% CI 0.69 to 2.83; 490 participants; 2 studies), between the DEB and control arms in participants with CLI. </p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD011319-sec-0091" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011319-sec-0091">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD011319-sec-0129">Español</a> </li> </nav> </div> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD011319-sec-0091"></div> <section id="CD011319-sec-0092"> <h3 class="title" id="CD011319-sec-0092">Summary of main results</h3> <p>DEB angioplasty was associated with improved primary vessel patency and late lumen loss for up to two years and target lesion revascularization and binary restenosis rates for up to five years. However, there was no advantage for DEB in clinical endpoints such as amputation, change in Rutherford class, QoL scores, functional walking ability, or mortality compared with uncoated balloon angioplasty. On subgroup analysis, DEB angioplasty showed improved late lumen loss, target lesion revascularization, and binary restenosis for up to six months, and late lumen loss and target lesion revascularization for up to 12 months in femoropopliteal vessels. However, DEB angioplasty of tibial vessels was not superior to uncoated balloon angioplasty in any domains. Furthermore, DEB angioplasty was not superior to uncoated balloon angioplasty in people with CLI. </p> </section> <section id="CD011319-sec-0093"> <h3 class="title" id="CD011319-sec-0093">Overall completeness and applicability of evidence</h3> <p>We included 11 prospective randomized trials that were designed to compare clinical differences after DEB versus uncoated balloon angioplasty. The trial endpoints in all of the included studies were clinically relevant, patient‐oriented, and included a widely utilized mix of anatomic and clinical endpoints, which makes our findings clinically applicable. </p> <p>While the trials had several limitations (listed in <a href="#CD011319-sec-0043">Assessment of risk of bias in included studies</a>), most were conducted at high‐volume centers with experience in device‐efficacy trials. Three trials were at a high risk of bias and their impact was assessed with serial sensitivity analyses, but in most instances their exclusion had no significant impact (<a href="./references#CD011319-bbs2-0001" title="A prospective, multi‐centre, randomized controlled, first in man study to assess the safety and performance of the Passeo‐18 Lux paclitaxel releasing PTA balloon catheter vs. the uncoated Passeo 18 balloon catheter in patients with stenosis and occlusion of the femoropopliteal arteries (BIOLUX P‐I). clinicaltrials.gov/ct2/show/NCT01221610 (accessed 15 August 2015). ScheinertD , SchulteKL , ZellerT , LammerJ , TepeG . Paclitaxel‐releasing balloon in femoropopliteal lesions using a BTHC excipient: twelve‐month results from the BIOLUX P‐I randomized trial. Journal of Endovascular Therapy2015;22:14‐21. TepeG , SchulteK‐L , ZellerT , LammerJ , PfaffingerP , SchmidtA , et al. Six‐month results of the BIOLUX P‐I first in man study comparing a paclitaxel‐releasing balloon catheter versus an uncoated balloon catheter in femoropopliteal lesions. Cardiovascular and Interventional Radiology2012; Vol. 35:S264‐5. ZellerT , LammerJ , RastanA , SchulteK , TepeG , ScheinertD . Twelve‐month results of the BIOLUX P‐I first‐in‐man study comparing a paclitaxel‐releasing balloon catheter versus an uncoated catheter in femoropopliteal lesions. Vasa ‐ Journal of Vascular Diseases2013;42(Suppl 84):FV 9.7. ">BIOLUX P‐I</a>; <a href="./references#CD011319-bbs2-0002" title="BIOTONIK's ‐ first in men study of the Passeo‐18 LUX drug releasing PTA balloon catheter vs. the uncoated Passeo 18 balloon catheter in subjects requiring revascularization of infrapopliteal arteries (BIOLUX P‐II). clinicaltrials.gov/ct2/show/NCT01867736 (accessed 15 August 2015). DelooseK , ZellerT , ScheinertD , BeschornerU . BIOLUX P‐II: a randomized clinical trial of Passeo‐18 Lux DRB vs POBA for the treatment of infrapopliteal artery lesions. Journal of the American College of Cardiology2014; Vol. 64, issue Suppl B. ScheinertD , BrodmannM , ZellerT , BosiersM , PeetersP , Karl‐LudwigS , et al. BIOLUX P‐II: a randomized clinical trial of Passeo‐18 lux drug releasing balloon versus plain old balloon angioplasty for the treatment of infrapopliteal artery lesions. Journal of the American College of Cardiology2014;64(11 Suppl 1):B79. ">BIOLUX P‐II</a>; <a href="./references#CD011319-bbs2-0005" title="WerkM , LangnerS , ReinkensmeierB , BoettcherHF , TepeG , DietzU , et al. Inhibition of restenosis in femoropopliteal arteries: paclitaxel‐coated versus uncoated balloon: femoral paclitaxel randomized pilot trial. Circulation2008;118(13):1358‐65. ">FemPac 2008</a>). </p> <p>A limitation of our subgroup analysis was that there were only three trials available for the tibial vessel analysis (<a href="./references#CD011319-bbs2-0002" title="BIOTONIK's ‐ first in men study of the Passeo‐18 LUX drug releasing PTA balloon catheter vs. the uncoated Passeo 18 balloon catheter in subjects requiring revascularization of infrapopliteal arteries (BIOLUX P‐II). clinicaltrials.gov/ct2/show/NCT01867736 (accessed 15 August 2015). DelooseK , ZellerT , ScheinertD , BeschornerU . BIOLUX P‐II: a randomized clinical trial of Passeo‐18 Lux DRB vs POBA for the treatment of infrapopliteal artery lesions. Journal of the American College of Cardiology2014; Vol. 64, issue Suppl B. ScheinertD , BrodmannM , ZellerT , BosiersM , PeetersP , Karl‐LudwigS , et al. BIOLUX P‐II: a randomized clinical trial of Passeo‐18 lux drug releasing balloon versus plain old balloon angioplasty for the treatment of infrapopliteal artery lesions. Journal of the American College of Cardiology2014;64(11 Suppl 1):B79. ">BIOLUX P‐II</a>; <a href="./references#CD011319-bbs2-0003" title="LiistroF , PortoI , AngioliP , GrottiS , RicciL , DucciK , et al. Drug‐eluting balloon in peripheral intervention for below the knee angioplasty evaluation (DEBATE‐BTK): a randomized trial in diabetic patients with critical limb ischemia. Circulation2013;128(6):615‐21. ">DEBATE‐BTK 2013</a>; <a href="./references#CD011319-bbs2-0006" title="ZellerT , BaumgartnerI , ScheinertD , BrodmannM , BosiersM , MicariA , et al. Drug‐eluting balloon versus standard balloon angioplasty for infrapopliteal arterial revascularization in critical limb ischemia: 12‐month results from the IN.PACT DEEP randomized trial. Journal of the American College of Cardiology2014;64(15):1568‐76. ZellerT , BaumgartnerI , ScheinertD , BrodmannM , BosiersM , MicariA , et al. IN.PACT Amphirion paclitaxel eluting balloon versus standard percutaneous transluminal angioplasty for infrapopliteal revascularization of critical limb ischemia: rationale and protocol for an ongoing randomized controlled trial. Trials2014;15:63. ">IN.PACT DEEP 2014</a>), and only two trials for the CLI subgroup analysis (<a href="./references#CD011319-bbs2-0003" title="LiistroF , PortoI , AngioliP , GrottiS , RicciL , DucciK , et al. Drug‐eluting balloon in peripheral intervention for below the knee angioplasty evaluation (DEBATE‐BTK): a randomized trial in diabetic patients with critical limb ischemia. Circulation2013;128(6):615‐21. ">DEBATE‐BTK 2013</a>; <a href="./references#CD011319-bbs2-0006" title="ZellerT , BaumgartnerI , ScheinertD , BrodmannM , BosiersM , MicariA , et al. Drug‐eluting balloon versus standard balloon angioplasty for infrapopliteal arterial revascularization in critical limb ischemia: 12‐month results from the IN.PACT DEEP randomized trial. Journal of the American College of Cardiology2014;64(15):1568‐76. ZellerT , BaumgartnerI , ScheinertD , BrodmannM , BosiersM , MicariA , et al. IN.PACT Amphirion paclitaxel eluting balloon versus standard percutaneous transluminal angioplasty for infrapopliteal revascularization of critical limb ischemia: rationale and protocol for an ongoing randomized controlled trial. Trials2014;15:63. ">IN.PACT DEEP 2014</a>). As such, it is unclear whether the subgroup analysis results were due to the effects of tibial arteries or CLI. Furthermore, we were unable to carry out any subgroup analyses by severity of PAD because none of the trials reported their outcomes by degree of severity. </p> <p>Finally, several of the ongoing trials (listed in <a href="./references#CD011319-sec-0114" title="">Characteristics of ongoing studies</a> table) have not published their results in peer‐reviewed publications despite having completed enrolment for several years. Two of those trials started enrolling participants in 2008 (<a href="./references#CD011319-bbs2-0029" title="Advance® 18PTX® Balloon Catheter Study: treatment of lesions in superficial femoral artery/popliteal artery with a paclitaxel‐coated balloon. clinicaltrials.gov/ct2/show/NCT00776906 (accessed 15 August 2015). ">Advance 18PTX Balloon Catheter Study</a>; <a href="./references#CD011319-bbs2-0036" title="Paclitaxel coated balloons for prevention of restenosis in small arteries below the knee compared to angioplasty using uncoated balloons. clinicaltrials.gov/ct2/show/NCT00696956 (accessed 15 August 2015). ">PICCOLO</a>). This is concerning for possible reporting bias if those privately sponsored trials were not published because of unfavorable results. We have attempted to contact the authors of all ongoing trials with limited success. </p> <p>We have identified several trials that are still enrolling participants or have not published their results, and several of the studies included in our analysis have not yet published their long‐term results. As such, future versions of this review will hopefully be able to provide better evidence for the efficacy of DEB in managing lower‐limb ischemia. </p> </section> <section id="CD011319-sec-0094"> <h3 class="title" id="CD011319-sec-0094">Quality of the evidence</h3> <p>There was heterogeneity in the frequency of stent deployment and the type and duration of antiplatelet therapy between trials. Using GRADE assessment criteria, the quality of the evidence presented was low for the outcome of target lesion revascularization; moderate for binary restenosis and change in Rutherford category; and high for amputation, primary vessel patency, death, and change in ABI. </p> <p>The included studies were powered to detect anatomic endpoints that were measured according to angiographic and ultrasound imaging criteria. As such, caution must be taken in interpreting the clinical endpoint results, since the included studies were unlikely to be powered to specifically assess those endpoints. </p> <p>Risk of selection bias was low in most of the studies. Conversely, performance bias was uniformly high because of the difficulty in blinding operators to the interventions. However, this, is a limitation intrinsic to most surgical and procedural trials. The included studies mostly took adequate steps to address this limitation by implementing measures, such as independent core lab evaluation, to avoid detection bias. While follow‐up compliance was good in half of the included studies, most studies were at low risk for reporting bias. </p> <p>There was a substantial amount of heterogeneity in the studies that may have biased the analysis. First, while the DEB in all of the included studies employed the mitotic inhibitor paclitaxel, the medication doses varied and were not consistently reported. Second, the DEB devices in the studies employed different drug carriers, as described in <a href="./references#CD011319-bbs2-0057" title="SchnorrB , AlbrechtT . Drug‐coated balloons and their place in treating peripheral arterial disease. Expert Review of Medical Devices2013;10(1):105‐14. ">Schnorr 2013</a>. The effect of different drug carriers on the results was not clear. Third, the type and duration of antiplatelet therapy differed between trials. Finally, the wide use of stenting in most of the included trials invariably affected the outcomes, but few data were available on the stented subgroups of participants. </p> <p>It is unclear what criteria were used to determine the need for target lesion revascularization, resulting in heterogeneity between studies reporting this outcome. While most studies stated that target lesion revascularization was carried out for clinically driven indications (<a href="./references#CD011319-bbs2-0001" title="A prospective, multi‐centre, randomized controlled, first in man study to assess the safety and performance of the Passeo‐18 Lux paclitaxel releasing PTA balloon catheter vs. the uncoated Passeo 18 balloon catheter in patients with stenosis and occlusion of the femoropopliteal arteries (BIOLUX P‐I). clinicaltrials.gov/ct2/show/NCT01221610 (accessed 15 August 2015). ScheinertD , SchulteKL , ZellerT , LammerJ , TepeG . Paclitaxel‐releasing balloon in femoropopliteal lesions using a BTHC excipient: twelve‐month results from the BIOLUX P‐I randomized trial. Journal of Endovascular Therapy2015;22:14‐21. TepeG , SchulteK‐L , ZellerT , LammerJ , PfaffingerP , SchmidtA , et al. Six‐month results of the BIOLUX P‐I first in man study comparing a paclitaxel‐releasing balloon catheter versus an uncoated balloon catheter in femoropopliteal lesions. Cardiovascular and Interventional Radiology2012; Vol. 35:S264‐5. ZellerT , LammerJ , RastanA , SchulteK , TepeG , ScheinertD . Twelve‐month results of the BIOLUX P‐I first‐in‐man study comparing a paclitaxel‐releasing balloon catheter versus an uncoated catheter in femoropopliteal lesions. Vasa ‐ Journal of Vascular Diseases2013;42(Suppl 84):FV 9.7. ">BIOLUX P‐I</a>; <a href="./references#CD011319-bbs2-0003" title="LiistroF , PortoI , AngioliP , GrottiS , RicciL , DucciK , et al. Drug‐eluting balloon in peripheral intervention for below the knee angioplasty evaluation (DEBATE‐BTK): a randomized trial in diabetic patients with critical limb ischemia. Circulation2013;128(6):615‐21. ">DEBATE‐BTK 2013</a>; <a href="./references#CD011319-bbs2-0004" title='FanelliF , CannavaleA , BoattaE , CoronaM , LucatelliP , WlderkA , et al. Lower limb multilevel treatment with drug‐eluting balloons: 6‐month results from the DEBELLUM randomized trial. Journal of Endovascular Therapy2012;19(5):571‐80. FanelliF , CannavaleA , CoronaM , LucatelliP , WlderkA , SalvatoriFM . The "DEBELLUM" ‐ lower limb multilevel treatment with drug eluting balloon ‐ randomized trial: 1‐year results. Journal of Cardiovascular Surgery2014;55(2):207‐16. '>DEBELLUM 2012</a>; <a href="./references#CD011319-bbs2-0006" title="ZellerT , BaumgartnerI , ScheinertD , BrodmannM , BosiersM , MicariA , et al. Drug‐eluting balloon versus standard balloon angioplasty for infrapopliteal arterial revascularization in critical limb ischemia: 12‐month results from the IN.PACT DEEP randomized trial. Journal of the American College of Cardiology2014;64(15):1568‐76. ZellerT , BaumgartnerI , ScheinertD , BrodmannM , BosiersM , MicariA , et al. IN.PACT Amphirion paclitaxel eluting balloon versus standard percutaneous transluminal angioplasty for infrapopliteal revascularization of critical limb ischemia: rationale and protocol for an ongoing randomized controlled trial. Trials2014;15:63. ">IN.PACT DEEP 2014</a>; <a href="./references#CD011319-bbs2-0007" title="LairdJR , SchneiderP , TepeG , BrodmannM , ZellerT , MetzgerC , et al. Durability of treatment effect using a drug‐coated balloon for femoropopliteal lesions 24‐month results of IN.PACT SFA. Journal of the American College of Cardiology2015;66(21):2329‐38. TepeG , LairdJ , SchneiderP , BrodmannM , KrishnanP , MicariA , et al. Drug‐coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12‐month results from the IN.PACT SFA randomized trial. Circulation2015;131(5):495‐502. ">IN.PACT SFA 2015</a>; <a href="./references#CD011319-bbs2-0009" title="RosenfieldK , JaffMR , WhiteCJ , Rocha‐SinghK , Mena‐HurtadoC , MetzgerDC , et al. Trial of a paclitaxel‐coated balloon for femoropopliteal artery disease. New England Journal of Medicine2015;373(2):145‐53. ">LEVANT II 2015</a>; <a href="./references#CD011319-bbs2-0010" title="WerkM , AlbrechtT , MeyerDR , AhmedMN , BehneA , DietzU , et al. Paclitaxel‐coated balloons reduce restenosis after femoro‐popliteal angioplasty: evidence from the randomized PACIFIER trial. Circulation. Cardiovascular Interventions2012;5(6):831‐40. ">PACIFIER 2012</a>), those indications were not defined or explained. </p> <p>Those limitations notwithstanding, our analysis demonstrates an advantage for DEB compared with uncoated balloon angioplasty in the management of PAD for up to two years of follow‐up in several anatomic endpoints. There is insufficient evidence to support an advantage for either treatment modality beyond two years. However, with many other ongoing or unreported studies, short‐ and long‐term data will hopefully become available to assess the efficacy of this treatment modality better in the near future. </p> </section> <section id="CD011319-sec-0095"> <h3 class="title" id="CD011319-sec-0095">Potential biases in the review process</h3> <p>We carried out our review in a transparent manner consistent with Cochrane guidelines. We conducted intention‐to‐treat analysis on all of the data in this study, and used the initial number of randomized participants in each study arm for all subsequent calculations regardless of participant death or loss to follow‐up. We encountered difficulty in obtaining unpublished information from some study authors (<a href="./references#CD011319-bbs2-0007" title="LairdJR , SchneiderP , TepeG , BrodmannM , ZellerT , MetzgerC , et al. Durability of treatment effect using a drug‐coated balloon for femoropopliteal lesions 24‐month results of IN.PACT SFA. Journal of the American College of Cardiology2015;66(21):2329‐38. TepeG , LairdJ , SchneiderP , BrodmannM , KrishnanP , MicariA , et al. Drug‐coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12‐month results from the IN.PACT SFA randomized trial. Circulation2015;131(5):495‐502. ">IN.PACT SFA 2015</a>; <a href="./references#CD011319-bbs2-0008" title="ScheinertD , DudaS , ZellerT , KrankenbergH , RickeJ , BosiersM , et al. The LEVANT I (Lutonix paclitaxel‐coated balloon for the prevention of femoropopliteal restenosis) trial for femoropopliteal revascularization: first‐in‐human randomized trial of low‐dose drug‐coated balloon versus uncoated balloon angioplasty. JACC. Cardiovascular Interventions2014;7(1):10‐9. ">LEVANT I 2014</a>; <a href="./references#CD011319-bbs2-0009" title="RosenfieldK , JaffMR , WhiteCJ , Rocha‐SinghK , Mena‐HurtadoC , MetzgerDC , et al. Trial of a paclitaxel‐coated balloon for femoropopliteal artery disease. New England Journal of Medicine2015;373(2):145‐53. ">LEVANT II 2015</a>). Despite several attempts to contact the authors with requests for information, only three authors provided us with data for this analysis (<a href="./references#CD011319-bbs2-0001" title="A prospective, multi‐centre, randomized controlled, first in man study to assess the safety and performance of the Passeo‐18 Lux paclitaxel releasing PTA balloon catheter vs. the uncoated Passeo 18 balloon catheter in patients with stenosis and occlusion of the femoropopliteal arteries (BIOLUX P‐I). clinicaltrials.gov/ct2/show/NCT01221610 (accessed 15 August 2015). ScheinertD , SchulteKL , ZellerT , LammerJ , TepeG . Paclitaxel‐releasing balloon in femoropopliteal lesions using a BTHC excipient: twelve‐month results from the BIOLUX P‐I randomized trial. Journal of Endovascular Therapy2015;22:14‐21. TepeG , SchulteK‐L , ZellerT , LammerJ , PfaffingerP , SchmidtA , et al. Six‐month results of the BIOLUX P‐I first in man study comparing a paclitaxel‐releasing balloon catheter versus an uncoated balloon catheter in femoropopliteal lesions. Cardiovascular and Interventional Radiology2012; Vol. 35:S264‐5. ZellerT , LammerJ , RastanA , SchulteK , TepeG , ScheinertD . Twelve‐month results of the BIOLUX P‐I first‐in‐man study comparing a paclitaxel‐releasing balloon catheter versus an uncoated catheter in femoropopliteal lesions. Vasa ‐ Journal of Vascular Diseases2013;42(Suppl 84):FV 9.7. ">BIOLUX P‐I</a>; <a href="./references#CD011319-bbs2-0002" title="BIOTONIK's ‐ first in men study of the Passeo‐18 LUX drug releasing PTA balloon catheter vs. the uncoated Passeo 18 balloon catheter in subjects requiring revascularization of infrapopliteal arteries (BIOLUX P‐II). clinicaltrials.gov/ct2/show/NCT01867736 (accessed 15 August 2015). DelooseK , ZellerT , ScheinertD , BeschornerU . BIOLUX P‐II: a randomized clinical trial of Passeo‐18 Lux DRB vs POBA for the treatment of infrapopliteal artery lesions. Journal of the American College of Cardiology2014; Vol. 64, issue Suppl B. ScheinertD , BrodmannM , ZellerT , BosiersM , PeetersP , Karl‐LudwigS , et al. BIOLUX P‐II: a randomized clinical trial of Passeo‐18 lux drug releasing balloon versus plain old balloon angioplasty for the treatment of infrapopliteal artery lesions. Journal of the American College of Cardiology2014;64(11 Suppl 1):B79. ">BIOLUX P‐II</a>; <a href="./references#CD011319-bbs2-0004" title='FanelliF , CannavaleA , BoattaE , CoronaM , LucatelliP , WlderkA , et al. Lower limb multilevel treatment with drug‐eluting balloons: 6‐month results from the DEBELLUM randomized trial. Journal of Endovascular Therapy2012;19(5):571‐80. FanelliF , CannavaleA , CoronaM , LucatelliP , WlderkA , SalvatoriFM . The "DEBELLUM" ‐ lower limb multilevel treatment with drug eluting balloon ‐ randomized trial: 1‐year results. Journal of Cardiovascular Surgery2014;55(2):207‐16. '>DEBELLUM 2012</a>). One trial reported medians instead of means for late lumen loss and change in ABI (<a href="./references#CD011319-bbs2-0005" title="WerkM , LangnerS , ReinkensmeierB , BoettcherHF , TepeG , DietzU , et al. Inhibition of restenosis in femoropopliteal arteries: paclitaxel‐coated versus uncoated balloon: femoral paclitaxel randomized pilot trial. Circulation2008;118(13):1358‐65. ">FemPac 2008</a>). We converted the median values to means and included them in the analysis. A subsequent sensitivity analysis did not demonstrate a significant impact of this study's inclusion on our results. Finally, our analysis at five years was based on only one study (<a href="./references#CD011319-bbs2-0011" title="TepeG , SchnorrB , AlbrechtT , BrechtelK , ClaussenCD , SchellerB , et al. Angioplasty of femoral‐popliteal arteries with drug‐coated balloons: 5‐year follow‐up of the THUNDER trial. JACC. Cardiovascular Interventions2015;8(1):102‐8. TepeG , ZellerT , AlbrechtT , HellerS , SchwarzwälderU , BeregiJP , et al. Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg. New England Journal of Medicine2008;358(7):689‐99. ">THUNDER 2008</a>). </p> </section> <section id="CD011319-sec-0096"> <h3 class="title" id="CD011319-sec-0096">Agreements and disagreements with other studies or reviews</h3> <p>In the past few years, several meta‐analyses have compared DEB with uncoated balloon angioplasty for femoropopliteal and tibial arterial lesions. </p> <p><a href="./references#CD011319-bbs2-0041" title="BaerlocherMO , KennedySA , RajebiMR , BaerlocherFJ , MisraJ , LiuD , et al. Meta‐analysis of drug‐eluting balloon angioplasty and drug‐eluting stent placement for infrainguinal peripheral arterial disease. Journal of Vascular and Interventional Radiology2015;26(4):459‐73. ">Baerlocher 2015</a> reported an advantage for DEB in the anatomic endpoints of late lumen loss, binary restenosis, and target lesion revascularization, and no advantage in clinical endpoints at 12 months. However, their analysis included <a href="./references#CD011319-bbs2-0050" title="SiablisD , KitrouPM , SpiliopoulosS , KatsanosK , KarnabatidisD . Paclitaxel‐coated balloon angioplasty versus drug‐eluting stenting for the treatment of infrapopliteal long‐segment arterial occlusive disease: the IDEAS randomized controlled trial. JACC. Cardiovascular Interventions2014;7:1048‐56. ">IDEAS 2014</a>, which compared DEB to drug‐eluting stents. The authors also carried out a tibial vessel analysis using <a href="./references#CD011319-bbs2-0003" title="LiistroF , PortoI , AngioliP , GrottiS , RicciL , DucciK , et al. Drug‐eluting balloon in peripheral intervention for below the knee angioplasty evaluation (DEBATE‐BTK): a randomized trial in diabetic patients with critical limb ischemia. Circulation2013;128(6):615‐21. ">DEBATE‐BTK 2013</a> and <a href="./references#CD011319-bbs2-0004" title='FanelliF , CannavaleA , BoattaE , CoronaM , LucatelliP , WlderkA , et al. Lower limb multilevel treatment with drug‐eluting balloons: 6‐month results from the DEBELLUM randomized trial. Journal of Endovascular Therapy2012;19(5):571‐80. FanelliF , CannavaleA , CoronaM , LucatelliP , WlderkA , SalvatoriFM . The "DEBELLUM" ‐ lower limb multilevel treatment with drug eluting balloon ‐ randomized trial: 1‐year results. Journal of Cardiovascular Surgery2014;55(2):207‐16. '>DEBELLUM 2012</a> and reported an advantage for DEBs in target lesion revascularization and binary restenosis at 12 months. We did not include <a href="./references#CD011319-bbs2-0004" title='FanelliF , CannavaleA , BoattaE , CoronaM , LucatelliP , WlderkA , et al. Lower limb multilevel treatment with drug‐eluting balloons: 6‐month results from the DEBELLUM randomized trial. Journal of Endovascular Therapy2012;19(5):571‐80. FanelliF , CannavaleA , CoronaM , LucatelliP , WlderkA , SalvatoriFM . The "DEBELLUM" ‐ lower limb multilevel treatment with drug eluting balloon ‐ randomized trial: 1‐year results. Journal of Cardiovascular Surgery2014;55(2):207‐16. '>DEBELLUM 2012</a> in our tibial vessel subgroup analysis because the authors of that study included both femoropopliteal and tibial lesions but did not report the results separately. </p> <p><a href="./references#CD011319-bbs2-0044" title="CanaudL , OzdemirBA , BelliAM , LoftusIM , ThompsonMM , HinchliffeRJ . Infrainguinal angioplasty with drug‐eluting stents and balloons. Journal of Vascular Surgery2014;59:1721‐36. ">Canaud 2014</a> also reported an advantage for DEB in target lesion revascularization and binary restenosis. However, the authors included fewer randomized trials and included two case series (<a href="./references#CD011319-bbs2-0053" title="MicariA , CioppaA , VadalaG , CastriotaF , LisoA , MarcheseA , et al. Clinical evaluation of a paclitaxel‐eluting balloon for treatment of femoropopliteal arterial disease: 12‐month results from a multicenter Italian registry. JACC. Cardiovascular Interventions2012;5:331‐8. ">Micari 2012</a>; <a href="./references#CD011319-bbs2-0056" title="SchmidtA , PiorkowskiM , WernerM , UlrichM , BausbackY , BraeunlichS , et al. First experience with drug‐eluting balloons in infrapopliteal arteries: restenosis rate and clinical outcome. Journal of the American College of Cardiology2011;58:1105‐9. ">Schmidt 2011</a>). </p> <p><a href="./references#CD011319-bbs2-0045" title="CasseseS , ByrneRA , OttI , NdrepepaG , NeradM , KastratiA , et al. Paclitaxel‐coated versus uncoated balloon angioplasty reduces target lesion revascularization in patients with femoropopliteal arterial disease: a meta‐analysis of randomized trials. Circulation. Cardiovascular Interventions2012;5:582‐9. ">Cassese 2012</a> analyzed four randomized controlled trials, which were also included in our analysis, and similarly reported an advantage for target lesion revascularization, binary restenosis, and late lumen loss compared with uncoated balloon angioplasty for femoropopliteal lesions. </p> <p>Finally, Jens and colleagues reported an advantage for DEB compared with uncoated balloon angioplasty in target lesion revascularization of femoropopliteal arterial lesions but no difference in clinical endpoints (<a href="./references#CD011319-bbs2-0051" title="JensS , ConijnAP , KoelemayMJW , BipatS , ReekersJA . Randomized trials for endovascular treatment of infrainguinal arterial disease: systematic review and meta‐analysis (part 1: above the knee). European Journal of Vascular and Endovascular Surgery2014;47(5):524‐35. ">Jens 2014a</a>). The authors also reported an advantage for DEB in wound healing, target lesion revascularization, binary restenosis, and change in Rutherford classification in treating tibial arterial lesions based on the DEBATE BTK trial (<a href="./references#CD011319-bbs2-0052" title="JensS , ConijnAP , KoelemayMJW , BipatS , ReekersJA . Randomized trials for endovascular treatment of infrainguinal arterial disease: systematic review and meta‐analysis (part 2: below the knee). European Journal of Vascular and Endovascular Surgery2014;47(5):536‐44. ">Jens 2014b</a>). However, our tibial subgroup analysis included both <a href="./references#CD011319-bbs2-0003" title="LiistroF , PortoI , AngioliP , GrottiS , RicciL , DucciK , et al. Drug‐eluting balloon in peripheral intervention for below the knee angioplasty evaluation (DEBATE‐BTK): a randomized trial in diabetic patients with critical limb ischemia. Circulation2013;128(6):615‐21. ">DEBATE‐BTK 2013</a> and <a href="./references#CD011319-bbs2-0006" title="ZellerT , BaumgartnerI , ScheinertD , BrodmannM , BosiersM , MicariA , et al. Drug‐eluting balloon versus standard balloon angioplasty for infrapopliteal arterial revascularization in critical limb ischemia: 12‐month results from the IN.PACT DEEP randomized trial. Journal of the American College of Cardiology2014;64(15):1568‐76. ZellerT , BaumgartnerI , ScheinertD , BrodmannM , BosiersM , MicariA , et al. IN.PACT Amphirion paclitaxel eluting balloon versus standard percutaneous transluminal angioplasty for infrapopliteal revascularization of critical limb ischemia: rationale and protocol for an ongoing randomized controlled trial. Trials2014;15:63. ">IN.PACT DEEP 2014</a> and demonstrated no advantage for DEB compared with uncoated balloon angioplasty in anatomic or clinical endpoints. Furthermore, the change in Rutherford classification data reported by Jens and colleagues was not included in the manuscript published by Liistro and colleagues when <a href="./references#CD011319-bbs2-0003" title="LiistroF , PortoI , AngioliP , GrottiS , RicciL , DucciK , et al. Drug‐eluting balloon in peripheral intervention for below the knee angioplasty evaluation (DEBATE‐BTK): a randomized trial in diabetic patients with critical limb ischemia. Circulation2013;128(6):615‐21. ">DEBATE‐BTK 2013</a> was published. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD011319-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/urn:x-wiley:14651858:media:CD011319:CD011319-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_t/tCD011319-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD011319-fig-0001" src="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/full#CD011319-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011319-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/urn:x-wiley:14651858:media:CD011319:CD011319-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_t/tCD011319-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgments about each risk of bias item presented as percentages across all included studies." data-id="CD011319-fig-0002" src="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgments about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/full#CD011319-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011319-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/urn:x-wiley:14651858:media:CD011319:CD011319-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_t/tCD011319-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgments about each risk of bias item for each included study." data-id="CD011319-fig-0003" src="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgments about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/full#CD011319-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011319-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/urn:x-wiley:14651858:media:CD011319:CD011319-AFig-FIG04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_t/tCD011319-AFig-FIG04.png" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: 2 Drug‐eluting balloon versus uncoated balloon angioplasty at 12 months, outcome: 2.5 Target lesion revascularization." data-id="CD011319-fig-0004" src="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-AFig-FIG04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Funnel plot of comparison: 2 Drug‐eluting balloon versus uncoated balloon angioplasty at 12 months, outcome: 2.5 Target lesion revascularization. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/full#CD011319-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-AFig-FIG04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011319-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/urn:x-wiley:14651858:media:CD011319:CD011319-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_t/tCD011319-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at six months, Outcome 1 Amputation." data-id="CD011319-fig-0005" src="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at six months, Outcome 1 Amputation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/references#CD011319-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011319-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/urn:x-wiley:14651858:media:CD011319:CD011319-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_t/tCD011319-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at six months, Outcome 2 Primary vessel patency." data-id="CD011319-fig-0006" src="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at six months, Outcome 2 Primary vessel patency. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/references#CD011319-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011319-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/urn:x-wiley:14651858:media:CD011319:CD011319-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_t/tCD011319-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at six months, Outcome 3 Late lumen loss." data-id="CD011319-fig-0007" src="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at six months, Outcome 3 Late lumen loss. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/references#CD011319-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011319-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/urn:x-wiley:14651858:media:CD011319:CD011319-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_t/tCD011319-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at six months, Outcome 4 Target lesion revascularization." data-id="CD011319-fig-0008" src="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at six months, Outcome 4 Target lesion revascularization. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/references#CD011319-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011319-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/urn:x-wiley:14651858:media:CD011319:CD011319-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_t/tCD011319-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at six months, Outcome 5 Binary restenosis." data-id="CD011319-fig-0009" src="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at six months, Outcome 5 Binary restenosis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/references#CD011319-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011319-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/urn:x-wiley:14651858:media:CD011319:CD011319-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_t/tCD011319-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at six months, Outcome 6 Death." data-id="CD011319-fig-0010" src="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at six months, Outcome 6 Death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/references#CD011319-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011319-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/urn:x-wiley:14651858:media:CD011319:CD011319-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_t/tCD011319-CMP-001-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at six months, Outcome 7 Change in Rutherford category." data-id="CD011319-fig-0011" src="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at six months, Outcome 7 Change in Rutherford category. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/references#CD011319-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011319-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/urn:x-wiley:14651858:media:CD011319:CD011319-CMP-001-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_t/tCD011319-CMP-001-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at six months, Outcome 8 Change in ankle‐brachial index." data-id="CD011319-fig-0012" src="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-001-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at six months, Outcome 8 Change in ankle‐brachial index. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/references#CD011319-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-001-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011319-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/urn:x-wiley:14651858:media:CD011319:CD011319-CMP-001-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_t/tCD011319-CMP-001-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at six months, Outcome 9 Change in quality of life (EQ‐5D)." data-id="CD011319-fig-0013" src="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-001-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at six months, Outcome 9 Change in quality of life (EQ‐5D). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/references#CD011319-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-001-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011319-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/urn:x-wiley:14651858:media:CD011319:CD011319-CMP-001-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_t/tCD011319-CMP-001-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at six months, Outcome 10 Change in walking impairment score." data-id="CD011319-fig-0014" src="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-001-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.10</div> <div class="figure-caption"> <p>Comparison 1 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at six months, Outcome 10 Change in walking impairment score. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/references#CD011319-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-001-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011319-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/urn:x-wiley:14651858:media:CD011319:CD011319-CMP-001-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_t/tCD011319-CMP-001-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at six months, Outcome 11 Amputation (sensitivity analysis)." data-id="CD011319-fig-0015" src="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-001-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.11</div> <div class="figure-caption"> <p>Comparison 1 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at six months, Outcome 11 Amputation (sensitivity analysis). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/references#CD011319-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-001-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011319-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/urn:x-wiley:14651858:media:CD011319:CD011319-CMP-001-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_t/tCD011319-CMP-001-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at six months, Outcome 12 Primary vessel patency (sensitivity analysis)." data-id="CD011319-fig-0016" src="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-001-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.12</div> <div class="figure-caption"> <p>Comparison 1 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at six months, Outcome 12 Primary vessel patency (sensitivity analysis). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/references#CD011319-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-001-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011319-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/urn:x-wiley:14651858:media:CD011319:CD011319-CMP-001-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_t/tCD011319-CMP-001-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at six months, Outcome 13 Late lumen loss (sensitivity analysis)." data-id="CD011319-fig-0017" src="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-001-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.13</div> <div class="figure-caption"> <p>Comparison 1 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at six months, Outcome 13 Late lumen loss (sensitivity analysis). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/references#CD011319-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-001-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011319-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/urn:x-wiley:14651858:media:CD011319:CD011319-CMP-001-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_t/tCD011319-CMP-001-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at six months, Outcome 14 Target lesion revascularization (sensitivity analysis)." data-id="CD011319-fig-0018" src="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-001-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.14</div> <div class="figure-caption"> <p>Comparison 1 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at six months, Outcome 14 Target lesion revascularization (sensitivity analysis). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/references#CD011319-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-001-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011319-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/urn:x-wiley:14651858:media:CD011319:CD011319-CMP-001-15" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_t/tCD011319-CMP-001-15.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at six months, Outcome 15 Binary restenosis (sensitivity analysis)." data-id="CD011319-fig-0019" src="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-001-15.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.15</div> <div class="figure-caption"> <p>Comparison 1 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at six months, Outcome 15 Binary restenosis (sensitivity analysis). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/references#CD011319-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-001-15.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011319-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/urn:x-wiley:14651858:media:CD011319:CD011319-CMP-001-16" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_t/tCD011319-CMP-001-16.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at six months, Outcome 16 Death (sensitivity analysis)." data-id="CD011319-fig-0020" src="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-001-16.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.16</div> <div class="figure-caption"> <p>Comparison 1 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at six months, Outcome 16 Death (sensitivity analysis). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/references#CD011319-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-001-16.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011319-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/urn:x-wiley:14651858:media:CD011319:CD011319-CMP-001-17" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_t/tCD011319-CMP-001-17.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at six months, Outcome 17 Change in Rutherford category (sensitivity analysis)." data-id="CD011319-fig-0021" src="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-001-17.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.17</div> <div class="figure-caption"> <p>Comparison 1 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at six months, Outcome 17 Change in Rutherford category (sensitivity analysis). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/references#CD011319-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-001-17.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011319-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/urn:x-wiley:14651858:media:CD011319:CD011319-CMP-001-18" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_t/tCD011319-CMP-001-18.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at six months, Outcome 18 Change in ankle‐brachial index (sensitivity analysis)." data-id="CD011319-fig-0022" src="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-001-18.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.18</div> <div class="figure-caption"> <p>Comparison 1 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at six months, Outcome 18 Change in ankle‐brachial index (sensitivity analysis). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/references#CD011319-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-001-18.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011319-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/urn:x-wiley:14651858:media:CD011319:CD011319-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_t/tCD011319-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at twelve months, Outcome 1 Amputation." data-id="CD011319-fig-0023" src="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at twelve months, Outcome 1 Amputation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/references#CD011319-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011319-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/urn:x-wiley:14651858:media:CD011319:CD011319-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_t/tCD011319-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at twelve months, Outcome 2 Amputation‐free survival." data-id="CD011319-fig-0024" src="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at twelve months, Outcome 2 Amputation‐free survival. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/references#CD011319-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011319-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/urn:x-wiley:14651858:media:CD011319:CD011319-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_t/tCD011319-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at twelve months, Outcome 3 Primary vessel patency." data-id="CD011319-fig-0025" src="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at twelve months, Outcome 3 Primary vessel patency. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/references#CD011319-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011319-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/urn:x-wiley:14651858:media:CD011319:CD011319-CMP-002-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_t/tCD011319-CMP-002-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at twelve months, Outcome 4 Late lumen loss." data-id="CD011319-fig-0026" src="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-002-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at twelve months, Outcome 4 Late lumen loss. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/references#CD011319-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-002-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011319-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/urn:x-wiley:14651858:media:CD011319:CD011319-CMP-002-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_t/tCD011319-CMP-002-05.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at twelve months, Outcome 5 Target lesion revascularization." data-id="CD011319-fig-0027" src="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-002-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at twelve months, Outcome 5 Target lesion revascularization. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/references#CD011319-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-002-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011319-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/urn:x-wiley:14651858:media:CD011319:CD011319-CMP-002-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_t/tCD011319-CMP-002-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at twelve months, Outcome 6 Binary restenosis." data-id="CD011319-fig-0028" src="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-002-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.6</div> <div class="figure-caption"> <p>Comparison 2 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at twelve months, Outcome 6 Binary restenosis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/references#CD011319-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-002-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011319-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/urn:x-wiley:14651858:media:CD011319:CD011319-CMP-002-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_t/tCD011319-CMP-002-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at twelve months, Outcome 7 Death." data-id="CD011319-fig-0029" src="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-002-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.7</div> <div class="figure-caption"> <p>Comparison 2 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at twelve months, Outcome 7 Death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/references#CD011319-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-002-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011319-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/urn:x-wiley:14651858:media:CD011319:CD011319-CMP-002-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_t/tCD011319-CMP-002-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at twelve months, Outcome 8 Change in Rutherford category." data-id="CD011319-fig-0030" src="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-002-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.8</div> <div class="figure-caption"> <p>Comparison 2 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at twelve months, Outcome 8 Change in Rutherford category. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/references#CD011319-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-002-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011319-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/urn:x-wiley:14651858:media:CD011319:CD011319-CMP-002-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_t/tCD011319-CMP-002-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at twelve months, Outcome 9 Change in ankle‐brachial index." data-id="CD011319-fig-0031" src="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-002-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.9</div> <div class="figure-caption"> <p>Comparison 2 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at twelve months, Outcome 9 Change in ankle‐brachial index. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/references#CD011319-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-002-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011319-fig-0032"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/urn:x-wiley:14651858:media:CD011319:CD011319-CMP-002-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_t/tCD011319-CMP-002-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at twelve months, Outcome 10 Change in Quality of Life (EQ‐5D)." data-id="CD011319-fig-0032" src="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-002-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.10</div> <div class="figure-caption"> <p>Comparison 2 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at twelve months, Outcome 10 Change in Quality of Life (EQ‐5D). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/references#CD011319-fig-0032">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-002-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011319-fig-0033"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/urn:x-wiley:14651858:media:CD011319:CD011319-CMP-002-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_t/tCD011319-CMP-002-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at twelve months, Outcome 11 Change in walking impairment score." data-id="CD011319-fig-0033" src="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-002-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.11</div> <div class="figure-caption"> <p>Comparison 2 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at twelve months, Outcome 11 Change in walking impairment score. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/references#CD011319-fig-0033">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-002-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011319-fig-0034"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/urn:x-wiley:14651858:media:CD011319:CD011319-CMP-002-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_t/tCD011319-CMP-002-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at twelve months, Outcome 12 Amputation (sensitivity analysis)." data-id="CD011319-fig-0034" src="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-002-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.12</div> <div class="figure-caption"> <p>Comparison 2 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at twelve months, Outcome 12 Amputation (sensitivity analysis). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/references#CD011319-fig-0034">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-002-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011319-fig-0035"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/urn:x-wiley:14651858:media:CD011319:CD011319-CMP-002-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_t/tCD011319-CMP-002-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at twelve months, Outcome 13 Target lesion revascularization (sensitivity analysis)." data-id="CD011319-fig-0035" src="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-002-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.13</div> <div class="figure-caption"> <p>Comparison 2 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at twelve months, Outcome 13 Target lesion revascularization (sensitivity analysis). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/references#CD011319-fig-0035">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-002-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011319-fig-0036"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/urn:x-wiley:14651858:media:CD011319:CD011319-CMP-002-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_t/tCD011319-CMP-002-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at twelve months, Outcome 14 Death (sensitivity analysis)." data-id="CD011319-fig-0036" src="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-002-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.14</div> <div class="figure-caption"> <p>Comparison 2 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at twelve months, Outcome 14 Death (sensitivity analysis). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/references#CD011319-fig-0036">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-002-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011319-fig-0037"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/urn:x-wiley:14651858:media:CD011319:CD011319-CMP-002-15" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_t/tCD011319-CMP-002-15.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at twelve months, Outcome 15 Late lumen loss (sensitivity analysis)." data-id="CD011319-fig-0037" src="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-002-15.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.15</div> <div class="figure-caption"> <p>Comparison 2 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at twelve months, Outcome 15 Late lumen loss (sensitivity analysis). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/references#CD011319-fig-0037">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-002-15.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011319-fig-0038"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/urn:x-wiley:14651858:media:CD011319:CD011319-CMP-002-16" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_t/tCD011319-CMP-002-16.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at twelve months, Outcome 16 Change in Rutherford category (sensitivity analysis)." data-id="CD011319-fig-0038" src="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-002-16.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.16</div> <div class="figure-caption"> <p>Comparison 2 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at twelve months, Outcome 16 Change in Rutherford category (sensitivity analysis). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/references#CD011319-fig-0038">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-002-16.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011319-fig-0039"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/urn:x-wiley:14651858:media:CD011319:CD011319-CMP-002-17" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_t/tCD011319-CMP-002-17.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at twelve months, Outcome 17 Change in ankle‐brachial index (sensitivity analysis)." data-id="CD011319-fig-0039" src="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-002-17.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.17</div> <div class="figure-caption"> <p>Comparison 2 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at twelve months, Outcome 17 Change in ankle‐brachial index (sensitivity analysis). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/references#CD011319-fig-0039">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-002-17.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011319-fig-0040"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/urn:x-wiley:14651858:media:CD011319:CD011319-CMP-002-18" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_t/tCD011319-CMP-002-18.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at twelve months, Outcome 18 Change in quality of life (EQ‐5D) (sensitivity analysis)." data-id="CD011319-fig-0040" src="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-002-18.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.18</div> <div class="figure-caption"> <p>Comparison 2 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at twelve months, Outcome 18 Change in quality of life (EQ‐5D) (sensitivity analysis). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/references#CD011319-fig-0040">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-002-18.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011319-fig-0041"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/urn:x-wiley:14651858:media:CD011319:CD011319-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_t/tCD011319-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at two years, Outcome 1 Amputation." data-id="CD011319-fig-0041" src="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at two years, Outcome 1 Amputation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/references#CD011319-fig-0041">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011319-fig-0042"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/urn:x-wiley:14651858:media:CD011319:CD011319-CMP-003-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_t/tCD011319-CMP-003-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at two years, Outcome 2 Primary vessel patency." data-id="CD011319-fig-0042" src="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-003-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at two years, Outcome 2 Primary vessel patency. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/references#CD011319-fig-0042">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-003-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011319-fig-0043"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/urn:x-wiley:14651858:media:CD011319:CD011319-CMP-003-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_t/tCD011319-CMP-003-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at two years, Outcome 3 Late lumen loss." data-id="CD011319-fig-0043" src="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-003-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at two years, Outcome 3 Late lumen loss. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/references#CD011319-fig-0043">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-003-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011319-fig-0044"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/urn:x-wiley:14651858:media:CD011319:CD011319-CMP-003-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_t/tCD011319-CMP-003-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at two years, Outcome 4 Target lesion revascularization." data-id="CD011319-fig-0044" src="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-003-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.4</div> <div class="figure-caption"> <p>Comparison 3 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at two years, Outcome 4 Target lesion revascularization. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/references#CD011319-fig-0044">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-003-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011319-fig-0045"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/urn:x-wiley:14651858:media:CD011319:CD011319-CMP-003-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_t/tCD011319-CMP-003-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at two years, Outcome 5 Binary restenosis." data-id="CD011319-fig-0045" src="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-003-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.5</div> <div class="figure-caption"> <p>Comparison 3 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at two years, Outcome 5 Binary restenosis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/references#CD011319-fig-0045">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-003-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011319-fig-0046"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/urn:x-wiley:14651858:media:CD011319:CD011319-CMP-003-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_t/tCD011319-CMP-003-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at two years, Outcome 6 Death." data-id="CD011319-fig-0046" src="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-003-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.6</div> <div class="figure-caption"> <p>Comparison 3 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at two years, Outcome 6 Death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/references#CD011319-fig-0046">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-003-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011319-fig-0047"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/urn:x-wiley:14651858:media:CD011319:CD011319-CMP-003-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_t/tCD011319-CMP-003-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at two years, Outcome 7 Change in Rutherford category." data-id="CD011319-fig-0047" src="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-003-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.7</div> <div class="figure-caption"> <p>Comparison 3 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at two years, Outcome 7 Change in Rutherford category. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/references#CD011319-fig-0047">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-003-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011319-fig-0048"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/urn:x-wiley:14651858:media:CD011319:CD011319-CMP-003-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_t/tCD011319-CMP-003-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at two years, Outcome 8 Change in ankle‐brachial index." data-id="CD011319-fig-0048" src="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-003-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.8</div> <div class="figure-caption"> <p>Comparison 3 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at two years, Outcome 8 Change in ankle‐brachial index. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/references#CD011319-fig-0048">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-003-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011319-fig-0049"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/urn:x-wiley:14651858:media:CD011319:CD011319-CMP-003-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_t/tCD011319-CMP-003-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at two years, Outcome 9 Change in quality of life (EQ‐5D)." data-id="CD011319-fig-0049" src="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-003-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.9</div> <div class="figure-caption"> <p>Comparison 3 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at two years, Outcome 9 Change in quality of life (EQ‐5D). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/references#CD011319-fig-0049">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-003-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011319-fig-0050"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/urn:x-wiley:14651858:media:CD011319:CD011319-CMP-003-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_t/tCD011319-CMP-003-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at two years, Outcome 10 Change in walking impairment score." data-id="CD011319-fig-0050" src="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-003-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.10</div> <div class="figure-caption"> <p>Comparison 3 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at two years, Outcome 10 Change in walking impairment score. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/references#CD011319-fig-0050">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-003-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011319-fig-0051"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/urn:x-wiley:14651858:media:CD011319:CD011319-CMP-003-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_t/tCD011319-CMP-003-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at two years, Outcome 11 Amputation (sensitivity analysis)." data-id="CD011319-fig-0051" src="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-003-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.11</div> <div class="figure-caption"> <p>Comparison 3 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at two years, Outcome 11 Amputation (sensitivity analysis). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/references#CD011319-fig-0051">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-003-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011319-fig-0052"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/urn:x-wiley:14651858:media:CD011319:CD011319-CMP-003-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_t/tCD011319-CMP-003-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at two years, Outcome 12 Death (sensitivity analysis)." data-id="CD011319-fig-0052" src="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-003-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.12</div> <div class="figure-caption"> <p>Comparison 3 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at two years, Outcome 12 Death (sensitivity analysis). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/references#CD011319-fig-0052">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-003-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011319-fig-0053"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/urn:x-wiley:14651858:media:CD011319:CD011319-CMP-004-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_t/tCD011319-CMP-004-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at five years, Outcome 1 Amputation." data-id="CD011319-fig-0053" src="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-004-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at five years, Outcome 1 Amputation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/references#CD011319-fig-0053">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-004-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011319-fig-0054"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/urn:x-wiley:14651858:media:CD011319:CD011319-CMP-004-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_t/tCD011319-CMP-004-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at five years, Outcome 2 Target lesion revascularization." data-id="CD011319-fig-0054" src="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-004-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at five years, Outcome 2 Target lesion revascularization. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/references#CD011319-fig-0054">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-004-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011319-fig-0055"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/urn:x-wiley:14651858:media:CD011319:CD011319-CMP-004-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_t/tCD011319-CMP-004-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at five years, Outcome 3 Binary restenosis." data-id="CD011319-fig-0055" src="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-004-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.3</div> <div class="figure-caption"> <p>Comparison 4 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at five years, Outcome 3 Binary restenosis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/references#CD011319-fig-0055">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-004-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011319-fig-0056"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/urn:x-wiley:14651858:media:CD011319:CD011319-CMP-004-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_t/tCD011319-CMP-004-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at five years, Outcome 4 Death." data-id="CD011319-fig-0056" src="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-004-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.4</div> <div class="figure-caption"> <p>Comparison 4 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at five years, Outcome 4 Death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/references#CD011319-fig-0056">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-004-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011319-fig-0057"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/urn:x-wiley:14651858:media:CD011319:CD011319-CMP-005-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_t/tCD011319-CMP-005-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at six months: arterial segment subgroup analysis, Outcome 1 Amputation." data-id="CD011319-fig-0057" src="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-005-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at six months: arterial segment subgroup analysis, Outcome 1 Amputation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/references#CD011319-fig-0057">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-005-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011319-fig-0058"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/urn:x-wiley:14651858:media:CD011319:CD011319-CMP-005-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_t/tCD011319-CMP-005-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at six months: arterial segment subgroup analysis, Outcome 2 Late lumen loss." data-id="CD011319-fig-0058" src="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-005-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.2</div> <div class="figure-caption"> <p>Comparison 5 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at six months: arterial segment subgroup analysis, Outcome 2 Late lumen loss. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/references#CD011319-fig-0058">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-005-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011319-fig-0059"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/urn:x-wiley:14651858:media:CD011319:CD011319-CMP-005-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_t/tCD011319-CMP-005-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at six months: arterial segment subgroup analysis, Outcome 3 Target lesion revascularization." data-id="CD011319-fig-0059" src="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-005-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.3</div> <div class="figure-caption"> <p>Comparison 5 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at six months: arterial segment subgroup analysis, Outcome 3 Target lesion revascularization. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/references#CD011319-fig-0059">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-005-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011319-fig-0060"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/urn:x-wiley:14651858:media:CD011319:CD011319-CMP-005-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_t/tCD011319-CMP-005-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at six months: arterial segment subgroup analysis, Outcome 4 Binary restenosis." data-id="CD011319-fig-0060" src="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-005-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.4</div> <div class="figure-caption"> <p>Comparison 5 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at six months: arterial segment subgroup analysis, Outcome 4 Binary restenosis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/references#CD011319-fig-0060">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-005-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011319-fig-0061"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/urn:x-wiley:14651858:media:CD011319:CD011319-CMP-005-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_t/tCD011319-CMP-005-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at six months: arterial segment subgroup analysis, Outcome 5 Death." data-id="CD011319-fig-0061" src="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-005-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.5</div> <div class="figure-caption"> <p>Comparison 5 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at six months: arterial segment subgroup analysis, Outcome 5 Death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/references#CD011319-fig-0061">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-005-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011319-fig-0062"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/urn:x-wiley:14651858:media:CD011319:CD011319-CMP-005-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_t/tCD011319-CMP-005-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at six months: arterial segment subgroup analysis, Outcome 6 Change in Rutherford category." data-id="CD011319-fig-0062" src="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-005-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.6</div> <div class="figure-caption"> <p>Comparison 5 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at six months: arterial segment subgroup analysis, Outcome 6 Change in Rutherford category. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/references#CD011319-fig-0062">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-005-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011319-fig-0063"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/urn:x-wiley:14651858:media:CD011319:CD011319-CMP-005-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_t/tCD011319-CMP-005-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at six months: arterial segment subgroup analysis, Outcome 7 Change in ankle‐brachial index." data-id="CD011319-fig-0063" src="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-005-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.7</div> <div class="figure-caption"> <p>Comparison 5 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at six months: arterial segment subgroup analysis, Outcome 7 Change in ankle‐brachial index. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/references#CD011319-fig-0063">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-005-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011319-fig-0064"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/urn:x-wiley:14651858:media:CD011319:CD011319-CMP-005-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_t/tCD011319-CMP-005-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at six months: arterial segment subgroup analysis, Outcome 8 Amputation (sensitivity analysis)." data-id="CD011319-fig-0064" src="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-005-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.8</div> <div class="figure-caption"> <p>Comparison 5 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at six months: arterial segment subgroup analysis, Outcome 8 Amputation (sensitivity analysis). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/references#CD011319-fig-0064">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-005-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011319-fig-0065"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/urn:x-wiley:14651858:media:CD011319:CD011319-CMP-005-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_t/tCD011319-CMP-005-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at six months: arterial segment subgroup analysis, Outcome 9 Late lumen loss (sensitivity analysis)." data-id="CD011319-fig-0065" src="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-005-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.9</div> <div class="figure-caption"> <p>Comparison 5 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at six months: arterial segment subgroup analysis, Outcome 9 Late lumen loss (sensitivity analysis). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/references#CD011319-fig-0065">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-005-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011319-fig-0066"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/urn:x-wiley:14651858:media:CD011319:CD011319-CMP-005-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_t/tCD011319-CMP-005-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at six months: arterial segment subgroup analysis, Outcome 10 Target lesion revascularization (sensitivity analysis)." data-id="CD011319-fig-0066" src="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-005-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.10</div> <div class="figure-caption"> <p>Comparison 5 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at six months: arterial segment subgroup analysis, Outcome 10 Target lesion revascularization (sensitivity analysis). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/references#CD011319-fig-0066">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-005-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011319-fig-0067"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/urn:x-wiley:14651858:media:CD011319:CD011319-CMP-005-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_t/tCD011319-CMP-005-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at six months: arterial segment subgroup analysis, Outcome 11 Binary restenosis (sensitivity analysis)." data-id="CD011319-fig-0067" src="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-005-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.11</div> <div class="figure-caption"> <p>Comparison 5 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at six months: arterial segment subgroup analysis, Outcome 11 Binary restenosis (sensitivity analysis). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/references#CD011319-fig-0067">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-005-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011319-fig-0068"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/urn:x-wiley:14651858:media:CD011319:CD011319-CMP-005-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_t/tCD011319-CMP-005-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at six months: arterial segment subgroup analysis, Outcome 12 Death (sensitivity analysis)." data-id="CD011319-fig-0068" src="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-005-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.12</div> <div class="figure-caption"> <p>Comparison 5 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at six months: arterial segment subgroup analysis, Outcome 12 Death (sensitivity analysis). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/references#CD011319-fig-0068">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-005-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011319-fig-0069"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/urn:x-wiley:14651858:media:CD011319:CD011319-CMP-005-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_t/tCD011319-CMP-005-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at six months: arterial segment subgroup analysis, Outcome 13 Change in ankle‐brachial index (sensitivity analysis)." data-id="CD011319-fig-0069" src="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-005-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.13</div> <div class="figure-caption"> <p>Comparison 5 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at six months: arterial segment subgroup analysis, Outcome 13 Change in ankle‐brachial index (sensitivity analysis). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/references#CD011319-fig-0069">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-005-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011319-fig-0070"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/urn:x-wiley:14651858:media:CD011319:CD011319-CMP-006-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_t/tCD011319-CMP-006-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at twelve months: arterial segment subgroup analysis, Outcome 1 Amputation." data-id="CD011319-fig-0070" src="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-006-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.1</div> <div class="figure-caption"> <p>Comparison 6 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at twelve months: arterial segment subgroup analysis, Outcome 1 Amputation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/references#CD011319-fig-0070">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-006-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011319-fig-0071"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/urn:x-wiley:14651858:media:CD011319:CD011319-CMP-006-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_t/tCD011319-CMP-006-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at twelve months: arterial segment subgroup analysis, Outcome 2 Late lumen loss." data-id="CD011319-fig-0071" src="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-006-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.2</div> <div class="figure-caption"> <p>Comparison 6 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at twelve months: arterial segment subgroup analysis, Outcome 2 Late lumen loss. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/references#CD011319-fig-0071">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-006-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011319-fig-0072"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/urn:x-wiley:14651858:media:CD011319:CD011319-CMP-006-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_t/tCD011319-CMP-006-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at twelve months: arterial segment subgroup analysis, Outcome 3 Target lesion revascularization." data-id="CD011319-fig-0072" src="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-006-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.3</div> <div class="figure-caption"> <p>Comparison 6 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at twelve months: arterial segment subgroup analysis, Outcome 3 Target lesion revascularization. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/references#CD011319-fig-0072">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-006-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011319-fig-0073"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/urn:x-wiley:14651858:media:CD011319:CD011319-CMP-006-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_t/tCD011319-CMP-006-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at twelve months: arterial segment subgroup analysis, Outcome 4 Binary restenosis." data-id="CD011319-fig-0073" src="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-006-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.4</div> <div class="figure-caption"> <p>Comparison 6 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at twelve months: arterial segment subgroup analysis, Outcome 4 Binary restenosis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/references#CD011319-fig-0073">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-006-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011319-fig-0074"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/urn:x-wiley:14651858:media:CD011319:CD011319-CMP-006-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_t/tCD011319-CMP-006-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at twelve months: arterial segment subgroup analysis, Outcome 5 Death." data-id="CD011319-fig-0074" src="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-006-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.5</div> <div class="figure-caption"> <p>Comparison 6 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at twelve months: arterial segment subgroup analysis, Outcome 5 Death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/references#CD011319-fig-0074">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-006-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011319-fig-0075"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/urn:x-wiley:14651858:media:CD011319:CD011319-CMP-006-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_t/tCD011319-CMP-006-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at twelve months: arterial segment subgroup analysis, Outcome 6 Change in Rutherford category." data-id="CD011319-fig-0075" src="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-006-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.6</div> <div class="figure-caption"> <p>Comparison 6 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at twelve months: arterial segment subgroup analysis, Outcome 6 Change in Rutherford category. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/references#CD011319-fig-0075">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-006-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011319-fig-0076"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/urn:x-wiley:14651858:media:CD011319:CD011319-CMP-006-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_t/tCD011319-CMP-006-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at twelve months: arterial segment subgroup analysis, Outcome 7 Change in ankle‐brachial index." data-id="CD011319-fig-0076" src="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-006-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.7</div> <div class="figure-caption"> <p>Comparison 6 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at twelve months: arterial segment subgroup analysis, Outcome 7 Change in ankle‐brachial index. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/references#CD011319-fig-0076">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-006-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011319-fig-0077"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/urn:x-wiley:14651858:media:CD011319:CD011319-CMP-006-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_t/tCD011319-CMP-006-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at twelve months: arterial segment subgroup analysis, Outcome 8 Change in quality of life (EQ‐5D)." data-id="CD011319-fig-0077" src="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-006-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.8</div> <div class="figure-caption"> <p>Comparison 6 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at twelve months: arterial segment subgroup analysis, Outcome 8 Change in quality of life (EQ‐5D). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/references#CD011319-fig-0077">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-006-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011319-fig-0078"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/urn:x-wiley:14651858:media:CD011319:CD011319-CMP-006-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_t/tCD011319-CMP-006-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at twelve months: arterial segment subgroup analysis, Outcome 9 Amputation (sensitivity analysis)." data-id="CD011319-fig-0078" src="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-006-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.9</div> <div class="figure-caption"> <p>Comparison 6 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at twelve months: arterial segment subgroup analysis, Outcome 9 Amputation (sensitivity analysis). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/references#CD011319-fig-0078">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-006-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011319-fig-0079"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/urn:x-wiley:14651858:media:CD011319:CD011319-CMP-006-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_t/tCD011319-CMP-006-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at twelve months: arterial segment subgroup analysis, Outcome 10 Target lesion revascularization (sensitivity analysis)." data-id="CD011319-fig-0079" src="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-006-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.10</div> <div class="figure-caption"> <p>Comparison 6 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at twelve months: arterial segment subgroup analysis, Outcome 10 Target lesion revascularization (sensitivity analysis). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/references#CD011319-fig-0079">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-006-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011319-fig-0080"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/urn:x-wiley:14651858:media:CD011319:CD011319-CMP-006-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_t/tCD011319-CMP-006-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at twelve months: arterial segment subgroup analysis, Outcome 11 Death (sensitivity analysis)." data-id="CD011319-fig-0080" src="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-006-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.11</div> <div class="figure-caption"> <p>Comparison 6 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at twelve months: arterial segment subgroup analysis, Outcome 11 Death (sensitivity analysis). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/references#CD011319-fig-0080">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-006-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011319-fig-0081"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/urn:x-wiley:14651858:media:CD011319:CD011319-CMP-007-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_t/tCD011319-CMP-007-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at twelve months: severe peripheral arterial disease (PAD) subgroup analysis, Outcome 1 Amputation." data-id="CD011319-fig-0081" src="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-007-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.1</div> <div class="figure-caption"> <p>Comparison 7 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at twelve months: severe peripheral arterial disease (PAD) subgroup analysis, Outcome 1 Amputation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/references#CD011319-fig-0081">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-007-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011319-fig-0082"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/urn:x-wiley:14651858:media:CD011319:CD011319-CMP-007-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_t/tCD011319-CMP-007-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at twelve months: severe peripheral arterial disease (PAD) subgroup analysis, Outcome 2 Late lumen loss." data-id="CD011319-fig-0082" src="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-007-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.2</div> <div class="figure-caption"> <p>Comparison 7 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at twelve months: severe peripheral arterial disease (PAD) subgroup analysis, Outcome 2 Late lumen loss. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/references#CD011319-fig-0082">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-007-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011319-fig-0083"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/urn:x-wiley:14651858:media:CD011319:CD011319-CMP-007-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_t/tCD011319-CMP-007-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at twelve months: severe peripheral arterial disease (PAD) subgroup analysis, Outcome 3 Target lesion revascularization." data-id="CD011319-fig-0083" src="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-007-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.3</div> <div class="figure-caption"> <p>Comparison 7 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at twelve months: severe peripheral arterial disease (PAD) subgroup analysis, Outcome 3 Target lesion revascularization. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/references#CD011319-fig-0083">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-007-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011319-fig-0084"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/urn:x-wiley:14651858:media:CD011319:CD011319-CMP-007-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_t/tCD011319-CMP-007-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at twelve months: severe peripheral arterial disease (PAD) subgroup analysis, Outcome 4 Binary restenosis." data-id="CD011319-fig-0084" src="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-007-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.4</div> <div class="figure-caption"> <p>Comparison 7 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at twelve months: severe peripheral arterial disease (PAD) subgroup analysis, Outcome 4 Binary restenosis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/references#CD011319-fig-0084">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-007-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011319-fig-0085"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/urn:x-wiley:14651858:media:CD011319:CD011319-CMP-007-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_t/tCD011319-CMP-007-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at twelve months: severe peripheral arterial disease (PAD) subgroup analysis, Outcome 5 Death." data-id="CD011319-fig-0085" src="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-007-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.5</div> <div class="figure-caption"> <p>Comparison 7 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at twelve months: severe peripheral arterial disease (PAD) subgroup analysis, Outcome 5 Death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/references#CD011319-fig-0085">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/media/CDSR/CD011319/image_n/nCD011319-CMP-007-05.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD011319-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Drug‐eluting balloon versus uncoated balloon angioplasty at 12 months</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>Drug‐eluting balloon compared to uncoated balloon angioplasty at 12 months</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> people with peripheral arterial disease of the lower limbs<br/> <b>Setting:</b> hospital<br/> <b>Intervention:</b> drug‐eluting balloon angioplasty<br/> <b>Comparison:</b> uncoated balloon angioplasty </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with uncoated balloon angioplasty at 12 months</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with drug‐eluting balloon angioplasty at 12 months</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Amputation</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 1.56<br/> (0.73 to 3.33) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1649<br/> (9 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊕<br/> High <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>14 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>22 per 1000<br/> (10 to 46) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Primary vessel patency</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>OR 1.92<br/> (1.45 to 2.56) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>882<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕⊕<br/> High <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>479 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>638 per 1000<br/> (571 to 702) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>487 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>645 per 1000<br/> (579 to 708) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Target lesion revascularization</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>OR 0.40<br/> (0.31 to 0.51) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>1900<br/> (11 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> Low <sup>1, 2, 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>264 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>126 per 1000<br/> (100 to 155) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>368 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>189 per 1000<br/> (153 to 229) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Binary restenosis</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>OR 0.38<br/> (0.15 to 0.98) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>1094<br/> (4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕⊝<br/> Moderate <sup>1, 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>350 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>170 per 1000<br/> (75 to 346) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>477 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>257 per 1000<br/> (120 to 472) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Death</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>OR 1.09<br/> (0.64 to 1.85) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>1649<br/> (9 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕⊕<br/> High <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>43 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>46 per 1000<br/> (28 to 76) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>45 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>49 per 1000<br/> (29 to 80) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Change in Rutherford category</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in Rutherford category in the intervention group was 0.1 lower (0.29 lower to 0.1 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>623<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> Moderate <sup>1 4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>A positive change in Rutherford category reflects a worsening clinical status, although in this case the difference was not statistically significant </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Change in ankle‐brachial index</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in ankle‐brachial index in the intervention group was 0.03 lower (0.07 lower to 0.01 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>656<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> High <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>A negative change in the ankle‐brachial index reflects a worsening clinical status, although in this case the difference was not statistically significant </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>OR:</b> odds ratio; <b>RCT:</b> randomized controlled trial. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> All of the included trials were at a high risk of performance bias due to lack of blinding of operators. However, because this is an intrinsic limitation to intervention trials, we did not downgrade the GRADE class because of performance bias.<br/> <sup>2</sup> Funnel plot analysis indicated a likely publication bias, which resulted in downgrading of the GRADE class.<br/> <sup>3</sup> There was moderate heterogeneity between the included studies (P &lt; 0.001), which resulted in downgrading of the GRADE class.<br/> <sup>4</sup> There was moderate heterogeneity between the included studies (P = 0.04), which resulted in downgrading of the GRADE class. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Drug‐eluting balloon versus uncoated balloon angioplasty at 12 months</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/full#CD011319-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011319-tbl-0002"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at six months</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Amputation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>541</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.21 [0.39, 3.80]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Primary vessel patency <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>162</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.47 [0.22, 9.57]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Late lumen loss <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>603</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.64 [‐1.00, ‐0.28]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Target lesion revascularization <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>603</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.28 [0.17, 0.47]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Binary restenosis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>528</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.44 [0.29, 0.67]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>541</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.81 [0.31, 2.14]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Change in Rutherford category <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>249</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.07 [‐0.49, 0.36]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Change in ankle‐brachial index <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>369</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.00 [‐0.19, 0.18]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Change in quality of life (EQ‐5D) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Change in walking impairment score <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Amputation (sensitivity analysis) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>322</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.77 [0.42, 7.54]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Primary vessel patency (sensitivity analysis) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Late lumen loss (sensitivity analysis) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>343</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.96 [‐1.21, ‐0.71]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Target lesion revascularization (sensitivity analysis) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>343</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.22 [0.11, 0.44]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15 Binary restenosis (sensitivity analysis) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>268</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.25 [0.13, 0.50]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16 Death (sensitivity analysis) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>322</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.57 [0.15, 2.11]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">17 Change in Rutherford category (sensitivity analysis) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>177</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.04 [‐0.42, 0.50]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">18 Change in ankle‐brachial index (sensitivity analysis) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>177</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.01 [‐0.09, 0.08]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at six months</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/references#CD011319-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011319-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at twelve months</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Amputation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1649</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.56 [0.73, 3.33]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Amputation‐free survival <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Primary vessel patency <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>882</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.92 [1.45, 2.56]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Late lumen loss <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>535</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.73 [‐1.59, 0.13]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Target lesion revascularization <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1900</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.40 [0.31, 0.51]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Binary restenosis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1094</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.38 [0.15, 0.98]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1649</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.04 [0.64, 1.71]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Change in Rutherford category <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>623</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.10 [‐0.29, 0.10]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Change in ankle‐brachial index <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>656</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.03 [‐0.07, 0.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Change in Quality of Life (EQ‐5D) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>879</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.01 [‐0.02, 0.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Change in walking impairment score <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>551</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.57 [‐1.23, 8.38]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Amputation (sensitivity analysis) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1517</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.78 [0.79, 4.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Target lesion revascularization (sensitivity analysis) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1640</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.18, 0.61]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Death (sensitivity analysis) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1517</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.09 [0.64, 1.85]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15 Late lumen loss (sensitivity analysis) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>177</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.10 [‐1.41, ‐0.79]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16 Change in Rutherford category (sensitivity analysis) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>551</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.09 [‐0.58, 0.77]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">17 Change in ankle‐brachial index (sensitivity analysis) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>551</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.01 [‐0.05, 0.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">18 Change in quality of life (EQ‐5D) (sensitivity analysis) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>807</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.02 [‐0.01, 0.05]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at twelve months</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/references#CD011319-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011319-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at two years</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Amputation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>493</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.65 [0.11, 3.88]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Primary vessel patency <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>406</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.51 [2.26, 5.46]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Late lumen loss <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Target lesion revascularization <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>508</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.28 [0.18, 0.44]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Binary restenosis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>595</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.13 [1.08, 4.20]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Change in Rutherford category <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Change in ankle‐brachial index <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Change in quality of life (EQ‐5D) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Change in walking impairment score <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Amputation (sensitivity analysis) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>406</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.16 [0.12, 80.19]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Death (sensitivity analysis) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>508</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.16 [1.00, 4.67]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at two years</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/references#CD011319-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011319-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at five years</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Amputation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Target lesion revascularization <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Binary restenosis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at five years</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/references#CD011319-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011319-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at six months: arterial segment subgroup analysis</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Amputation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Femoropopliteal lesions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>415</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.87 [0.40, 8.75]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Tibial lesions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>72</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.06, 16.63]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Late lumen loss <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Femoropopliteal lesions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>423</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.65 [‐0.86, ‐0.45]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Tibial lesions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>105</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.02 [‐0.23, 0.27]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Target lesion revascularization <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Femoropopliteal lesions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>423</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.22 [0.12, 0.41]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Tibial lesions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>105</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [0.26, 3.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Binary restenosis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Femoropopliteal lesions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>348</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.26 [0.15, 0.46]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Tibial lesions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>105</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.85 [0.78, 4.39]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Femoropopliteal lesions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>415</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.66 [0.22, 1.97]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 Tibial lesions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>72</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.06 [0.18, 23.77]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Change in Rutherford category <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Femoropopliteal lesions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>177</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.04 [‐0.42, 0.50]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 Tibial lesions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>72</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.60 [‐1.64, 0.44]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Change in ankle‐brachial index <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 Femoropopliteal lesions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>264</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.07 [‐0.09, 0.22]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 Tibial lesions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>105</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.2 [‐0.31, ‐0.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Amputation (sensitivity analysis) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 Femoropopliteal lesions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>268</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.47 [0.49, 40.67]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Late lumen loss (sensitivity analysis) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1 Femoropopliteal lesions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>268</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.92 [‐1.27, ‐0.57]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Target lesion revascularization (sensitivity analysis) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.1 Femoropopliteal lesions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>268</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.23 [0.11, 0.48]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Binary restenosis (sensitivity analysis) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.1 Femoropopliteal lesions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>193</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.26 [0.12, 0.57]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Death (sensitivity analysis) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.1 Femoropopliteal lesions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>268</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.57 [0.15, 2.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Change in ankle‐brachial index (sensitivity analysis) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.1 Femoropopliteal lesions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>177</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.01 [‐0.09, 0.08]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at six months: arterial segment subgroup analysis</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/references#CD011319-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011319-tbl-0007"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at twelve months: arterial segment subgroup analysis</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Amputation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Femoropopliteal lesions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1033</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.21 [0.23, 21.51]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Tibial lesions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>562</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.95 [0.78, 4.89]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Late lumen loss <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Femoropopliteal lesions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>102</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.2 [‐1.86, ‐0.54]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Tibial lesions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>358</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.01 [‐0.18, 0.16]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Target lesion revascularization <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Femoropopliteal lesions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1230</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.26 [0.13, 0.56]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Tibial lesions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>595</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.65 [0.30, 1.44]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Binary restenosis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Femoropopliteal lesions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>578</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.37 [0.11, 1.26]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Tibial lesions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>516</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.40 [0.05, 3.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Femoropopliteal lesions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1033</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.67 [0.31, 1.46]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 Tibial lesions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>562</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.41 [0.73, 2.74]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Change in Rutherford category <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Femoropopliteal lesions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>551</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.09 [‐0.58, 0.77]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 Tibial lesions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>72</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.60 [‐0.46, 1.66]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Change in ankle‐brachial index <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 Femoropopliteal lesions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>551</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.01 [‐0.05, 0.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 Tibial lesions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>105</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.2 [‐0.31, ‐0.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Change in quality of life (EQ‐5D) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 Femoropopliteal lesions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>807</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.02 [‐0.01, 0.05]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.2 Tibial lesions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>72</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.10 [‐0.22, 0.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Amputation (sensitivity analysis) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1 Femoropopliteal lesions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>973</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.21 [0.23, 21.51]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.2 Tibial lesions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>490</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.10 [0.79, 5.59]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Target lesion revascularization (sensitivity analysis) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.1 Femoropopliteal lesions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1075</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.28 [0.10, 0.73]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.2 Tibial lesions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>490</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.52 [0.18, 1.52]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Death (sensitivity analysis) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.1 Femoropopliteal lesions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>973</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.77 [0.34, 1.73]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.2 Tibial lesions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>490</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.40 [0.69, 2.83]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at twelve months: arterial segment subgroup analysis</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/references#CD011319-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011319-tbl-0008"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at twelve months: severe peripheral arterial disease (PAD) subgroup analysis</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Amputation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>490</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.10 [0.79, 5.59]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Late lumen loss <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Target lesion revascularization <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>490</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.52 [0.18, 1.52]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Binary restenosis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>516</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.40 [0.05, 3.14]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>490</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.40 [0.69, 2.83]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at twelve months: severe peripheral arterial disease (PAD) subgroup analysis</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011319.pub2/references#CD011319-tbl-0008">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD011319.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD011319-note-0002">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD011319-note-0003">فارسی</a> </li> <li class="section-language"> <a class="" href="ru#CD011319-note-0001">Русский</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD011319-note-0008">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011319\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011319\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011319\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011319\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011319\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011319\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011319\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011319\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011319\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011319\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011319\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011319\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011319\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011319\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011319\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011319\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011319\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011319\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=p32VIvbS&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011319.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD011319.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD011319.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD011319.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011319.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740725878347"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD011319.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740725878351"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD011319.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918e85fc3bf19371',t:'MTc0MDcyNTg3OC4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 